|
G |
A2m |
alpha-2-macroglobulin |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of A2M mRNA ochratoxin A results in decreased expression of A2M mRNA |
CTD |
PMID:12700408 PMID:30008028 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aadac |
arylacetamide deacetylase |
affects expression |
EXP |
ochratoxin A affects the expression of AADAC mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
|
|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABAT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Abca8 |
ATP binding cassette subfamily A member 8 |
affects transport multiple interactions |
ISO |
ABCA8 protein affects the transport of ochratoxin A ochratoxin A inhibits the reaction [ABCA8 protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:12379217 |
|
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABCB11 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABCB1A mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
EXP |
ochratoxin A results in increased expression of ABCB1B mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ABCB6 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions affects export affects transport decreases expression increases expression |
ISO EXP |
biochanin A inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; chrysin inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Genistein inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Polyphenols inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Polyphenols metabolite inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Quercetin inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; resveratrol inhibits the reaction [ABCC2 protein affects the export of ochratoxin A] ABCC2 protein affects the transport of ochratoxin A ochratoxin A results in decreased expression of ABCC2 mRNA ochratoxin A results in increased expression of ABCC2 mRNA |
CTD |
PMID:15955639 PMID:16251485 PMID:19505989 PMID:23358140 PMID:26505656 PMID:28532671 PMID:29126803 More...
|
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ABCG1 mRNA; ochratoxin A results in decreased expression of ABCG1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
affects response to substance decreases transport affects transport decreases response to substance decreases expression increases expression increases transport |
ISO EXP |
ABCG2 protein affects the susceptibility to ochratoxin A ABCG2 protein results in decreased transport of ochratoxin A ABCG2 protein affects the transport of ochratoxin A ABCG2 protein results in decreased susceptibility to ochratoxin A ochratoxin A results in decreased expression of ABCG2 mRNA ochratoxin A results in increased expression of ABCG2 mRNA ABCG2 protein results in increased transport of ochratoxin A |
CTD |
PMID:28532671 PMID:29126803 PMID:32470353 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg4 |
ATP binding cassette subfamily G member 4 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of ABCG4 gene ochratoxin A results in increased expression of ABCG4 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
|
|
G |
Abhd14a |
abhydrolase domain containing 14A |
increases expression |
EXP |
ochratoxin A results in increased expression of ABHD14A mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:107,079,139...107,089,004
Ensembl chr 8:107,079,144...107,086,985
|
|
G |
Abhd3 |
abhydrolase domain containing 3, phospholipase |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of ABHD3 mRNA ochratoxin A results in increased methylation of ABHD3 gene |
CTD |
PMID:37162024 |
|
NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
|
|
G |
Abi3 |
ABI family, member 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ABI3 mRNA; ochratoxin A results in decreased expression of ABI3 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:80,769,819...80,780,816
Ensembl chr10:80,769,822...80,780,816
|
|
G |
Abraxas1 |
abraxas 1, BRCA1 A complex subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABRAXAS1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:8,796,281...8,810,625
Ensembl chr14:8,796,266...8,810,622
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of ACAA1 mRNA ochratoxin A results in decreased expression of ACAA1A mRNA |
CTD |
PMID:12700408 PMID:19287073 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acp4 |
acid phosphatase 4 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of ACP4 gene ochratoxin A results in increased expression of ACP4 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:94,736,376...94,751,871
Ensembl chr 1:94,735,514...94,744,623
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ACSL1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
increases methylation decreases expression |
EXP |
ochratoxin A results in increased methylation of ACSS1 gene ochratoxin A results in decreased expression of ACSS1 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ACSS2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of ACTA2 protein Ethanol affects the reaction [ochratoxin A results in increased expression of ACTA2 protein] 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of ACTA2 protein]; [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 protein; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein] ochratoxin A results in increased expression of ACTA2 mRNA; ochratoxin A results in increased expression of ACTA2 protein |
CTD |
PMID:16622519 PMID:29673704 PMID:32617660 PMID:33543323 PMID:35543154 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
ochratoxin A results in increased expression of ACTB protein |
CTD |
PMID:31276768 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actn1 |
actinin, alpha 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ACTN1 mRNA; ochratoxin A results in increased expression of ACTN1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Acvr2a |
activin A receptor type 2A |
increases expression |
EXP |
ochratoxin A results in increased expression of ACVR2A mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 3:33,204,961...33,292,673
Ensembl chr 3:33,205,523...33,289,968
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ACY1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ADH1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh6 |
alcohol dehydrogenase 6 (class V) |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ADH6 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
|
|
G |
Adm |
adrenomedullin |
increases expression |
EXP |
ochratoxin A results in increased expression of ADM mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora2a |
adenosine A2a receptor |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of ADORA2A promoter |
CTD |
PMID:29098329 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Afp |
alpha-fetoprotein |
increases expression |
ISO |
ochratoxin A results in increased expression of AFP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Aggf1 |
angiogenic factor with G patch and FHA domains 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AGGF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:26,619,336...26,646,050
Ensembl chr 2:26,619,339...26,645,952
|
|
G |
Agt |
angiotensinogen |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AGT mRNA |
CTD |
PMID:16251485 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression affects localization multiple interactions |
ISO |
ochratoxin A results in increased expression of AHR mRNA ochratoxin A affects the localization of AHR protein AHR protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA]; AHR protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; AHR protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; AHR protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:21834667 PMID:30291945 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions decreases expression |
ISO |
BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of AIFM1 mRNA] |
CTD |
PMID:24755393 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of AIMP1 mRNA; ochratoxin A results in increased expression of AIMP1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Ak1 |
adenylate kinase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of AK1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
|
|
G |
Ak2 |
adenylate kinase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of AK2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
increases expression |
EXP |
ochratoxin A results in increased expression of AKAP12 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akap17a |
A-kinase anchoring protein 17A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AKAP17B mRNA |
CTD |
PMID:30449730 |
|
NCBI chr12:16,310,427...16,315,166
Ensembl chr12:16,310,437...16,314,479
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AKR1A1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
ochratoxin A results in increased expression of AKR1B1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of AKR1B10 mRNA |
CTD |
PMID:18417182 PMID:32905824 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AKR1B7 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AKR1C1 mRNA |
CTD |
PMID:19287073 PMID:32905824 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of AKR1C2 mRNA |
CTD |
PMID:19287073 PMID:30449730 PMID:32905824 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AKR1C3 mRNA |
CTD |
PMID:19287073 PMID:32905824 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
multiple interactions decreases expression |
EXP |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of AKR7A3 protein] ochratoxin A results in decreased expression of AKR7A3 mRNA; ochratoxin A results in decreased expression of AKR7A3 protein |
CTD |
PMID:16251485 PMID:17110534 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases expression increases phosphorylation multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of AKT1 mRNA ochratoxin A results in increased phosphorylation of AKT1 protein 5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one inhibits the reaction [ochratoxin A results in increased phosphorylation of AKT1 protein]; INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [ochratoxin A results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:16251485 PMID:23172667 PMID:25002221 PMID:30287338 PMID:31154016 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ALAD mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alb |
albumin |
affects binding decreases transport |
EXP ISO |
ochratoxin A binds to ALB protein ALB protein results in decreased transport of ochratoxin A |
CTD |
PMID:10454219 PMID:22037670 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ALDH1A1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ALDH1A2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of ALDH3A2 mRNA ochratoxin A results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:16251485 PMID:32905824 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ALDH4A1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of ALDH7A1 promoter |
CTD |
PMID:29098329 |
|
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ALDH8A1 mRNA; ochratoxin A results in increased expression of ALDH8A1 mRNA |
CTD |
PMID:23824090 PMID:24356939 |
|
NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385
|
|
G |
Alg13 |
ALG13, UDP-N-acetylglucosaminyltransferase subunit |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ALG13 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:107,906,320...107,968,232
Ensembl chr X:107,885,093...107,942,695
|
|
G |
Alox15b |
arachidonate 15-lipoxygenase, type B |
increases expression |
EXP |
ochratoxin A results in increased expression of ALOX15B mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:53,892,496...53,901,812
Ensembl chr10:53,892,466...53,901,812
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
affects expression decreases expression |
ISO |
ochratoxin A affects the expression of ALOX5 mRNA ochratoxin A results in decreased expression of ALOX5 mRNA |
CTD |
PMID:26505656 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
ochratoxin A results in increased expression of ALPL protein |
CTD |
PMID:35543154 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases acetylation multiple interactions decreases expression affects expression |
ISO |
ochratoxin A results in decreased acetylation of AMIGO2 promoter [ochratoxin A results in decreased acetylation of AMIGO2 promoter] which results in decreased expression of AMIGO2 mRNA ochratoxin A results in decreased expression of AMIGO2 mRNA ochratoxin A affects the expression of AMIGO2 mRNA |
CTD |
PMID:29098329 PMID:30008028 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Amotl2 |
angiomotin like 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AMOTL2 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
|
|
G |
Ang |
angiogenin |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ANG mRNA; ochratoxin A results in decreased expression of ANG mRNA |
CTD |
PMID:26314263 |
|
NCBI chr15:24,312,711...24,323,361
|
|
G |
Angpt1 |
angiopoietin 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANGPT1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Ankrd2 |
ankyrin repeat domain 2 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of ANKRD2 mRNA ochratoxin A results in decreased methylation of ANKRD2 gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:240,847,111...240,856,563
Ensembl chr 1:240,847,072...240,856,566
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
ISO |
ochratoxin A results in increased expression of ANLN mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Ano6 |
anoctamin 6 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of ANO6 gene |
CTD |
PMID:26431795 |
|
NCBI chr 7:126,933,919...127,113,588
Ensembl chr 7:126,933,936...127,113,589
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANXA1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa13 |
annexin A13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ANXA13 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
|
|
G |
Anxa2 |
annexin A2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANXA2 mRNA |
CTD |
PMID:12700408 PMID:18417182 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa3 |
annexin A3 |
increases expression decreases methylation |
EXP ISO |
ochratoxin A results in increased expression of ANXA3 mRNA ochratoxin A results in increased expression of ANXA3 mRNA; ochratoxin A results in increased expression of ANXA3 protein ochratoxin A results in decreased methylation of ANXA3 gene |
CTD |
PMID:18417182 PMID:31276768 PMID:37162024 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa4 |
annexin A4 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANXA4 protein |
CTD |
PMID:31369848 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of AOC3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:86,272,757...86,280,702
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of APAF1 mRNA ochratoxin A results in decreased expression of APAF1 mRNA [fumonisin B1 co-treated with ochratoxin A] results in increased expression of APAF1 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 mRNA] |
CTD |
PMID:17316727 PMID:19562491 PMID:36397609 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APEX1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Aplf |
aprataxin and PNKP like factor |
increases expression |
EXP |
ochratoxin A results in increased expression of APLF mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Apoa4 |
apolipoprotein A4 |
increases expression |
EXP |
ochratoxin A results in increased expression of APOA4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apob |
apolipoprotein B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APOB mRNA |
CTD |
PMID:16251485 PMID:19717638 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc1 |
apolipoprotein C1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APOC1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apoe |
apolipoprotein E |
increases expression |
EXP |
ochratoxin A results in increased expression of APOE mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
ISO |
ochratoxin A results in increased expression of APP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Appbp2 |
amyloid beta precursor protein binding protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of APPBP2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:70,057,774...70,099,877
Ensembl chr10:70,057,774...70,099,835
|
|
G |
Aptx |
aprataxin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APTX mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:55,798,896...55,822,963
Ensembl chr 5:55,800,248...55,822,855
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AQP1 mRNA |
CTD |
PMID:16251485 PMID:18417182 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp8 |
aquaporin 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AQP8 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
|
|
G |
Ar |
androgen receptor |
decreases activity |
ISO |
ochratoxin A results in decreased activity of AR protein |
CTD |
PMID:27481073 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arap2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of ARAP2 gene |
CTD |
PMID:26431795 |
|
NCBI chr14:46,717,657...46,917,326
Ensembl chr14:46,718,760...46,917,154
|
|
G |
Arfgap2 |
ADP-ribosylation factor GTPase activating protein 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ARFGAP2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:77,236,305...77,248,445
Ensembl chr 3:77,236,322...77,248,455
|
|
G |
Arfgef1 |
ADP ribosylation factor guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARFGEF1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 5:8,982,061...9,076,326
Ensembl chr 5:8,981,540...9,076,326
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARG1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap35 |
Rho GTPase activating protein 35 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ARHGAP35 mRNA; ochratoxin A results in decreased expression of ARHGAP35 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
|
|
G |
Arl4c |
ADP ribosylation factor like GTPase 4C |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARL4C mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
|
|
G |
Arl5a |
ADP-ribosylation factor like GTPase 5A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARL5A mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:36,878,461...36,903,362
Ensembl chr 3:36,880,712...36,903,211
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ARRDC3 mRNA; ochratoxin A results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ASB13 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr17:66,564,653...66,583,365
Ensembl chr17:66,562,434...66,583,337
|
|
G |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of ASCL1 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of ASCL1 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of ASIC1 promoter ochratoxin A results in increased expression of ASIC1 mRNA [ochratoxin A results in increased acetylation of ASIC1 promoter] which results in increased expression of ASIC1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Asl |
argininosuccinate lyase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ASL mRNA |
CTD |
PMID:12700408 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ASNS mRNA; ochratoxin A results in decreased expression of ASNS mRNA |
CTD |
PMID:24356939 PMID:30559759 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Aspa |
aspartoacylase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ASPA mRNA |
CTD |
PMID:12700408 |
|
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
multiple interactions decreases expression decreases acetylation |
ISO |
[ochratoxin A results in decreased acetylation of ASXL1 promoter] which results in decreased expression of ASXL1 mRNA ochratoxin A results in decreased expression of ASXL1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
|
|
G |
Atf3 |
activating transcription factor 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ATF3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
decreases expression increases expression |
ISO |
ochratoxin A results in decreased expression of ATF4 mRNA ochratoxin A results in increased expression of ATF4 protein |
CTD |
PMID:30559759 PMID:33465424 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
ISO |
ochratoxin A results in increased expression of ATF6 mRNA; ochratoxin A results in increased expression of ATF6 protein |
CTD |
PMID:30559759 PMID:36058351 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atp1a4 |
ATPase Na+/K+ transporting subunit alpha 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ATP1A4 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr13:84,683,766...84,719,790
Ensembl chr13:84,683,768...84,719,687
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of ATP2A2 mRNA ochratoxin A results in decreased expression of ATP2A2 mRNA |
CTD |
PMID:16251485 PMID:19287073 PMID:22124623 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp2c1 |
ATPase secretory pathway Ca2+ transporting 1 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of ATP2C1 promoter] which results in increased expression of ATP2C1 mRNA ochratoxin A results in increased expression of ATP2C1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of ATP5F1A protein |
CTD |
PMID:31369848 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
increases expression |
ISO |
ochratoxin A results in increased expression of ATP5F1B mRNA ochratoxin A results in increased expression of ATP5F1B protein |
CTD |
PMID:17316727 PMID:19445961 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
increases expression decreases expression |
ISO EXP |
ochratoxin A results in increased expression of ATP5F1D mRNA ochratoxin A results in decreased expression of ATP5F1D protein |
CTD |
PMID:17316727 PMID:31369848 |
|
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
increases expression |
ISO |
ochratoxin A results in increased expression of ATP5PF mRNA |
CTD |
PMID:17316727 |
|
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Atp6v0c |
ATPase H+ transporting V0 subunit C |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of ATP6V0C promoter] which results in increased expression of ATP6V0C mRNA ochratoxin A results in increased expression of ATP6V0C mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:13,196,204...13,202,580
Ensembl chr10:13,196,204...13,201,500
|
|
G |
Atp9a |
ATPase phospholipid transporting 9A (putative) |
increases expression |
EXP |
ochratoxin A results in increased expression of ATP9A mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 3:157,360,354...157,467,628
Ensembl chr 3:157,360,359...157,467,818
|
|
G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of ATPAF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:129,265,789...129,292,463
Ensembl chr 5:129,266,404...129,293,556
|
|
G |
Aurka |
aurora kinase A |
multiple interactions increases expression |
ISO |
TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of AURKA mRNA] |
CTD |
PMID:25636497 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
increases activity increases expression |
EXP |
ochratoxin A results in increased activity of AURKB protein ochratoxin A results in increased expression of AURKB mRNA |
CTD |
PMID:19237604 PMID:19717638 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Avil |
advillin |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of AVIL mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AZGP1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
Azi2 |
5-azacytidine induced 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of AZI2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:117,773,248...117,797,844
Ensembl chr 8:117,773,279...117,797,847
|
|
G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of B3GNT2 mRNA ochratoxin A results in increased expression of B3GNT2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr14:96,808,473...96,833,674
Ensembl chr14:96,806,664...96,835,273
|
|
G |
B4galt7 |
beta-1,4-galactosyltransferase 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of B4GALT7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr17:9,018,514...9,027,591
Ensembl chr17:9,018,935...9,027,573
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BAAT mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of BAD mRNA BNIP3L protein inhibits the reaction [ochratoxin A results in increased expression of BAD mRNA] |
CTD |
PMID:19562491 PMID:24755393 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bag3 |
BAG cochaperone 3 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of BAG3 mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of BAG3 mRNA ochratoxin A results in decreased expression of BAG3 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of BAK1 mRNA ochratoxin A results in decreased expression of BAK1 mRNA; ochratoxin A results in decreased expression of BAK1 protein [Citrinin co-treated with ochratoxin A] results in decreased expression of BAK1 mRNA |
CTD |
PMID:19367635 PMID:23358140 PMID:30428381 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BARD1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression increases response to substance increases expression affects localization multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of BAX mRNA; ochratoxin A results in decreased expression of BAX protein BAX protein results in increased susceptibility to ochratoxin A ochratoxin A results in increased expression of BAX mRNA; ochratoxin A results in increased expression of BAX protein ochratoxin A affects the localization of BAX protein [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of BAX protein; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of BAX mRNA]; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of BAX protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein] [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX mRNA] |
CTD |
PMID:19367635 PMID:20549612 PMID:23208426 PMID:24755393 PMID:31154016 PMID:33465424 PMID:34101318 PMID:34126166 PMID:36397609 PMID:36587836 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of BBC3 mRNA; ochratoxin A results in decreased expression of BBC3 protein ochratoxin A results in increased expression of BBC3 mRNA [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of BBC3 protein; ochratoxin A promotes the reaction [NFE2L2 protein affects the expression of BBC3 mRNA]; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of BBC3 mRNA] |
CTD |
PMID:19367635 PMID:23208426 PMID:28710020 PMID:30763683 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
affects expression |
ISO |
ochratoxin A affects the expression of BBOX1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of BCAM mRNA ochratoxin A results in decreased methylation of BCAM gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BCKDK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression decreases response to substance increases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of BCL2 mRNA BCL2 protein results in decreased susceptibility to ochratoxin A ochratoxin A results in decreased expression of BCL2 mRNA; ochratoxin A results in decreased expression of BCL2 protein ochratoxin A results in increased expression of BCL2 mRNA [Aflatoxin M1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein; Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein]; TRAP1 protein affects the reaction [ochratoxin A results in decreased expression of BCL2 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein] fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein] |
CTD |
PMID:12700408 PMID:20549612 PMID:23208426 PMID:24755393 PMID:33465424 PMID:34101318 PMID:34126166 PMID:36397609 PMID:36587836 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
EXP |
ochratoxin A results in increased expression of BCL2A1 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression decreases response to substance increases expression |
ISO EXP |
ochratoxin A results in decreased expression of BCL2L1 mRNA; ochratoxin A results in decreased expression of BCL2L1 protein BCL2L1 protein results in decreased susceptibility to ochratoxin A ochratoxin A results in increased expression of BCL2L1 mRNA |
CTD |
PMID:15056805 PMID:20549612 PMID:23208426 PMID:24755393 PMID:30763683 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:30559759 PMID:30763683 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl2l12 |
Bcl2 like 12 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of BCL2L12 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of BCL2L12 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:95,472,272...95,480,991
Ensembl chr 1:95,472,272...95,480,991
|
|
G |
Bcl6 |
BCL6, transcription repressor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BCL6 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of BDH2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
EXP |
ochratoxin A results in increased expression of BDNF mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of BECN1 protein 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of BECN1 protein] |
CTD |
PMID:36058351 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bex1 |
brain expressed X-linked 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BEX2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BHMT mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BID mRNA |
CTD |
PMID:24755393 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
EXP |
ochratoxin A results in increased expression of BIK mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of BIRC3 mRNA; ochratoxin A results in decreased expression of BIRC3 mRNA |
CTD |
PMID:24356939 PMID:30763683 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of BIRC5 mRNA; ochratoxin A results in increased expression of BIRC5 protein ochratoxin A results in decreased expression of BIRC5 mRNA |
CTD |
PMID:19237604 PMID:19562491 PMID:27193732 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blcap |
BLCAP, apoptosis inducing factor |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BLCAP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:146,222,699...146,232,859
Ensembl chr 3:146,222,240...146,232,909
|
|
G |
Blvra |
biliverdin reductase A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BLVRA mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
|
|
G |
Blvrb |
biliverdin reductase B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BLVRB mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of BMP4 promoter ochratoxin A results in increased expression of BMP4 mRNA [ochratoxin A results in increased acetylation of BMP4 promoter] which results in increased expression of BMP4 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bnip2 |
BCL2 interacting protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of BNIP2 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 8:70,640,436...70,661,782
Ensembl chr 8:70,640,445...70,675,590
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of BNIP3 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
multiple interactions increases response to substance |
ISO |
BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of AIFM1 mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of BAX mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA protein]; BNIP3L protein inhibits the reaction [ochratoxin A results in increased expression of BAD mRNA]; BNIP3L protein promotes the reaction [ochratoxin A results in decreased expression of CASP9 mRNA] BNIP3L protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:24755393 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
EXP |
ochratoxin A results in increased expression of BRCA1 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brcc3 |
BRCA1/BRCA2-containing complex subunit 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BRCC3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:1,986,942...1,989,484
Ensembl chr 9:1,986,575...1,991,080
|
|
G |
Brd4 |
bromodomain containing 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of BRD4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Brf1 |
BRF1, RNA polymerase III transcription initiation factor subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BRF1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 6:132,034,378...132,081,313
Ensembl chr 6:132,037,272...132,081,278
|
|
G |
Brip1 |
BRCA1 interacting helicase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of BRIP1 mRNA |
CTD |
PMID:23358140 PMID:24243707 |
|
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
Bsnd |
barttin CLCNK type accessory subunit beta |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of BSND mRNA ochratoxin A results in decreased methylation of BSND gene |
CTD |
PMID:37162024 |
|
NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:121,251,774...121,260,571
|
|
G |
Btg1 |
BTG anti-proliferation factor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BTG1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
increases expression |
EXP |
ochratoxin A results in increased expression of BUB1B mRNA |
CTD |
PMID:19237604 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C1qa |
complement C1q A chain |
affects expression |
EXP |
ochratoxin A affects the expression of C1QA mRNA |
CTD |
PMID:32468156 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qb |
complement C1q B chain |
increases expression |
EXP |
ochratoxin A results in increased expression of C1QB mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C2h3orf33 |
similar to human chromosome 3 open reading frame 33 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of C2H3ORF33 mRNA ochratoxin A results in increased methylation of C2H3ORF33 gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:148,376,598...148,404,343
Ensembl chr 2:148,380,581...148,404,387
|
|
G |
C2h5orf34 |
similar to human chromosome 5 open reading frame 34 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of C2H5ORF34 mRNA ochratoxin A results in increased methylation of C2H5ORF34 gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:51,553,223...51,577,090
Ensembl chr 2:51,555,432...51,577,085
|
|
G |
C8h15orf39 |
similar to human chromosome 15 open reading frame 39 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of C15ORF39 mRNA; ochratoxin A results in decreased expression of C15ORF39 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
|
|
G |
C9 |
complement C9 |
increases expression |
ISO |
ochratoxin A results in increased expression of C9 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
|
|
G |
Cabp1 |
calcium binding protein 1 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of CABP1 promoter] which results in increased expression of CABP1 mRNA ochratoxin A results in increased expression of CABP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927
|
|
G |
Cacng5 |
calcium voltage-gated channel auxiliary subunit gamma 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CACNG5 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:92,827,441...92,869,632
Ensembl chr10:92,829,196...92,869,614
|
|
G |
Calb1 |
calbindin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CALB1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
|
|
G |
Calm1 |
calmodulin 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CALM1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of CAMK2A mRNA |
CTD |
PMID:19237604 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
EXP |
ochratoxin A results in increased expression of CAMK2B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Capn6 |
calpain 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CAPN6 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:107,380,774...107,405,489
Ensembl chr X:107,380,774...107,405,489
|
|
G |
Capza1 |
capping actin protein of muscle Z-line subunit alpha 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CAPZA1 protein |
CTD |
PMID:31276768 |
|
NCBI chr 2:192,319,696...192,364,755
Ensembl chr 2:192,319,702...192,364,480
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of CAPZB promoter ochratoxin A results in increased expression of CAPZB mRNA [ochratoxin A results in increased acetylation of CAPZB promoter] which results in increased expression of CAPZB mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
|
|
G |
Car10 |
carbonic anhydrase 10 |
increases expression |
ISO |
ochratoxin A results in increased expression of CA10 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:78,055,875...78,556,490
Ensembl chr10:78,054,114...78,555,834
|
|
G |
Casp1 |
caspase 1 |
increases expression increases cleavage |
ISO |
ochratoxin A results in increased expression of CASP1 mRNA ochratoxin A results in increased cleavage of CASP1 protein |
CTD |
PMID:33543323 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
increases expression |
EXP |
ochratoxin A results in increased expression of CASP12 mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp2 |
caspase 2 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CASP2 mRNA ochratoxin A results in decreased expression of CASP2 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases cleavage decreases expression multiple interactions increases activity increases expression |
ISO EXP |
ochratoxin A results in increased cleavage of CASP3 protein ochratoxin A results in decreased expression of CASP3 mRNA [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of CASP3 protein; Citrinin inhibits the reaction [ochratoxin A results in increased activity of CASP3 protein]; ochratoxin A results in increased cleavage of and results in increased activity of CASP3 protein; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [ochratoxin A results in increased activity of CASP3 protein]; Wortmannin promotes the reaction [ochratoxin A results in increased activity of CASP3 protein] ochratoxin A analog results in increased activity of CASP3 protein; ochratoxin A results in increased activity of CASP3 protein ochratoxin A results in increased expression of CASP3 mRNA; ochratoxin A results in increased expression of CASP3 protein SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CASP3 mRNA]; SLC22A2 protein promotes the reaction [ochratoxin A results in increased expression of CASP3 protein] [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP3 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 mRNA] |
CTD |
PMID:12700408 PMID:15056805 PMID:17316727 PMID:19367635 PMID:19815060 PMID:20060447 PMID:20549612 PMID:24755393 PMID:25002221 PMID:27193732 PMID:27422291 PMID:29673704 PMID:30120945 PMID:33465424 PMID:34101318 PMID:34126166 PMID:36397609 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases expression decreases expression multiple interactions increases activity |
EXP ISO |
ochratoxin A results in increased expression of CASP7 mRNA ochratoxin A results in decreased expression of CASP7 mRNA U 0126 inhibits the reaction [ochratoxin A results in increased activity of CASP7 protein]; wortmannin promotes the reaction [ochratoxin A results in increased activity of CASP7 protein] |
CTD |
PMID:17316727 PMID:19562491 PMID:25002221 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
decreases expression increases activity |
ISO |
ochratoxin A results in decreased expression of CASP8 mRNA ochratoxin A results in increased activity of CASP8 protein |
CTD |
PMID:17316727 PMID:24755393 PMID:27193732 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity increases cleavage decreases expression increases expression |
ISO EXP |
BNIP3L protein promotes the reaction [ochratoxin A results in decreased expression of CASP9 mRNA]; ochratoxin A results in increased cleavage of and results in increased activity of CASP9 protein; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased cleavage of CASP9 protein] ochratoxin A results in increased activity of CASP9 protein [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP9 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA] |
CTD |
PMID:15056805 PMID:17316727 PMID:19367635 PMID:19562491 PMID:20549612 PMID:24755393 PMID:33465424 PMID:36397609 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression increases expression decreases activity multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of CAT mRNA ochratoxin A results in increased expression of CAT mRNA ochratoxin A results in decreased activity of CAT protein Quercetin inhibits the reaction [ochratoxin A results in decreased activity of CAT protein] [Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased activity of CAT protein]; Chitosan analog inhibits the reaction [ochratoxin A results in decreased activity of CAT protein] [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of CAT mRNA |
CTD |
PMID:12700408 PMID:17316727 PMID:25532488 PMID:27923682 PMID:28710020 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CCDC113 gene |
CTD |
PMID:26431795 |
|
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
|
|
G |
Ccdc97 |
coiled-coil domain containing 97 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CCDC97 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:81,219,225...81,227,017
Ensembl chr 1:81,219,230...81,226,986
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
affects expression |
EXP |
ochratoxin A affects the expression of CCL5 mRNA |
CTD |
PMID:32468156 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of CCN1 mRNA ochratoxin A results in decreased methylation of CCN1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression decreases expression |
EXP |
ochratoxin A results in increased expression of CCN2 mRNA ochratoxin A results in decreased expression of CCN2 mRNA |
CTD |
PMID:19717638 PMID:23358140 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn4 |
cellular communication network factor 4 |
increases expression |
ISO |
ochratoxin A analog results in increased expression of CCN4 mRNA; ochratoxin A results in increased expression of CCN4 mRNA |
CTD |
PMID:27422291 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccna2 |
cyclin A2 |
increases expression decreases acetylation multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CCNA2 mRNA ochratoxin A results in decreased acetylation of CCNA2 promoter [ochratoxin A results in decreased acetylation of CCNA2 promoter] which results in decreased expression of CCNA2 mRNA ochratoxin A results in decreased expression of CCNA2 mRNA |
CTD |
PMID:18417182 PMID:19237604 PMID:23358140 PMID:24243707 PMID:29098329 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions decreases expression increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNB1 mRNA; MAPK1 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; ochratoxin A inhibits the reaction [CCNB1 protein binds to CDK1 protein]; ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]; SB 203580 inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein] ochratoxin A results in decreased expression of CCNB1 mRNA; ochratoxin A results in decreased expression of CCNB1 protein ochratoxin A results in increased expression of CCNB1 mRNA |
CTD |
PMID:19237604 PMID:19717638 PMID:20060447 PMID:22230261 PMID:23358140 PMID:30428381 PMID:36058351 More...
|
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CCNB2 mRNA |
CTD |
PMID:19237604 PMID:19717638 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
ISO |
ochratoxin A promotes the reaction [FOS protein binds to CCND1 promoter]; ochratoxin A promotes the reaction [RELA protein binds to CCND1 promoter] ochratoxin A results in increased expression of CCND1 mRNA; ochratoxin A results in increased expression of CCND1 protein |
CTD |
PMID:23172667 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of CCND2 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of CCND2 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccne1 |
cyclin E1 |
increases expression multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CCNE1 mRNA TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CCNE1 mRNA] ochratoxin A results in decreased expression of CCNE1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNE1 mRNA |
CTD |
PMID:19237604 PMID:23358140 PMID:25636497 PMID:30428381 PMID:31154016 PMID:37162024 More...
|
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CCNE2 mRNA ochratoxin A results in decreased expression of CCNE2 mRNA |
CTD |
PMID:19237604 PMID:30763683 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccng1 |
cyclin G1 |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of CCNG1 mRNA ochratoxin A results in increased expression of CCNG1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNG1 mRNA; [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNG1 protein |
CTD |
PMID:19287073 PMID:23358140 PMID:30428381 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccng2 |
cyclin G2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CCNG2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Cct8 |
chaperonin containing TCP1 subunit 8 |
affects expression |
ISO |
ochratoxin A affects the expression of CCT8 protein |
CTD |
PMID:26861962 |
|
NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
|
|
G |
Cd22 |
CD22 molecule |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of CD22 mRNA [ochratoxin A results in increased acetylation of CD22 promoter] which results in increased expression of CD22 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CD24 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd2bp2 |
Cd2 (cytoplasmic tail) binding protein 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CD2BP2 mRNA |
CTD |
PMID:19287073 PMID:22124623 |
|
NCBI chr 1:181,809,399...181,815,269
Ensembl chr 1:181,809,406...181,813,448
|
|
G |
Cd44 |
CD44 molecule |
increases expression |
EXP |
ochratoxin A results in increased expression of CD44 mRNA |
CTD |
PMID:23358140 PMID:37162024 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd69 |
Cd69 molecule |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CD69 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
EXP |
ochratoxin A results in increased expression of CD74 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd81 |
Cd81 molecule |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of CD81 promoter [ochratoxin A results in increased acetylation of CD81 promoter] which results in increased expression of CD81 mRNA ochratoxin A results in increased expression of CD81 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
EXP |
ochratoxin A results in increased expression of CD86 mRNA |
CTD |
PMID:24792326 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc20 |
cell division cycle 20 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDC20 mRNA |
CTD |
PMID:19237604 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc23 |
cell division cycle 23 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC23 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC23 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:26,236,891...26,260,611
Ensembl chr18:26,236,890...26,291,163
|
|
G |
Cdc25a |
cell division cycle 25A |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC25A mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC25A mRNA |
CTD |
PMID:30428381 PMID:30763683 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC25C mRNA; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein] ochratoxin A results in decreased expression of CDC25C mRNA; ochratoxin A results in decreased expression of CDC25C protein; ochratoxin A results in decreased expression of CDC25C protein modified form |
CTD |
PMID:20060447 PMID:22230261 PMID:30428381 PMID:36058351 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc26 |
cell division cycle 26 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC26 mRNA ochratoxin A results in decreased expression of CDC26 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:75,844,852...75,859,830
|
|
G |
Cdc34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC34 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC34 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdc42ep1 |
CDC42 effector protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDC42EP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:110,395,287...110,403,203
Ensembl chr 7:110,395,332...110,403,200
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDC42SE1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
|
|
G |
Cdc6 |
cell division cycle 6 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC6 mRNA ochratoxin A results in decreased expression of CDC6 mRNA |
CTD |
PMID:30428381 PMID:30763683 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdc7 |
cell division cycle 7 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC7 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC7 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of CDH1 mRNA ochratoxin A results in decreased expression of CDH1 mRNA; ochratoxin A results in decreased expression of CDH1 protein 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in decreased expression of CDH1 protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CDH1 mRNA; [ochratoxin A co-treated with Citrinin] results in decreased expression of CDH1 protein |
CTD |
PMID:16857307 PMID:29673704 PMID:32617660 PMID:35543154 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CDK1 mRNA; MAPK1 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein]; MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein]; ochratoxin A inhibits the reaction [CCNB1 protein binds to CDK1 protein]; ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]; SB 203580 inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein] ochratoxin A results in decreased expression of CDK1 mRNA; ochratoxin A results in decreased expression of CDK1 protein; ochratoxin A results in decreased expression of CDK1 protein modified form ochratoxin A results in increased expression of CDK1 mRNA TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CDK1 mRNA] ochratoxin A results in increased expression of CDK1 mRNA; ochratoxin A results in increased expression of CDK1 protein SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CDK1 protein] |
CTD |
PMID:19237604 PMID:19717638 PMID:20060447 PMID:22230261 PMID:24243707 PMID:25636497 PMID:30120945 PMID:30428381 PMID:36058351 More...
|
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDK10 mRNA ochratoxin A results in decreased expression of CDK10 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
|
|
G |
Cdk14 |
cyclin-dependent kinase 14 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDK14 mRNA ochratoxin A results in decreased acetylation of CDK14 promoter [ochratoxin A results in decreased acetylation of CDK14 promoter] which results in decreased expression of CDK14 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CDK2 mRNA ochratoxin A results in decreased expression of CDK2 protein |
CTD |
PMID:23358140 PMID:28286205 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CDK4 mRNA |
CTD |
PMID:31154016 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of CDK5R1 mRNA; ochratoxin A results in decreased expression of CDK5R1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression increases expression multiple interactions decreases methylation |
ISO EXP |
ochratoxin A results in decreased expression of CDKN1A mRNA; ochratoxin A results in decreased expression of CDKN1A protein ochratoxin A results in increased expression of CDKN1A mRNA; ochratoxin A results in increased expression of CDKN1A protein TRP53 gene mutant form inhibits the reaction [ochratoxin A results in increased expression of CDKN1A mRNA] ochratoxin A results in decreased methylation of CDKN1A gene |
CTD |
PMID:16251485 PMID:17316727 PMID:18417182 PMID:19237604 PMID:19367635 PMID:23208426 PMID:23358140 PMID:25636497 PMID:28710020 PMID:30008028 PMID:30559759 PMID:30763683 PMID:32910239 PMID:37162024 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions increases expression decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDKN1B mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of CDKN1B mRNA ochratoxin A results in increased expression of CDKN1B mRNA ochratoxin A results in decreased expression of CDKN1B mRNA |
CTD |
PMID:30428381 PMID:30763683 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression |
ISO |
ochratoxin A results in increased expression of CDKN2A protein |
CTD |
PMID:28286205 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
decreases acetylation decreases expression |
ISO |
ochratoxin A results in decreased acetylation of CDKN2B promoter ochratoxin A results in decreased expression of CDKN2B mRNA |
CTD |
PMID:29098329 PMID:30763683 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CDO1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CEBPA |
CTD |
PMID:20590410 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
ISO EXP |
ochratoxin A metabolite results in decreased expression of CEBPB mRNA; ochratoxin A results in decreased expression of CEBPB mRNA |
CTD |
PMID:19287073 PMID:23358140 PMID:24356939 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
EXP |
ochratoxin A results in increased expression of CEBPG mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Cebpz |
CCAAT/enhancer binding protein zeta |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CEBPZ mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 6:16,119,871...16,137,600
Ensembl chr 6:16,119,872...16,137,600
|
|
G |
Cenps |
centromere protein S |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CENPS gene |
CTD |
PMID:26431795 |
|
NCBI chr 5:159,563,917...159,573,534
|
|
G |
Cep55 |
centrosomal protein 55 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of CEP55 promoter ochratoxin A results in decreased expression of CEP55 mRNA [ochratoxin A results in decreased acetylation of CEP55 promoter] which results in decreased expression of CEP55 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CES1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces3a |
carboxylesterase 3a |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CES3 mRNA |
CTD |
PMID:16251485 PMID:17483316 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cfap53 |
cilia and flagella associated protein 53 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of CFAP53 promoter |
CTD |
PMID:29098329 |
|
NCBI chr18:67,884,651...67,955,873
Ensembl chr18:67,869,855...67,952,318
|
|
G |
Cfap95 |
cilia and flagella associated protein 95 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CFAP95 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:221,123,786...221,242,963
Ensembl chr 1:221,131,813...221,242,963
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CFLAR mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
affects expression decreases expression |
ISO |
ochratoxin A affects the expression of CHAC1 mRNA ochratoxin A metabolite results in decreased expression of CHAC1 mRNA |
CTD |
PMID:23824090 PMID:24356939 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHD1L mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
|
|
G |
Chd8 |
chromodomain helicase DNA binding protein 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of CHD8 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:24,905,789...24,965,461
Ensembl chr15:24,905,789...24,951,285
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression decreases acetylation |
EXP ISO |
ochratoxin A results in increased expression of CHEK1 mRNA ochratoxin A results in decreased acetylation of CHEK1 promoter |
CTD |
PMID:19237604 PMID:23358140 PMID:24243707 PMID:29098329 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chka |
choline kinase alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CHKA mRNA |
CTD |
PMID:32910239 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chmp7 |
charged multivesicular body protein 7 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of CHMP7 promoter |
CTD |
PMID:29098329 |
|
NCBI chr15:44,790,983...44,806,216
Ensembl chr15:44,790,996...44,806,216
|
|
G |
Chrd |
chordin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHRD mRNA |
CTD |
PMID:18417182 |
|
NCBI chr11:80,171,994...80,181,166
Ensembl chr11:80,171,994...80,180,673
|
|
G |
Chrna10 |
cholinergic receptor nicotinic alpha 10 subunit |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of CHRNA10 gene ochratoxin A results in increased expression of CHRNA10 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:156,487,279...156,494,277
Ensembl chr 1:156,487,279...156,491,476
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHRNB2 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chrne |
cholinergic receptor nicotinic epsilon subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHRNE mRNA |
CTD |
PMID:12700408 |
|
NCBI chr10:55,331,211...55,339,923
Ensembl chr10:55,331,212...55,335,530
|
|
G |
Cib1 |
calcium and integrin binding 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CIB1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:134,178,331...134,183,895
Ensembl chr 1:134,178,331...134,213,423
|
|
G |
Cideb |
cell death-inducing DFFA-like effector b |
increases expression |
EXP |
ochratoxin A results in increased expression of CIDEB mRNA |
CTD |
PMID:19562491 |
|
NCBI chr15:29,252,208...29,256,482
Ensembl chr15:29,252,213...29,256,605
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CIDEC mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cirbp |
cold inducible RNA binding protein |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of CIRBP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Cisd2 |
CDGSH iron sulfur domain 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CISD2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
increases expression |
EXP |
ochratoxin A results in increased expression of CKS1B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CKS2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clasp2 |
cytoplasmic linker associated protein 2 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of CLASP2 promoter ochratoxin A results in decreased expression of CLASP2 mRNA [ochratoxin A results in decreased acetylation of CLASP2 promoter] which results in decreased expression of CLASP2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLCF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLDN1 protein |
CTD |
PMID:30763683 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn2 |
claudin 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLDN2 mRNA |
CTD |
PMID:28710020 PMID:30008028 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Cldn23 |
claudin 23 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLDN23 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523
|
|
G |
Cldn3 |
claudin 3 |
multiple interactions decreases expression |
ISO |
illite affects the reaction [ochratoxin A results in decreased expression of CLDN3 mRNA] [ochratoxin A results in increased susceptibility to Antigens] which results in decreased expression of CLDN3 mRNA |
CTD |
PMID:27153755 PMID:28935500 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Cldn4 |
claudin 4 |
multiple interactions decreases expression |
ISO |
illite affects the reaction [ochratoxin A results in decreased expression of CLDN4 mRNA] |
CTD |
PMID:27153755 PMID:30763683 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cldnd1 |
claudin domain containing 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CLDND1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:41,883,120...41,889,471
Ensembl chr11:41,883,134...41,889,354
|
|
G |
Clic4 |
chloride intracellular channel 4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of CLIC4 mRNA; ochratoxin A results in increased expression of CLIC4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452
|
|
G |
Clip2 |
CAP-GLY domain containing linker protein 2 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of CLIP2 promoter |
CTD |
PMID:29098329 |
|
NCBI chr12:22,163,044...22,227,023
Ensembl chr12:22,163,218...22,227,023
|
|
G |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit X |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of CLPX mRNA ochratoxin A results in increased methylation of CLPX gene |
CTD |
PMID:37162024 |
|
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
|
|
G |
Clu |
clusterin |
increases expression |
EXP |
ochratoxin A results in increased expression of CLU mRNA; ochratoxin A results in increased expression of CLU protein |
CTD |
PMID:12700408 PMID:18308701 PMID:23358140 PMID:25218026 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cmpk1 |
cytidine/uridine monophosphate kinase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CMPK1 protein |
CTD |
PMID:19445961 |
|
NCBI chr 5:128,480,301...128,507,830
Ensembl chr 5:128,480,301...128,507,830
|
|
G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of CMTM8 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 8:114,481,730...114,547,107
Ensembl chr 8:114,481,982...114,547,083
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CNDP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
|
|
G |
Cnn3 |
calponin 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CNN3 protein |
CTD |
PMID:19445961 |
|
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
|
|
G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of CNOT2 promoter ochratoxin A results in decreased expression of CNOT2 mRNA [ochratoxin A results in decreased acetylation of CNOT2 promoter] which results in decreased expression of CNOT2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:52,130,445...52,222,338
Ensembl chr 7:52,130,441...52,223,575
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CNR1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cntf |
ciliary neurotrophic factor |
increases expression |
EXP |
ochratoxin A results in increased expression of CNTF mRNA |
CTD |
PMID:12700408 PMID:18417182 |
|
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
|
|
G |
Cntn4 |
contactin 4 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of CNTN4 mRNA; ochratoxin A results in decreased expression of CNTN4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 4:138,624,584...139,622,499
Ensembl chr 4:139,099,152...139,621,090
|
|
G |
Cntnap4 |
contactin associated protein family member 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CNTNAP4 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr19:40,568,684...40,861,879
Ensembl chr19:40,568,684...40,854,656
|
|
G |
Coch |
cochlin |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of COCH promoter ochratoxin A results in increased expression of COCH mRNA [ochratoxin A results in increased acetylation of COCH promoter] which results in increased expression of COCH mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Col17a1 |
collagen type XVII alpha 1 chain |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COL17A1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 1:246,530,589...246,577,559
Ensembl chr 1:246,531,367...246,577,632
|
|
G |
Col24a1 |
collagen type XXIV alpha 1 chain |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COL24A1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 2:234,212,256...234,469,445
Ensembl chr 2:234,212,324...234,469,441
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COL2A1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of COL3A1 mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of and results in increased secretion of COL3A1 protein |
CTD |
PMID:29673704 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of COL6A1 promoter ochratoxin A results in increased expression of COL6A1 mRNA [ochratoxin A results in increased acetylation of COL6A1 promoter] which results in increased expression of COL6A1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Col6a5 |
collagen type VI alpha 5 chain |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of COL6A5 gene |
CTD |
PMID:26431795 |
|
NCBI chr 8:106,483,806...106,584,114
Ensembl chr 8:106,483,799...106,584,113
|
|
G |
Commd10 |
COMM domain containing 10 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of COMMD10 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr18:39,741,219...39,874,801
Ensembl chr18:39,741,298...39,874,903
|
|
G |
Commd2 |
COMM domain containing 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of COMMD2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:141,848,661...141,852,907
Ensembl chr 2:141,848,680...141,852,888
|
|
G |
Commd5 |
COMM domain containing 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COMMD5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
|
|
G |
Copg2 |
COPI coat complex subunit gamma 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of COPG2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of COPZ2 promoter] which results in increased expression of COPZ2 mRNA ochratoxin A results in increased expression of COPZ2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
|
|
G |
Coq7 |
coenzyme Q7, hydroxylase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of COQ7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:172,836,359...172,851,173
Ensembl chr 1:172,835,188...172,851,158
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COTL1 protein |
CTD |
PMID:31369848 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
increases expression decreases expression |
ISO EXP |
ochratoxin A results in increased expression of COX5B mRNA ochratoxin A results in decreased expression of COX5B protein |
CTD |
PMID:17316727 PMID:31369848 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cox7a2l |
cytochrome c oxidase subunit 7A2 like |
increases expression |
ISO |
ochratoxin A results in increased expression of COX7A2L mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 6:11,184,064...11,198,287
Ensembl chr 6:11,184,285...11,198,273
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
increases expression |
ISO |
ochratoxin A results in increased expression of COX7C protein |
CTD |
PMID:26861962 |
|
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
|
|
G |
Cox8a |
cytochrome c oxidase subunit 8A |
increases expression |
ISO |
ochratoxin A results in increased expression of COX8A mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 1:204,402,118...204,404,439
|
|
G |
Cp |
ceruloplasmin |
increases expression |
EXP |
ochratoxin A results in increased expression of CP mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpne4 |
copine 4 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CPNE4 gene |
CTD |
PMID:26431795 |
|
NCBI chr 8:105,177,376...105,653,075
Ensembl chr 8:105,177,376...105,653,068
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of CPS1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of CRHR1 promoter] which results in increased expression of CRHR1 mRNA ochratoxin A results in increased expression of CRHR1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
|
|
G |
Crlf1 |
cytokine receptor-like factor 1 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of CRLF1 mRNA [ochratoxin A results in increased acetylation of CRLF1 promoter] which results in increased expression of CRLF1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,924,722...18,935,997
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CRY2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Cryab |
crystallin, alpha B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CRYAB mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Crygd |
crystallin, gamma D |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CRYGD mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:66,442,057...66,443,668
Ensembl chr 9:66,442,054...66,444,067
|
|
G |
Crym |
crystallin, mu |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of CRYM mRNA; ochratoxin A results in decreased expression of CRYM protein ochratoxin A results in increased expression of CRYM protein |
CTD |
PMID:12700408 PMID:18417182 PMID:31369848 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Cs |
citrate synthase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CS protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csdc2 |
cold shock domain containing C2 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of CSDC2 gene ochratoxin A results in increased expression of CSDC2 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CSNK2A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
multiple interactions decreases expression |
EXP |
SHH protein inhibits the reaction [ochratoxin A results in decreased expression of CSPG4 mRNA] |
CTD |
PMID:24792326 |
|
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CSRP2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Cst3 |
cystatin C |
increases expression |
EXP |
ochratoxin A results in increased expression of CST3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Csta |
cystatin A |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of CSTA mRNA |
CTD |
PMID:24356939 |
|
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
|
|
G |
Cstf3 |
cleavage stimulation factor subunit 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of CSTF3 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:90,966,415...91,037,669
Ensembl chr 3:90,966,354...91,042,196
|
|
G |
Ctbs |
chitobiase |
increases expression |
ISO |
ochratoxin A results in increased expression of CTBS mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:235,340,520...235,355,091
Ensembl chr 2:235,340,547...235,355,091
|
|
G |
Cth |
cystathionine gamma-lyase |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of CTH mRNA |
CTD |
PMID:23358140 PMID:30559759 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnna1 |
catenin alpha 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of CTNNA1 mRNA ochratoxin A metabolite results in increased expression of CTNNA1 mRNA; ochratoxin A results in increased expression of CTNNA1 mRNA |
CTD |
PMID:22124623 PMID:26314263 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases expression multiple interactions |
ISO EXP |
ochratoxin A metabolite results in increased expression of CTNNB1 mRNA; ochratoxin A results in increased expression of CTNNB1 mRNA ochratoxin A results in increased expression of CTNNB1 protein ochratoxin A results in increased expression of and affects the localization of CTNNB1 protein |
CTD |
PMID:26314263 PMID:31369848 PMID:32617660 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctnnd1 |
catenin delta 1 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of CTNND1 mRNA ochratoxin A results in decreased acetylation of CTNND1 promoter [ochratoxin A results in decreased acetylation of CTNND1 promoter] which results in decreased expression of CTNND1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516
|
|
G |
Ctsa |
cathepsin A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CTSA protein |
CTD |
PMID:31369848 |
|
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
|
|
G |
Ctsk |
cathepsin K |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CTSK mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Cubn |
cubilin |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of CUBN promoter |
CTD |
PMID:29098329 |
|
NCBI chr17:76,385,046...76,593,133
Ensembl chr17:76,385,060...76,593,231
|
|
G |
Cul2 |
cullin 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of CUL2 gene |
CTD |
PMID:26431795 |
|
NCBI chr17:54,169,093...54,210,197
Ensembl chr17:54,169,086...54,209,968
|
|
G |
Cul7 |
cullin 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CUL7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:14,319,102...14,333,035
Ensembl chr 9:14,319,108...14,332,741
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of CX3CR1 mRNA; ochratoxin A results in increased expression of CX3CR1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CXCR4 mRNA ochratoxin A metabolite results in decreased expression of CXCR4 mRNA; ochratoxin A results in decreased expression of CXCR4 mRNA |
CTD |
PMID:19717638 PMID:26314263 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CYB5R3 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cyb5r4 |
cytochrome b5 reductase 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYB5R4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
increases expression increases acetylation multiple interactions |
ISO EXP |
ochratoxin A results in increased expression of CYBA mRNA ochratoxin A results in increased acetylation of CYBA promoter [ochratoxin A results in increased acetylation of CYBA promoter] which results in increased expression of CYBA mRNA |
CTD |
PMID:17316727 PMID:23358140 PMID:29098329 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
increases expression |
EXP |
ochratoxin A results in increased expression of CYBB mRNA |
CTD |
PMID:23358140 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A affects the localization of CYCS protein ochratoxin A results in decreased expression of CYCS mRNA ochratoxin A results in increased expression of CYCS protein Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of CYCS protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of CYCS protein] ochratoxin A results in increased expression of CYCS mRNA fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CYCS mRNA] |
CTD |
PMID:20549612 PMID:23358140 PMID:33465424 PMID:36397609 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cygb |
cytoglobin |
increases expression |
EXP |
ochratoxin A results in increased expression of CYGB mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of CYP19A1 protein |
CTD |
PMID:23296098 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression increases response to substance increases expression |
EXP ISO |
ochratoxin A results in decreased expression of CYP1A1 mRNA CYP1A1 protein results in increased susceptibility to ochratoxin A ochratoxin A results in increased expression of CYP1A1 mRNA; ochratoxin A results in increased expression of CYP1A1 protein |
CTD |
PMID:8542584 PMID:17316727 PMID:19717638 PMID:21781659 PMID:21834667 PMID:26505656 PMID:30291945 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression increases response to substance |
ISO |
ochratoxin A results in increased expression of CYP1A2 mRNA; ochratoxin A results in increased expression of CYP1A2 protein CYP1A2 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:8542584 PMID:11189750 PMID:21781659 PMID:21834667 PMID:30291945 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP24A1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases expression increases expression |
ISO |
ochratoxin A results in decreased expression of CYP2B6 mRNA ochratoxin A results in increased expression of CYP2B6 mRNA |
CTD |
PMID:21834667 PMID:26505656 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases expression increases expression affects methylation |
EXP |
ochratoxin A results in decreased expression of CYP2C mRNA; ochratoxin A results in decreased expression of CYP2C11 mRNA ochratoxin A results in increased expression of CYP2C mRNA ochratoxin A affects the methylation of CYP2C11 promoter |
CTD |
PMID:16251485 PMID:18417182 PMID:30449730 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2C13 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
|
|
G |
Cyp2d1 |
cytochrome P450, family 2, subfamily d, polypeptide 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2D1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2D4 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2d5 |
cytochrome P450, family 2, subfamily d, polypeptide 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2D5 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:113,899,905...113,904,458
Ensembl chr 7:113,899,890...113,904,495
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases response to substance |
ISO |
CYP2E1 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:11189750 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2F4 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2J4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of CYP39A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression increases response to substance multiple interactions increases expression |
ISO |
ochratoxin A results in decreased expression of CYP3A4 mRNA CYP3A4 protein results in increased susceptibility to ochratoxin A ochratoxin A inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; ochratoxin A inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein] ochratoxin A results in increased expression of CYP3A4 mRNA; ochratoxin A results in increased expression of CYP3A4 protein |
CTD |
PMID:8542584 PMID:21781659 PMID:21834667 PMID:26341324 PMID:26505656 PMID:30291945 More...
|
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases response to substance increases expression decreases expression |
ISO |
CYP3A5 protein results in increased susceptibility to ochratoxin A ochratoxin A results in increased expression of CYP3A5 mRNA ochratoxin A results in decreased expression of CYP3A5 mRNA |
CTD |
PMID:11189750 PMID:21834667 PMID:26505656 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of CYP4A8 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
Dcun1d5 |
defective in cullin neddylation 1 domain containing 5 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of DCUN1D5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:4,412,266...4,433,380
Ensembl chr 8:4,412,221...4,433,367
|
|
G |
Dcx |
doublecortin |
multiple interactions decreases expression |
EXP |
SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DCX mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression decreases expression decreases methylation multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of DDIT3 mRNA ochratoxin A metabolite results in decreased expression of DDIT3 mRNA; ochratoxin A results in decreased expression of DDIT3 mRNA ochratoxin A results in increased expression of DDIT3 mRNA; ochratoxin A results in increased expression of DDIT3 protein ochratoxin A results in decreased methylation of DDIT3 promoter ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of DDIT3 protein]; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of DDIT3 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of DDIT3 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein] |
CTD |
PMID:12700408 PMID:24356939 PMID:30008028 PMID:30559759 PMID:30763683 PMID:33465424 PMID:36058351 PMID:36587836 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of DDIT4 mRNA; ochratoxin A results in decreased expression of DDIT4 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddt |
D-dopachrome tautomerase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DDT mRNA |
CTD |
PMID:12700408 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Ddx21 |
DExD-box helicase 21 |
multiple interactions decreases expression decreases acetylation |
ISO |
[ochratoxin A results in decreased acetylation of DDX21 promoter] which results in decreased expression of DDX21 mRNA ochratoxin A results in decreased expression of DDX21 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:30,534,319...30,554,513
Ensembl chr20:30,534,319...30,554,543
|
|
G |
Ddx24 |
DEAD-box helicase 24 |
increases expression |
ISO |
ochratoxin A results in increased expression of DDX24 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:122,564,767...122,582,032
Ensembl chr 6:122,564,767...122,581,927
|
|
G |
Ddx50 |
DExD-box helicase 50 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of DDX50 mRNA ochratoxin A results in decreased acetylation of DDX50 promoter [ochratoxin A results in decreased acetylation of DDX50 promoter] which results in decreased expression of DDX50 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152
|
|
G |
Dffa |
DNA fragmentation factor subunit alpha |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DFFA protein |
CTD |
PMID:19562491 |
|
NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
increases expression |
EXP |
ochratoxin A results in increased expression of DFFB mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dgcr6 |
DiGeorge syndrome critical region gene 6 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of DGCR6 promoter [ochratoxin A results in increased acetylation of DGCR6 promoter] which results in increased expression of DGCR6 mRNA ochratoxin A results in increased expression of DGCR6 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr11:82,927,725...82,932,823
Ensembl chr11:82,927,725...82,932,823
|
|
G |
Dgkg |
diacylglycerol kinase, gamma |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of DGKG gene |
CTD |
PMID:26431795 |
|
NCBI chr11:78,384,212...78,579,158
Ensembl chr11:78,384,458...78,577,212
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DHCR24 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DHCR7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DHRS7 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DIABLO mRNA |
CTD |
PMID:17316727 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dido1 |
death inducer-obliterator 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DIDO1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
|
|
G |
Dipk1a |
divergent protein kinase domain 1A |
increases expression |
ISO |
ochratoxin A results in increased expression of FAM69A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:1,772,412...1,843,508
Ensembl chr14:1,772,422...1,843,743
|
|
G |
Dis3l2 |
DIS3-like 3'-5' exoribonuclease 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of DIS3L2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:87,355,409...87,736,616
Ensembl chr 9:87,356,457...87,736,616
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
increases expression |
ISO |
ochratoxin A results in increased expression of DLD mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of DLG2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dll3 |
delta like canonical Notch ligand 3 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of DLL3 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DLL3 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 1:83,562,011...83,570,008
Ensembl chr 1:83,562,014...83,569,750
|
|
G |
Dlx5 |
distal-less homeobox 5 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DLX5 mRNA |
CTD |
PMID:20036863 |
|
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
|
|
G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DMRT1 |
CTD |
PMID:22069556 |
|
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
|
|
G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of DMTF1 promoter ochratoxin A results in decreased expression of DMTF1 mRNA [ochratoxin A results in decreased acetylation of DMTF1 promoter] which results in decreased expression of DMTF1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
|
|
G |
Dnaja2 |
DnaJ heat shock protein family (Hsp40) member A2 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of DNAJA2 promoter [ochratoxin A results in decreased acetylation of DNAJA2 promoter] which results in decreased expression of DNAJA2 mRNA ochratoxin A results in decreased expression of DNAJA2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr19:21,497,792...21,516,904
Ensembl chr19:21,497,729...21,516,901
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of DNAJB4 mRNA; ochratoxin A results in increased expression of DNAJB4 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
increases expression |
EXP |
ochratoxin A results in increased expression of DNAJB6 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnajc4 |
DnaJ heat shock protein family (Hsp40) member C4 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of DNAJC4 promoter] which results in increased expression of DNAJC4 mRNA ochratoxin A results in increased expression of DNAJC4 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:204,178,189...204,182,412
Ensembl chr 1:204,178,191...204,182,387
|
|
G |
Dnal4 |
dynein, axonemal, light chain 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of DNAL4 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:111,312,424...111,325,283
Ensembl chr 7:111,312,427...111,325,283
|
|
G |
Dnase1l3 |
deoxyribonuclease 1L3 |
increases expression |
EXP |
ochratoxin A results in increased expression of DNASE1L3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
|
|
G |
Dock1 |
dedicator of cyto-kinesis 1 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of DOCK1 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:189,467,143...189,983,777
Ensembl chr 1:189,467,143...189,983,768
|
|
G |
Dock3 |
dedicator of cyto-kinesis 3 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of DOCK3 gene |
CTD |
PMID:26431795 |
|
NCBI chr 8:107,552,462...107,903,527
Ensembl chr 8:107,552,463...107,903,514
|
|
G |
Dock6 |
dedicator of cytokinesis 6 |
increases expression |
EXP |
ochratoxin A results in increased expression of DOCK6 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 8:20,342,430...20,394,660
Ensembl chr 8:20,342,089...20,394,552
|
|
G |
Dolk |
dolichol kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DOLK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:13,557,826...13,559,864
Ensembl chr 3:13,557,817...13,559,917
|
|
G |
Dpagt1 |
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DPAGT1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
|
|
G |
Dppa3 |
developmental pluripotency-associated 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of DPPA3 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:155,851,461...155,854,845
Ensembl chr 4:155,815,296...155,854,861 Ensembl chr 5:155,815,296...155,854,861
|
|
G |
Dpy19l1 |
dpy-19 like C-mannosyltransferase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of DPY19L1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:22,933,163...23,021,461
Ensembl chr 8:22,933,163...23,021,751
|
|
G |
Dsc2 |
desmocollin 2 |
decreases expression increases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of DSC2 mRNA ochratoxin A results in increased expression of DSC2 mRNA [ochratoxin A co-treated with Ethanol] results in increased expression of DSC2 mRNA |
CTD |
PMID:16622519 PMID:16857307 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of E2F1 mRNA [ochratoxin A results in increased acetylation of E2F1 promoter] which results in increased expression of E2F1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of E2F2 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f3 |
E2F transcription factor 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of E2F3 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ECI1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Ect2 |
epithelial cell transforming 2 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of ECT2 mRNA ochratoxin A results in decreased acetylation of ECT2 promoter [ochratoxin A results in decreased acetylation of ECT2 promoter] which results in decreased expression of ECT2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EDN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EEF1A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of EEF1A2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Eef1d |
eukaryotic translation elongation factor 1 delta |
increases expression |
ISO |
ochratoxin A results in increased expression of EEF1D protein |
CTD |
PMID:19445961 |
|
NCBI chr 7:107,581,930...107,596,735
Ensembl chr 7:107,581,930...107,608,799
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of EEF2 protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EEPD1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
|
|
G |
Efcab14 |
EF-hand calcium binding domain 14 |
increases expression |
ISO |
ochratoxin A results in increased expression of EFCAB14 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:129,218,139...129,258,628
Ensembl chr 5:129,218,424...129,258,625
|
|
G |
Efcab5 |
EF-hand calcium binding domain 5 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of EFCAB5 gene |
CTD |
PMID:26431795 |
|
NCBI chr10:61,926,419...62,042,745
Ensembl chr10:61,926,953...62,042,749
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EFEMP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Egfr |
epidermal growth factor receptor |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of EGFR protein |
CTD |
PMID:23172667 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EHBP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
|
|
G |
Ehd4 |
EH-domain containing 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EHD4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:107,058,191...107,121,985
Ensembl chr 3:107,058,958...107,122,002
|
|
G |
Eif1 |
eukaryotic translation initiation factor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EIF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases expression |
ISO |
ochratoxin A results in increased expression of EIF2A protein |
CTD |
PMID:36058351 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
decreases expression increases phosphorylation multiple interactions increases expression |
ISO |
ochratoxin A results in decreased expression of EIF2AK3 mRNA ochratoxin A results in increased phosphorylation of EIF2AK3 protein Ursolic Acid inhibits the reaction [ochratoxin A results in increased phosphorylation of EIF2AK3 protein] ochratoxin A results in increased expression of EIF2AK3 protein |
CTD |
PMID:30763683 PMID:33465424 PMID:36058351 PMID:36587836 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation multiple interactions |
ISO |
ochratoxin A results in increased phosphorylation of EIF2S1 protein Ursolic Acid inhibits the reaction [ochratoxin A results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:33465424 PMID:36587836 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif2s2 |
eukaryotic translation initiation factor 2 subunit beta |
increases expression |
ISO |
ochratoxin A results in increased expression of EIF2S2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
|
|
G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EIF3A protein |
CTD |
PMID:19445961 |
|
NCBI chr 1:259,902,767...259,932,976
Ensembl chr 1:259,902,680...259,932,976
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of EIF4EBP1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
increases phosphorylation |
EXP |
ochratoxin A results in increased phosphorylation of ELK1 protein |
CTD |
PMID:17651772 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Elmo2 |
engulfment and cell motility 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ELMO2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 3:154,023,661...154,061,259
Ensembl chr 3:154,023,661...154,061,185
|
|
G |
Eml4 |
EMAP like 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EML4 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of EMP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of EMP3 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of EMX2 mRNA Folic Acid inhibits the reaction [ochratoxin A results in decreased expression of EMX2 mRNA] |
CTD |
PMID:17688467 |
|
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
|
|
G |
Endog |
endonuclease G |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ENDOG protein |
CTD |
PMID:19562491 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Eno1 |
enolase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ENO1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Eno2 |
enolase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ENO2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Ensa |
endosulfine alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ENSA mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:183,185,552...183,192,888
Ensembl chr 2:183,185,552...183,194,847
|
|
G |
Ep300 |
E1A binding protein p300 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EP300 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
multiple interactions decreases expression |
ISO |
EPAS1 protein inhibits the reaction [ochratoxin A results in decreased expression of VEGFA protein] ochratoxin A results in decreased expression of EPAS1 protein |
CTD |
PMID:21554934 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Ephb1 |
Eph receptor B1 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of EPHB1 promoter] which results in increased expression of EPHB1 mRNA ochratoxin A results in increased expression of EPHB1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
|
|
G |
Ephb6 |
Eph receptor B6 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of EPHB6 mRNA [ochratoxin A results in increased acetylation of EPHB6 promoter] which results in increased expression of EPHB6 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EPHX1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Epo |
erythropoietin |
affects expression |
ISO |
ochratoxin A affects the expression of EPO mRNA |
CTD |
PMID:30876885 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EPRS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ERBB4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
ochratoxin A results in increased expression of EREG mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions increases expression |
ISO |
Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of ERN1 protein] |
CTD |
PMID:36587836 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ERO1A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Erp44 |
endoplasmic reticulum protein 44 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of ERP44 promoter ochratoxin A results in increased expression of ERP44 mRNA [ochratoxin A results in increased acetylation of ERP44 promoter] which results in increased expression of ERP44 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
increases expression |
EXP |
ochratoxin A results in increased expression of ESPL1 mRNA |
CTD |
PMID:19237604 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Esrrg |
estrogen-related receptor gamma |
increases expression |
ISO |
ochratoxin A results in increased expression of ESRRG mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ETFDH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Etv1 |
ETS variant transcription factor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of ETV1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:55,590,234...55,681,775
|
|
G |
Etv5 |
ETS variant transcription factor 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ETV5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
|
|
G |
Evi2a |
ecotropic viral integration site 2A |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of EVI2A mRNA; ochratoxin A results in decreased expression of EVI2A mRNA |
CTD |
PMID:24356939 |
|
NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
|
|
G |
Exo1 |
exonuclease 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of EXO1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Exosc5 |
exosome component 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EXOSC5 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
|
|
G |
Eya3 |
EYA transcriptional coactivator and phosphatase 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EYA3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:144,806,523...144,934,522
Ensembl chr 5:144,806,577...144,934,518
|
|
G |
Ezr |
ezrin |
increases expression increases phosphorylation decreases expression |
ISO EXP |
ochratoxin A metabolite results in increased expression of EZR mRNA; ochratoxin A results in increased expression of EZR mRNA ochratoxin A results in increased phosphorylation of EZR protein ochratoxin A results in decreased expression of EZR mRNA ochratoxin A results in increased expression of EZR protein |
CTD |
PMID:26314263 PMID:28286205 PMID:30763683 PMID:31369848 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F11r |
F11 receptor |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of F11R mRNA; ochratoxin A results in increased expression of F11R mRNA |
CTD |
PMID:26314263 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of F2 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions increases expression |
ISO EXP |
ochratoxin A inhibits the reaction [IL1B protein results in increased expression of F3 protein]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased activity of F3 protein]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of F3 mRNA]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of F3 protein]; ochratoxin A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of F3 protein]; ochratoxin A inhibits the reaction [TNF protein results in increased expression of F3 protein] ochratoxin A results in increased expression of F3 mRNA |
CTD |
PMID:12700408 PMID:18289624 PMID:23358140 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
F5 |
coagulation factor V |
decreases expression |
ISO |
ochratoxin A results in decreased expression of F5 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FABP4 |
CTD |
PMID:20590410 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FABP5 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fadd |
Fas associated via death domain |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FADD mRNA |
CTD |
PMID:17316727 PMID:30763683 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FADS1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FAHD1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:13,873,539...13,874,978
Ensembl chr10:13,873,527...13,875,012
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FAM114A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fancc |
FA complementation group C |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FANCC mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of FAS mRNA ochratoxin A results in decreased expression of FAS mRNA |
CTD |
PMID:17316727 PMID:19562491 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
ochratoxin A results in increased expression of FASLG mRNA |
CTD |
PMID:19562491 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fastk |
Fas-activated serine/threonine kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FASTK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
|
|
G |
Fbn2 |
fibrillin 2 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of FBN2 promoter] which results in increased expression of FBN2 mRNA ochratoxin A results in increased expression of FBN2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of FBP1 protein |
CTD |
PMID:31369848 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fbp2 |
fructose-bisphosphatase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of FBP2 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
|
|
G |
Fbxo15 |
F-box protein 15 |
increases expression |
ISO |
ochratoxin A results in increased expression of FBXO15 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
|
|
G |
Fbxo22 |
F-box protein 22 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FBXO22 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
|
|
G |
Fbxo32 |
F-box protein 32 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of FBXO32 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
increases expression |
EXP |
ochratoxin A results in increased expression of FCER1G mRNA |
CTD |
PMID:22124623 |
|
NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fech |
ferrochelatase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FECH mRNA |
CTD |
PMID:32905824 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fgb |
fibrinogen beta chain |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FGB protein |
CTD |
PMID:31276768 |
|
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgd1 |
FYVE, RhoGEF and PH domain containing 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of FGD1 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr X:20,023,746...20,066,734
Ensembl chr X:20,023,746...20,066,566
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of FGF18 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
multiple interactions |
ISO |
[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA; Folic Acid inhibits the reaction [[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA]; ochratoxin A promotes the reaction [GLI3 gene mutant form results in increased expression of FGF8 protein] |
CTD |
PMID:16922921 PMID:17688467 |
|
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of FKBP1A mRNA ochratoxin A results in increased acetylation of FKBP1A promoter [ochratoxin A results in increased acetylation of FKBP1A promoter] which results in increased expression of FKBP1A mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FKBP1B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 6:27,832,128...27,850,600
Ensembl chr 6:27,838,802...27,848,653
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
increases expression |
EXP |
ochratoxin A results in increased expression of FKBP5 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fkbp8 |
FKBP prolyl isomerase 8 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of FKBP8 promoter [ochratoxin A results in increased acetylation of FKBP8 promoter] which results in increased expression of FKBP8 mRNA ochratoxin A results in increased expression of FKBP8 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
|
|
G |
Fn1 |
fibronectin 1 |
increases expression multiple interactions decreases expression |
ISO |
ochratoxin A results in increased expression of FN1 mRNA; ochratoxin A results in increased expression of FN1 protein NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of FN1 mRNA] ochratoxin A results in decreased expression of FN1 mRNA 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of FN1 mRNA]; 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of FN1 protein]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 protein]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 protein] |
CTD |
PMID:28710020 PMID:30559759 PMID:32617660 PMID:35543154 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fndc10 |
fibronectin type III domain containing 10 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FNDC10 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:166,300,122...166,310,326
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FNDC3B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions decreases expression |
ISO EXP |
ochratoxin A results in increased expression of FOS mRNA ochratoxin A promotes the reaction [FOS protein binds to CCND1 promoter]; ochratoxin A promotes the reaction [FOS protein binds to PTGS2 promoter] ochratoxin A results in increased expression of FOS protein ochratoxin A results in decreased expression of FOS mRNA |
CTD |
PMID:17316727 PMID:19237604 PMID:23172667 PMID:23358140 PMID:30763683 PMID:37162024 More...
|
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Frat1 |
FRAT regulator of WNT signaling pathway 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of FRAT1 mRNA; ochratoxin A results in decreased expression of FRAT1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:240,638,309...240,640,857
Ensembl chr 1:240,638,296...240,640,945
|
|
G |
Frmd3 |
FERM domain containing 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of FRMD3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:87,764,755...88,031,091
Ensembl chr 5:87,764,604...88,031,091
|
|
G |
Frzb |
frizzled-related protein |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of FRZB mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fsd1l |
fibronectin type III and SPRY domain containing 1-like |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FSD1L mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:68,258,877...68,334,931
Ensembl chr 5:68,258,932...68,334,928
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of FTH1 mRNA |
CTD |
PMID:30559759 PMID:32905824 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FUBP1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Fuca1 |
alpha-L-fucosidase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of FUCA1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:148,152,718...148,169,972
Ensembl chr 5:148,152,700...148,169,972
|
|
G |
Fut4-ps1 |
fucosyltransferase 4, pseudogene 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FUT6 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:1,569,605...1,572,022
|
|
G |
G2e3 |
G2/M-phase specific E3 ubiquitin protein ligase |
increases expression |
ISO |
ochratoxin A results in increased expression of G2E3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of G6PC1 mRNA |
CTD |
PMID:26341324 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of G6PD mRNA |
CTD |
PMID:32905824 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabbr2 |
gamma-aminobutyric acid type B receptor subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of GABBR2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of GADD45A mRNA ochratoxin A results in decreased expression of GADD45 mRNA; ochratoxin A results in decreased expression of GADD45A mRNA |
CTD |
PMID:12700408 PMID:17316727 PMID:30008028 PMID:30559759 PMID:30763683 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GADD45B mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GADD45G mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases activity |
EXP ISO |
ochratoxin A results in increased activity of GAL protein |
CTD |
PMID:28286205 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of GALNT11 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of GBP1 promoter ochratoxin A results in decreased expression of GBP1 mRNA [ochratoxin A results in decreased acetylation of GBP1 promoter] which results in decreased expression of GBP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gc |
GC, vitamin D binding protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GC mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gcfc2 |
GC-rich sequence DNA-binding factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GCFC2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 4:114,481,613...114,519,268
Ensembl chr 4:114,481,607...114,519,962
|
|
G |
Gck |
glucokinase |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of GCK gene ochratoxin A results in increased expression of GCK mRNA |
CTD |
PMID:37162024 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions decreases expression increases expression affects expression |
EXP ISO |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GCLC protein] ochratoxin A results in decreased expression of GCLC mRNA; ochratoxin A results in decreased expression of GCLC protein AHR protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA] ochratoxin A affects the expression of GCLC mRNA |
CTD |
PMID:16251485 PMID:17110534 PMID:18417182 PMID:23358140 PMID:30291945 PMID:32468156 PMID:32905824 More...
|
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression affects expression |
EXP ISO |
ochratoxin A results in decreased expression of GCLM mRNA ochratoxin A affects the expression of GCLM mRNA |
CTD |
PMID:16251485 PMID:18417182 PMID:30008028 PMID:30559759 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GCNT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gen1 |
GEN1 Holliday junction 5' flap endonuclease |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of GEN1 mRNA ochratoxin A results in increased methylation of GEN1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 6:33,947,599...33,978,461
Ensembl chr 6:33,948,206...33,978,401
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions decreases expression |
EXP |
15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]; SHH protein inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA] ochratoxin A results in decreased expression of GFAP mRNA; ochratoxin A results in decreased expression of GFAP protein |
CTD |
PMID:15994020 PMID:22954530 PMID:24792326 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
decreases activity decreases expression |
EXP |
ochratoxin A results in decreased activity of GGT1 protein ochratoxin A results in decreased expression of GGT1 mRNA |
CTD |
PMID:2569870 PMID:12700408 PMID:16251485 PMID:23358140 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Ggt5 |
gamma-glutamyltransferase 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GGT5 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr20:13,043,255...13,071,523
Ensembl chr20:13,043,257...13,071,450
|
|
G |
Ggt6 |
gamma-glutamyl transferase 6 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GGT6 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr10:57,051,977...57,054,900
Ensembl chr10:57,051,825...57,067,260
|
|
G |
Ghr |
growth hormone receptor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GHR mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
affects phosphorylation decreases expression increases phosphorylation |
EXP ISO |
ochratoxin A affects the phosphorylation of GJA1 protein ochratoxin A results in decreased expression of GJA1 mRNA ochratoxin A results in increased phosphorylation of GJA1 protein |
CTD |
PMID:11711124 PMID:16857307 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GJB1 mRNA |
CTD |
PMID:16857307 PMID:19237604 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GJB2 mRNA |
CTD |
PMID:16857307 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gk |
glycerol kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GK mRNA |
CTD |
PMID:12700408 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glb1l |
galactosidase, beta 1-like |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of GLB1L mRNA ochratoxin A results in increased methylation of GLB1L gene |
CTD |
PMID:37162024 |
|
NCBI chr 9:76,693,325...76,705,548
Ensembl chr 9:76,695,173...76,705,510
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of GLI1 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of GLI1 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gli3 |
GLI family zinc finger 3 |
multiple interactions affects response to substance increases response to substance |
ISO |
[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA; Folic Acid inhibits the reaction [[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA]; ochratoxin A promotes the reaction [GLI3 gene mutant form results in increased expression of FGF8 protein] GLI3 gene affects the susceptibility to ochratoxin A GLI3 gene mutant form results in increased susceptibility to ochratoxin A |
CTD |
PMID:16922921 PMID:17688467 PMID:20201966 |
|
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Glrx |
glutaredoxin |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GLRX mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Gls |
glutaminase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GLS mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases activity decreases expression |
EXP |
ochratoxin A results in decreased activity of GLUL protein ochratoxin A results in decreased expression of GLUL mRNA |
CTD |
PMID:12700408 PMID:20558201 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Glyat |
glycine-N-acyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GLYAT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Gng13 |
G protein subunit gamma 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GNG13 mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr10:14,741,179...14,743,083
Ensembl chr10:14,741,239...14,743,083
|
|
G |
Gng5 |
G protein subunit gamma 5 |
increases expression |
EXP |
ochratoxin A results in increased expression of GNG5 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 2:235,394,680...235,403,177
Ensembl chr 1:77,292,043...77,292,513
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GNMT mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of GNRH1 mRNA ochratoxin A metabolite results in increased expression of GNRH1 mRNA; ochratoxin A results in increased expression of GNRH1 mRNA |
CTD |
PMID:22124623 PMID:24356939 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gp5 |
glycoprotein V (platelet) |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of GP5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:70,443,613...70,446,705
Ensembl chr11:70,443,613...70,446,705
|
|
G |
Gpc1 |
glypican 1 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of GPC1 promoter] which results in increased expression of GPC1 mRNA ochratoxin A results in increased expression of GPC1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GPI protein |
CTD |
PMID:26861962 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of GPR17 mRNA; ochratoxin A results in increased expression of GPR17 mRNA |
CTD |
PMID:23824090 PMID:24356939 |
|
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
|
|
G |
Gpr18 |
G protein-coupled receptor 18 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of GPR18 mRNA; ochratoxin A results in decreased expression of GPR18 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of GPT protein [1-aminobenzotriazole co-treated with ochratoxin A] results in increased activity of GPT protein |
CTD |
PMID:35543154 PMID:36227364 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of GPT2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression decreases expression multiple interactions increases acetylation |
ISO EXP |
ochratoxin A results in increased expression of GPX1 mRNA ochratoxin A results in decreased expression of GPX1 mRNA [Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]; Chitosan analog inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]; Quercetin inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA] ochratoxin A results in increased acetylation of GPX1 promoter [ochratoxin A results in increased acetylation of GPX1 promoter] which results in increased expression of GPX1 mRNA |
CTD |
PMID:17316727 PMID:23358140 PMID:24120684 PMID:27923682 PMID:29098329 PMID:32905824 More...
|
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of GPX2 mRNA |
CTD |
PMID:24120684 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of GPX3 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of GPX4 promoter] which results in increased expression of GPX4 mRNA ochratoxin A results in increased expression of GPX4 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GPX7 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
|
|
G |
Gpx8 |
glutathione peroxidase 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of GPX8 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:44,676,448...44,680,042
Ensembl chr 2:44,676,454...44,680,195
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of GRIA1 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of GRIA2 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
increases expression multiple interactions increases acetylation decreases expression |
ISO |
ochratoxin A results in increased expression of GRIN1 mRNA [ochratoxin A results in increased acetylation of GRIN1 promoter] which results in increased expression of GRIN1 mRNA ochratoxin A results in decreased expression of GRIN1 mRNA |
CTD |
PMID:29098329 PMID:34748853 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
increases expression |
EXP |
ochratoxin A results in increased expression of GRIN2A mRNA |
CTD |
PMID:27346841 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Gsdma |
gasdermin A |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of GSDMA mRNA ochratoxin A results in decreased methylation of GSDMA gene |
CTD |
PMID:37162024 |
|
NCBI chr10:83,614,336...83,639,543
Ensembl chr10:83,627,051...83,639,543
|
|
G |
Gsdmd |
gasdermin D |
increases expression |
ISO |
ochratoxin A results in increased expression of GSDMD mRNA; ochratoxin A results in increased expression of GSDMD protein |
CTD |
PMID:33543323 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of GSK3B protein |
CTD |
PMID:25002221 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gspt1 |
G1 to S phase transition 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of GSPT1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
[NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of GSR mRNA |
CTD |
PMID:28710020 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSS mRNA |
CTD |
PMID:12700408 PMID:16251485 PMID:18417182 PMID:23358140 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTA1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of GSTA2 mRNA ochratoxin A results in increased expression of GSTA2 mRNA |
CTD |
PMID:16251485 PMID:23358140 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTA3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTA4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
multiple interactions decreases expression |
EXP |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTA5 protein] |
CTD |
PMID:17110534 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstcd |
glutathione S-transferase, C-terminal domain containing |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTCD mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:221,499,732...221,591,888
Ensembl chr 2:221,499,083...221,591,857
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTK1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases expression affects expression |
EXP ISO |
ochratoxin A results in decreased expression of GSTM1 mRNA; ochratoxin A results in decreased expression of GSTM1 protein ochratoxin A affects the expression of GSTM1 mRNA |
CTD |
PMID:17110534 PMID:23358140 PMID:32905824 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression affects expression |
EXP ISO |
ochratoxin A results in increased expression of GSTM2 mRNA ochratoxin A affects the expression of GSTM2 mRNA |
CTD |
PMID:24120684 PMID:32905824 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTM4 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
increases acetylation increases expression multiple interactions decreases expression |
ISO |
ochratoxin A results in increased acetylation of GSTM3 promoter ochratoxin A results in increased expression of GSTM3 mRNA [ochratoxin A results in increased acetylation of GSTM3 promoter] which results in increased expression of GSTM3 mRNA ochratoxin A results in decreased expression of GSTM3 mRNA |
CTD |
PMID:29098329 PMID:32905824 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTO1 mRNA; ochratoxin A results in decreased expression of GSTO1 protein |
CTD |
PMID:19287073 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of GSTP1 mRNA; ochratoxin A results in decreased expression of GSTP1 protein [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTP1 protein]; ochratoxin A inhibits the reaction [NFE2L2 protein binds to GSTP1 protein] |
CTD |
PMID:12700408 PMID:17110534 PMID:23358140 PMID:32905824 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTT1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gstt2 |
glutathione S-transferase theta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTT2 mRNA |
CTD |
PMID:16251485 PMID:18417182 PMID:23358140 |
|
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTZ1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
Gtf2h5 |
general transcription factor IIH subunit 5 |
increases expression |
ISO |
ochratoxin A results in increased expression of GTF2H5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:46,656,804...46,663,512
Ensembl chr 1:46,656,859...46,664,939
|
|
G |
Gtf3c5 |
general transcription factor IIIC subunit 5 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GTF3C5 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:11,893,867...11,914,187
Ensembl chr 3:11,893,875...11,914,180
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of GTSE1 mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
|
|
G |
Gucy1b2 |
guanylate cyclase 1 soluble subunit beta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GUCY1B2 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr15:36,589,501...36,669,441
Ensembl chr15:36,598,883...36,669,441
|
|
G |
H1f10 |
H1.10 linker histone |
decreases expression |
EXP |
ochratoxin A results in decreased expression of H1F10 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
|
|
G |
H1f6 |
H1.6 linker histone, cluster member |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of H1-6 mRNA ochratoxin A results in increased expression of H1F6 mRNA |
CTD |
PMID:22124623 PMID:30449730 |
|
NCBI chr17:41,427,365...41,428,109
Ensembl chr17:41,427,323...41,428,119
|
|
G |
H2ax |
H2A.X variant histone |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of H2AX mRNA ochratoxin A results in increased expression of H2AX protein ochratoxin A results in increased expression of H2AX mRNA; ochratoxin A results in increased expression of H2AX protein modified form |
CTD |
PMID:19287073 PMID:23358140 PMID:24243707 PMID:28286205 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HADHB protein |
CTD |
PMID:26861962 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hagh |
hydroxyacyl glutathione hydrolase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HAGH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504
|
|
G |
Has1 |
hyaluronan synthase 1 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of HAS1 mRNA ochratoxin A results in decreased methylation of HAS1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:58,693,411...58,705,653
Ensembl chr 1:58,693,411...58,705,397
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression increases secretion multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of HAVCR1; ochratoxin A results in increased expression of HAVCR1 mRNA; ochratoxin A results in increased expression of HAVCR1 protein ochratoxin A results in increased secretion of HAVCR1 mRNA AHR protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of HAVCR1 protein]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA] HSPA9 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 protein] [1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of HAVCR1 protein |
CTD |
PMID:16251485 PMID:18308701 PMID:25218026 PMID:30291945 PMID:30449730 PMID:31369848 PMID:36227364 More...
|
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hbs1l |
HBS1-like translational GTPase |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of HBS1L mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:16,092,529...16,170,082
Ensembl chr 1:16,092,547...16,170,074
|
|
G |
Hcfc1r1 |
host cell factor C1 regulator 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HCFC1R1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850
|
|
G |
Hdac3 |
histone deacetylase 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of HDAC3 protein |
CTD |
PMID:17651772 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hdgfl3 |
HDGF like 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of HDGFL3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:135,822,600...135,876,719
Ensembl chr 1:135,827,549...135,876,719
|
|
G |
Hdlbp |
high density lipoprotein binding protein |
increases expression |
EXP |
ochratoxin A results in increased expression of HDLBP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HES1 mRNA |
CTD |
PMID:21703336 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hes5 |
hes family bHLH transcription factor 5 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of HES5 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of HES5 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
EXP |
ochratoxin A inhibits the reaction [HGF protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:18031729 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression decreases expression affects expression |
EXP ISO |
ochratoxin A results in increased expression of HIF1A mRNA ochratoxin A results in decreased expression of HIF1A mRNA ochratoxin A affects the expression of HIF1A protein |
CTD |
PMID:12700408 PMID:23358140 PMID:30876885 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hif3a |
hypoxia inducible factor 3 subunit alpha |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of HIF3A mRNA ochratoxin A results in increased methylation of HIF3A gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758
|
|
G |
Hist1h2bq |
histone cluster 1 H2B family member Q |
increases expression |
EXP |
ochratoxin A results in increased expression of HIST1H2BQ mRNA |
CTD |
PMID:22124623 |
|
NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
increases expression |
EXP |
ochratoxin A results in increased expression of HIST1H4B mRNA |
CTD |
PMID:18417182 |
|
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
|
|
G |
Hk2 |
hexokinase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of HK2 protein |
CTD |
PMID:32835834 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmcn1 |
hemicentin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of HMCN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:62,615,461...63,084,524
Ensembl chr13:62,615,461...63,084,524
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HMGB2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgn5 |
high mobility group nucleosome binding domain 5 |
increases expression |
ISO |
ochratoxin A results in increased expression of HMGN5 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
increases expression |
EXP |
ochratoxin A results in increased expression of HMMR mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions decreases expression affects expression |
EXP ISO |
ochratoxin A results in increased expression of HMOX1 mRNA; ochratoxin A results in increased expression of HMOX1 protein 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; ochratoxin A inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HMOX1 mRNA] ochratoxin A results in decreased expression of HMOX1 mRNA; ochratoxin A results in decreased expression of HMOX1 protein ochratoxin A affects the reaction [NFE2L2 protein affects the expression of HMOX1 mRNA] AHR protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA] ochratoxin A affects the expression of HMOX1 mRNA |
CTD |
PMID:15994020 PMID:16251485 PMID:17316727 PMID:19414514 PMID:23358140 PMID:26260164 PMID:28710020 PMID:30008028 PMID:30291945 PMID:30559759 PMID:32905824 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hmox2 |
heme oxygenase 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HMOX2 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
|
|
G |
Hnf1a |
HNF1 homeobox A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HNF1A mRNA |
CTD |
PMID:23358140 |
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of HNF4A mRNA; ochratoxin A results in decreased expression of HNF4A protein |
CTD |
PMID:16251485 PMID:23358140 PMID:30008028 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hnf4g |
hepatocyte nuclear factor 4, gamma |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of HNF4G mRNA ochratoxin A results in increased methylation of HNF4G gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:97,885,773...98,036,650
Ensembl chr 2:97,887,432...98,036,592
|
|
G |
Hnrnpf |
heterogeneous nuclear ribonucleoprotein F |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HNRNPF protein |
CTD |
PMID:19445961 |
|
NCBI chr 4:151,083,262...151,104,464
Ensembl chr 4:151,083,062...151,109,038
|
|
G |
Hnrnpk |
heterogeneous nuclear ribonucleoprotein K |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HNRNPK protein |
CTD |
PMID:19445961 |
|
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases expression |
EXP |
ochratoxin A results in increased expression of HRAS mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of HSD3B1 mRNA; ochratoxin A results in increased expression of HSD3B1 protein |
CTD |
PMID:23466516 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of HSP90AA1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HSP90AB1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of HSPA1A mRNA ochratoxin A results in decreased expression of HSPA1A mRNA; ochratoxin A results in decreased expression of HSPA1A protein |
CTD |
PMID:16857307 PMID:17316727 PMID:19051279 PMID:19367635 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of HSPA2 mRNA ochratoxin A results in decreased acetylation of HSPA2 promoter [ochratoxin A results in decreased acetylation of HSPA2 promoter] which results in decreased expression of HSPA2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression increases expression decreases methylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of HSPA5 protein ochratoxin A results in decreased expression of HSPA5 mRNA ochratoxin A metabolite results in increased expression of HSPA5 mRNA; ochratoxin A results in increased expression of HSPA5 mRNA; ochratoxin A results in increased expression of HSPA5 protein ochratoxin A results in decreased methylation of HSPA5 promoter ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of HSPA5 protein]; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of HSPA5 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein] |
CTD |
PMID:19051279 PMID:19445961 PMID:24356939 PMID:30559759 PMID:33465424 PMID:36058351 PMID:36587836 More...
|
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of HSPA6 mRNA ochratoxin A results in increased acetylation of HSPA6 promoter [ochratoxin A results in increased acetylation of HSPA6 promoter] which results in increased expression of HSPA6 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HSPA8 protein |
CTD |
PMID:31369848 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of HSPA9 mRNA; ochratoxin A results in decreased expression of HSPA9 protein ochratoxin A results in increased expression of HSPA9 protein HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein]; HSPA9 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 protein] HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of HAVCR1 protein]; HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein] |
CTD |
PMID:19051279 PMID:31369848 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HSPB1 mRNA; ochratoxin A results in decreased expression of HSPB1 protein |
CTD |
PMID:19051279 PMID:19367635 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of HSPD1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
increases expression |
EXP |
ochratoxin A results in increased expression of HTR1A mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr4 |
5-hydroxytryptamine receptor 4 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of HTR4 gene ochratoxin A results in increased expression of HTR4 mRNA |
CTD |
PMID:26431795 PMID:27346841 |
|
NCBI chr18:55,765,981...55,949,921
Ensembl chr18:55,766,725...55,949,321
|
|
G |
Hyls1 |
HYLS1, centriolar and ciliogenesis associated |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of HYLS1 mRNA; ochratoxin A results in decreased expression of HYLS1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions increases expression |
ISO EXP |
[NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of ICAM1 protein ochratoxin A results in increased expression of ICAM1 mRNA |
CTD |
PMID:28710020 PMID:37162024 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ID1 mRNA |
CTD |
PMID:12700408 PMID:17483316 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ID2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ID3 mRNA |
CTD |
PMID:21703336 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ID4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IDH1 mRNA; ochratoxin A results in decreased expression of IDH1 protein |
CTD |
PMID:32835834 PMID:32905824 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Idh3b |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IDH3B mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982
|
|
G |
Idh3g |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IDH3G mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:151,515,244...151,524,175
Ensembl chr X:151,515,247...151,524,171
|
|
G |
Idi2l3 |
isopentenyl-diphosphate delta isomerase 2 like 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IDI2L3 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr17:61,518,138...61,535,484
Ensembl chr17:61,519,390...61,531,603
|
|
G |
Ier3 |
immediate early response 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of IER3 mRNA; ochratoxin A results in decreased expression of IER3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi35 |
interferon-induced protein 35 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IFI35 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of IFITM3 mRNA [ochratoxin A results in increased acetylation of IFITM3 promoter] which results in increased expression of IFITM3 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IFNG protein |
CTD |
PMID:28935500 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IFRD1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IGF1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
increases expression |
EXP |
ochratoxin A results in increased expression of IGF1R protein |
CTD |
PMID:17651772 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IGF2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of IGFBP1 mRNA; ochratoxin A results in decreased expression of IGFBP1 protein ochratoxin A results in increased expression of IGFBP1 mRNA |
CTD |
PMID:19287073 PMID:19717638 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IGFBP4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IHH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
|
|
G |
Il10 |
interleukin 10 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL10 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IL12A mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
[Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL12B protein |
CTD |
PMID:28935500 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il13 |
interleukin 13 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of IL13 promoter ochratoxin A results in increased expression of IL13 mRNA [ochratoxin A results in increased acetylation of IL13 promoter] which results in increased expression of IL13 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IL17A protein |
CTD |
PMID:28935500 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17rc |
interleukin 17 receptor C |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of IL17RC mRNA ochratoxin A results in increased acetylation of IL17RC promoter [ochratoxin A results in increased acetylation of IL17RC promoter] which results in increased expression of IL17RC mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:146,618,321...146,631,444
Ensembl chr 4:146,619,004...146,631,442
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
ochratoxin A results in increased expression of IL18 mRNA |
CTD |
PMID:33543323 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il19 |
interleukin 19 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL19 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr13:42,397,715...42,411,637
Ensembl chr13:42,399,138...42,405,473
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
ochratoxin A results in increased expression of IL1A mRNA |
CTD |
PMID:28286205 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO EXP |
ochratoxin A inhibits the reaction [IL1B protein results in increased expression of CXCL8 protein]; ochratoxin A inhibits the reaction [IL1B protein results in increased expression of F3 protein] ochratoxin A results in increased expression of IL1B mRNA ochratoxin A results in increased expression of IL1B mRNA; ochratoxin A results in increased expression of IL1B protein [Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL1B protein; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IL1B protein; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of IL1B mRNA] |
CTD |
PMID:18289624 PMID:18308354 PMID:24792326 PMID:28710020 PMID:28935500 PMID:33543323 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of IL1R2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il2 |
interleukin 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IL2 mRNA |
CTD |
PMID:27193732 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il20 |
interleukin 20 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL20 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr13:42,380,981...42,384,625
Ensembl chr13:42,380,981...42,384,625
|
|
G |
Il20ra |
interleukin 20 receptor subunit alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of IL20RA mRNA |
CTD |
PMID:35843423 |
|
NCBI chr 1:14,424,215...14,494,226
Ensembl chr 1:14,451,228...14,493,602
|
|
G |
Il24 |
interleukin 24 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL24 mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il4 |
interleukin 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IL4 mRNA |
CTD |
PMID:24792326 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of IL6 mRNA ochratoxin A results in increased expression of IL6 mRNA; ochratoxin A results in increased expression of IL6 protein Quercetin inhibits the reaction [ochratoxin A results in increased expression of IL6 protein] [Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL6 protein; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IL6 protein; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of IL6 mRNA] |
CTD |
PMID:24792326 PMID:25532488 PMID:28286205 PMID:28710020 PMID:28935500 PMID:37162024 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inhba |
inhibin subunit beta A |
increases expression |
EXP |
ochratoxin A results in increased expression of INHBA mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of AKT1 protein]; INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:30287338 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
increases expression decreases methylation |
ISO |
ochratoxin A results in increased expression of IPCEF1 mRNA ochratoxin A results in decreased methylation of IPCEF1 promoter |
CTD |
PMID:30559759 |
|
NCBI chr 1:43,237,903...43,451,735
Ensembl chr 1:43,269,202...43,427,969
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of IQGAP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
|
|
G |
Isl2 |
ISL LIM homeobox 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ISL2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:55,923,805...55,928,790
Ensembl chr 8:55,923,805...55,928,790
|
|
G |
Itch |
itchy E3 ubiquitin protein ligase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ITCH mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:143,642,348...143,733,745
Ensembl chr 3:143,645,637...143,733,543
|
|
G |
Itga4 |
integrin subunit alpha 4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ITGA4 mRNA; ochratoxin A results in increased expression of ITGA4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Itga7 |
integrin subunit alpha 7 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ITGA7 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450
|
|
G |
Itgal |
integrin subunit alpha L |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ITGAL mRNA; ochratoxin A results in increased expression of ITGAL mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression |
EXP |
ochratoxin A results in increased expression of ITGAM mRNA |
CTD |
PMID:24792326 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb2 |
integrin subunit beta 2 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ITGB2 mRNA; ochratoxin A results in increased expression of ITGB2 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Itgb4 |
integrin subunit beta 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of ITGB4 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Itk |
IL2-inducible T-cell kinase |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ITK mRNA; ochratoxin A results in decreased expression of ITK mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:30,753,344...30,814,685
Ensembl chr10:30,753,344...30,814,685
|
|
G |
Itpkb |
inositol-trisphosphate 3-kinase B |
increases expression |
ISO |
ochratoxin A results in increased expression of ITPKB mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
|
|
G |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of JAKMIP2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr18:35,532,552...35,747,938
Ensembl chr18:35,532,552...35,747,775
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of JAM3 mRNA; ochratoxin A results in increased expression of JAM3 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
|
|
G |
Jkamp |
JNK1/MAPK8-associated membrane protein |
increases expression |
ISO |
ochratoxin A results in increased expression of JKAMP mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:90,648,043...90,661,985
Ensembl chr 6:90,648,160...90,662,501
|
|
G |
Jmjd6 |
jumonji domain containing 6, arginine demethylase and lysine hydroxylase |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of JMJD6 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression increases expression affects expression |
ISO EXP |
ochratoxin A results in decreased expression of JUN mRNA ochratoxin A results in increased expression of JUN protein ochratoxin A affects the expression of JUN mRNA |
CTD |
PMID:17316727 PMID:23172667 PMID:30763683 PMID:35843423 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
ochratoxin A results in increased expression of JUNB mRNA |
CTD |
PMID:17316727 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of KANK1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
|
|
G |
Kat14 |
lysine acetyltransferase 14 |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of KAT14 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:131,736,430...131,781,732
Ensembl chr 3:131,736,549...131,781,706
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of KCND2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
|
|
G |
Kcnip1 |
potassium voltage-gated channel interacting protein 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of KCNIP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:18,219,519...18,588,833
Ensembl chr10:18,219,519...18,589,045
|
|
G |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of KCNJ1 mRNA ochratoxin A results in increased expression of KCNJ1 mRNA |
CTD |
PMID:22124623 PMID:30559759 |
|
NCBI chr 8:30,779,883...30,808,607
Ensembl chr 8:30,753,617...30,813,796
|
|
G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KCNJ15 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
|
|
G |
Kdm1b |
lysine demethylase 1B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of KDM1B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:17,602,961...17,643,865
Ensembl chr17:17,602,961...17,643,800
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KEAP1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kif18a |
kinesin family member 18A |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of KIF18A promoter ochratoxin A results in decreased expression of KIF18A mRNA [ochratoxin A results in decreased acetylation of KIF18A promoter] which results in decreased expression of KIF18A mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
|
|
G |
Kif21b |
kinesin family member 21B |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of KIF21B mRNA |
CTD |
PMID:24356939 |
|
NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127
|
|
G |
Kitlg |
KIT ligand |
decreases expression |
EXP |
ochratoxin A results in decreased expression of KITLG mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Klf2 |
KLF transcription factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KLF2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klhdc2 |
kelch domain containing 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KLHDC2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:87,777,183...87,791,609
Ensembl chr 6:87,777,183...87,804,187
|
|
G |
Klhl3 |
kelch-like family member 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of KLHL3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:6,523,089...6,645,971
Ensembl chr17:6,521,912...6,642,154
|
|
G |
Klk1b3 |
kallikrein 1-related peptidase B3 |
affects expression |
EXP |
ochratoxin A affects the expression of KLK1B3 mRNA |
CTD |
PMID:32468156 |
|
NCBI chr 1:94,709,105...94,713,308
Ensembl chr 1:94,709,105...94,713,308
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of KRAS mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krcc1 |
lysine-rich coiled-coil 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of KRCC1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 4:103,261,642...103,274,672
Ensembl chr 4:103,261,536...103,277,156
|
|
G |
Krt15 |
keratin 15 |
increases expression |
ISO |
ochratoxin A results in increased expression of KRT15 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Lactb2 |
lactamase, beta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of LACTB2 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
|
|
G |
Lama3 |
laminin subunit alpha 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of LAMA3 mRNA |
CTD |
PMID:17483316 PMID:18417182 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Lamb1 |
laminin subunit beta 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of LAMB1 mRNA; ochratoxin A results in decreased expression of LAMB1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
|
|
G |
Lars1 |
leucyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of LCN2; ochratoxin A results in increased expression of LCN2 mRNA [1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of LCN2 protein |
CTD |
PMID:18308701 PMID:25218026 PMID:36227364 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Ldha |
lactate dehydrogenase A |
increases expression |
ISO |
ochratoxin A results in increased expression of LDHA protein |
CTD |
PMID:32835834 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Ldhc |
lactate dehydrogenase C |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of LDHC promoter |
CTD |
PMID:29098329 |
|
NCBI chr 1:97,385,984...97,403,382
Ensembl chr 1:97,382,379...97,403,378
|
|
G |
Ldhd |
lactate dehydrogenase D |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of LDHD mRNA ochratoxin A results in increased methylation of LDHD gene |
CTD |
PMID:18417182 PMID:37162024 |
|
NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575
|
|
G |
Lig4 |
DNA ligase 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of LIG4 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr16:79,518,393...79,526,956
Ensembl chr16:79,518,312...79,527,040
|
|
G |
Limch1 |
LIM and calponin homology domains 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LIMCH1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:41,112,579...41,425,001
Ensembl chr14:41,114,803...41,425,191
|
|
G |
Lmnb1 |
lamin B1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LMNB1 protein |
CTD |
PMID:26861962 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lmo1 |
LIM domain only 1 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of LMO1 mRNA ochratoxin A results in decreased methylation of LMO1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:163,132,338...163,168,521
Ensembl chr 1:163,132,339...163,168,522
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of LONP1 protein HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein] HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein]; Ursolic Acid inhibits the reaction [ochratoxin A results in decreased expression of LONP1 protein] |
CTD |
PMID:31369848 PMID:36587836 |
|
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
|
|
G |
Lpl |
lipoprotein lipase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LPL |
CTD |
PMID:20590410 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Lpo |
lactoperoxidase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LPO mRNA |
CTD |
PMID:34748853 |
|
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
|
|
G |
Lpp |
LIM domain containing preferred translocation partner in lipoma |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LPP mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
|
|
G |
Lratd1 |
LRAT domain containing 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of LRATD1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:36,916,969...36,922,143
Ensembl chr 6:36,913,469...36,922,319
|
|
G |
Lrba |
LPS responsive beige-like anchor protein |
increases expression |
ISO |
ochratoxin A results in increased expression of LRBA mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:171,623,668...172,202,576
Ensembl chr 2:171,621,507...172,202,724
|
|
G |
Lrrc14 |
leucine rich repeat containing 14 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of LRRC14 mRNA ochratoxin A results in increased methylation of LRRC14 gene |
CTD |
PMID:37162024 |
|
NCBI chr 7:108,430,755...108,437,118
Ensembl chr 7:108,430,792...108,437,111
|
|
G |
Lrrc37a |
leucine rich repeat containing 37A |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of LRRC37A3 mRNA; ochratoxin A results in increased expression of LRRC37A3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr10:88,395,837...88,433,519
Ensembl chr10:88,396,663...88,433,323
|
|
G |
Lsm10 |
LSM10, U7 small nuclear RNA associated |
decreases expression |
EXP |
ochratoxin A results in decreased expression of LSM10 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:138,365,983...138,375,856
Ensembl chr 5:138,373,119...138,377,505
|
|
G |
Ly6g6c |
lymphocyte antigen 6 family member G6C |
increases expression |
EXP |
ochratoxin A results in increased expression of LY6G6C mRNA |
CTD |
PMID:30449730 |
|
NCBI chr20:3,753,632...3,757,205
Ensembl chr20:3,753,632...3,758,867
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
ochratoxin A results in increased expression of MAFG mRNA |
CTD |
PMID:32905824 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Mall |
mal, T-cell differentiation protein-like |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MALL mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785
|
|
G |
Maoa |
monoamine oxidase A |
increases methylation |
EXP |
ochratoxin A results in increased methylation of MAOA gene |
CTD |
PMID:26431795 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of MAP1LC3B protein] |
CTD |
PMID:36058351 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of MAP2K1 protein |
CTD |
PMID:25002221 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of MAP2K2 protein |
CTD |
PMID:25002221 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MAP3K1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MAP3K14 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr10:88,165,349...88,215,558
Ensembl chr10:88,165,351...88,215,523
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MAP3K8 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MAP4K4 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases response to substance increases phosphorylation |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in increased phosphorylation of MAPK1 protein]; Citrinin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK1 protein]; MAPK1 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein]; ochratoxin A promotes the reaction [Citrinin results in increased phosphorylation of MAPK1 protein]; ochratoxin A results in increased phosphorylation of and results in increased activity of MAPK1 protein; wortmannin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK1 protein] MAPK1 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:11711124 PMID:17651772 PMID:22230261 PMID:23172667 PMID:25002221 PMID:27193732 PMID:29673704 PMID:31154016 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk12 |
mitogen-activated protein kinase 12 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of MAPK12 mRNA; ochratoxin A results in decreased expression of MAPK12 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 7:120,206,005...120,216,711
Ensembl chr 7:120,206,271...120,216,664
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions increases response to substance increases expression |
ISO |
MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein] MAPK14 protein results in increased susceptibility to ochratoxin A ochratoxin A metabolite results in increased expression of MAPK14 mRNA; ochratoxin A results in increased expression of MAPK14 mRNA |
CTD |
PMID:22230261 PMID:26314263 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk15 |
mitogen-activated protein kinase 15 |
affects expression |
EXP |
ochratoxin A affects the expression of MAPK15 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr 7:107,694,907...107,714,640
Ensembl chr 7:107,694,964...107,714,645
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in increased phosphorylation of MAPK3 protein]; Citrinin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK3 protein]; ochratoxin A promotes the reaction [Citrinin results in increased phosphorylation of MAPK3 protein]; ochratoxin A results in increased phosphorylation of and results in increased activity of MAPK3 protein; Wortmannin promotes the reaction [ochratoxin A results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11711124 PMID:17651772 PMID:22230261 PMID:23172667 PMID:25002221 PMID:27193732 PMID:29673704 PMID:31154016 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk4 |
mitogen-activated protein kinase 4 |
increases acetylation affects expression |
ISO EXP |
ochratoxin A results in increased acetylation of MAPK4 promoter ochratoxin A affects the expression of MAPK4 mRNA |
CTD |
PMID:29098329 PMID:35843423 |
|
NCBI chr18:67,512,805...67,661,271
Ensembl chr18:67,512,807...67,661,842
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases phosphorylation |
EXP ISO |
ochratoxin A results in increased phosphorylation of and results in increased activity of MAPK8 protein ochratoxin A results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:17651772 PMID:31154016 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
affects expression |
EXP |
ochratoxin A affects the expression of MAPK8IP2 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr 7:120,526,732...120,536,982
Ensembl chr 7:120,526,732...120,536,982
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
decreases phosphorylation |
ISO |
ochratoxin A results in decreased phosphorylation of MAPK9 protein |
CTD |
PMID:25002221 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
decreases expression multiple interactions decreases acetylation |
ISO |
ochratoxin A results in decreased expression of MAPRE1 mRNA [ochratoxin A results in decreased acetylation of MAPRE1 promoter] which results in decreased expression of MAPRE1 mRNA |
CTD |
PMID:19287073 PMID:29098329 |
|
NCBI chr 3:142,218,846...142,246,990
Ensembl chr 3:142,212,955...142,246,983
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
increases expression |
EXP |
ochratoxin A results in increased expression of MARCKS mRNA |
CTD |
PMID:19717638 |
|
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Mars1 |
methionyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:63,121,142...63,138,550
Ensembl chr 7:63,121,142...63,138,495
|
|
G |
Marveld3 |
MARVEL domain containing 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MARVELD3 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr19:37,908,727...37,923,420
Ensembl chr19:37,905,638...37,923,420
|
|
G |
Mbp |
myelin basic protein |
increases expression multiple interactions decreases expression |
ISO EXP |
ochratoxin A results in increased expression of MBP mRNA [MT1A protein co-treated with MT2A protein] inhibits the reaction [ochratoxin A results in decreased expression of MBP protein] ochratoxin A results in decreased expression of MBP mRNA; ochratoxin A results in decreased expression of MBP protein |
CTD |
PMID:22124623 PMID:24792326 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of MCL1 mRNA ochratoxin A results in decreased expression of MCL1 mRNA |
CTD |
PMID:19562491 PMID:30763683 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of MCM3 mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of MDM2 mRNA ochratoxin A results in decreased expression of MDM2 mRNA |
CTD |
PMID:23358140 PMID:30763683 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Me1 |
malic enzyme 1 |
decreases expression increases expression |
EXP ISO |
ochratoxin A results in decreased expression of ME1 mRNA ochratoxin A results in increased expression of ME1 mRNA |
CTD |
PMID:16251485 PMID:30008028 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Med21 |
mediator complex subunit 21 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MED21 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
|
|
G |
Mefv |
MEFV innate immunity regulator, pyrin |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of MEFV gene |
CTD |
PMID:26431795 |
|
NCBI chr10:11,786,948...11,796,977
Ensembl chr10:11,787,422...11,796,973
|
|
G |
Meltf |
melanotransferrin |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of MELTF gene ochratoxin A results in increased expression of MELTF mRNA |
CTD |
PMID:37162024 |
|
NCBI chr11:68,884,446...68,906,300
Ensembl chr11:68,884,446...68,906,300
|
|
G |
Mesd |
mesoderm development LRP chaperone |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MESD mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:137,866,707...137,879,999
Ensembl chr 1:137,874,242...137,879,999
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
multiple interactions |
ISO |
5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one inhibits the reaction [ochratoxin A results in increased phosphorylation of MET protein]; ochratoxin A results in increased phosphorylation of and results in increased expression of MET protein |
CTD |
PMID:25002221 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mettl9 |
methyltransferase 9, His-X-His N1(pi)-histidine |
increases expression |
ISO |
ochratoxin A results in increased expression of METTL9 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:175,575,805...175,623,065
Ensembl chr 1:175,577,890...175,623,061
|
|
G |
Mgat4b |
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MGAT4B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:34,548,918...34,559,229
Ensembl chr10:34,549,433...34,559,229
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
ochratoxin A results in increased expression of MGMT mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
decreases expression affects expression |
EXP ISO |
ochratoxin A results in decreased expression of MGST1 mRNA ochratoxin A affects the expression of MGST1 mRNA |
CTD |
PMID:17483316 PMID:22124623 PMID:23358140 PMID:32905824 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Micu3 |
mitochondrial calcium uptake family, member 3 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of MICU3 gene |
CTD |
PMID:26431795 |
|
NCBI chr16:51,919,859...52,010,705
Ensembl chr16:51,925,225...52,010,613
|
|
G |
Mif |
macrophage migration inhibitory factor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MIF mRNA |
CTD |
PMID:23358140 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Miox |
myo-inositol oxygenase |
affects expression |
EXP |
ochratoxin A affects the expression of MIOX mRNA |
CTD |
PMID:32468156 |
|
NCBI chr 7:120,405,031...120,407,529
Ensembl chr 7:120,405,031...120,407,537
|
|
G |
Mir1 |
microRNA 1 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR1 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:1,887,537...1,887,623
|
|
G |
Mir122 |
microRNA 122 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR122 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR122 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir1224 |
microRNA 1224 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR1224 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr11:80,306,902...80,306,986
Ensembl chr11:80,306,902...80,306,986
|
|
G |
Mir127 |
microRNA 127 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR127 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:128,546,215...128,546,311
|
|
G |
Mir132 |
microRNA 132 |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR132 mRNA ochratoxin A results in increased expression of MIR132 mRNA |
CTD |
PMID:30428381 PMID:30559759 |
|
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
|
|
G |
Mir134 |
microRNA 134 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR134 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:128,748,908...128,748,980
|
|
G |
Mir139 |
microRNA 139 |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR139 mRNA ochratoxin A results in increased expression of MIR139 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:155,878,828...155,878,895
Ensembl chr 1:155,878,825...155,878,902
|
|
G |
Mir141 |
microRNA 141 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR141 mRNA |
CTD |
PMID:30428381 PMID:30559759 |
|
NCBI chr 4:157,523,239...157,523,332
Ensembl chr 4:157,523,239...157,523,332
|
|
G |
Mir142 |
microRNA 142 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR142 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR142 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:72,557,864...72,557,950
Ensembl chr10:72,557,857...72,557,967
|
|
G |
Mir144 |
microRNA 144 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR144 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR144 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir146a |
microRNA 146a |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR146A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir146b |
microRNA 146b |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR146B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:245,203,438...245,203,525
|
|
G |
Mir147 |
microRNA 147 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR147B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 3:109,722,692...109,722,770
Ensembl chr 3:109,722,692...109,722,770
|
|
G |
Mir148a |
microRNA 148a |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR148A mRNA |
CTD |
PMID:26341324 |
|
NCBI chr 4:80,333,762...80,333,858
Ensembl chr 4:80,333,762...80,333,858
|
|
G |
Mir152 |
microRNA 152 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR152 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR152 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:81,832,936...81,833,020
Ensembl chr10:81,832,936...81,833,020
|
|
G |
Mir184 |
microRNA 184 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR184 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR184 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
|
|
G |
Mir187 |
microRNA 187 |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR187 mRNA ochratoxin A results in increased expression of MIR187 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:15,731,194...15,731,297
Ensembl chr18:15,731,194...15,731,297
|
|
G |
Mir190b |
microRNA 190b |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR190B mRNA ochratoxin A results in increased expression of MIR190B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:175,514,800...175,514,877
Ensembl chr 2:175,514,800...175,514,877
|
|
G |
Mir200b |
microRNA 200b |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR200B mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR200B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
|
|
G |
Mir200c |
microRNA 200c |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR200C mRNA ochratoxin A results in increased expression of MIR200C mRNA |
CTD |
PMID:30428381 PMID:30559759 |
|
NCBI chr 4:157,523,679...157,523,747
|
|
G |
Mir21 |
microRNA 21 |
increases expression decreases expression |
ISO |
ochratoxin A results in increased expression of MIR21A mRNA ochratoxin A results in decreased expression of MIR21 mRNA |
CTD |
PMID:28710020 PMID:30559759 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir219a1 |
microRNA 219a-1 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR219A1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr20:4,829,687...4,829,796
Ensembl chr20:4,829,687...4,829,796
|
|
G |
Mir23b |
microRNA 23b |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR23B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
|
|
G |
Mir295-1 |
microRNA 295-1 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR372 mRNA [Citrinin co-treated with ochratoxin A] results in increased expression of MIR372 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:65,962,566...65,962,646
Ensembl chr 1:65,962,566...65,962,646
|
|
G |
Mir29b1 |
microRNA 29b-1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR29B1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:59,650,987...59,651,067
Ensembl chr 4:59,650,986...59,651,067
|
|
G |
Mir32 |
microRNA 32 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR32 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:71,596,083...71,596,152
Ensembl chr 5:71,596,083...71,596,152
|
|
G |
Mir331 |
microRNA 331 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR331 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:28,527,390...28,527,485
Ensembl chr 7:28,527,390...28,527,485
|
|
G |
Mir34a |
microRNA 34a |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MIR34A mRNA sulforaphane inhibits the reaction [ochratoxin A results in increased expression of MIR34A mRNA] |
CTD |
PMID:28710020 |
|
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
|
|
G |
Mir34b |
microRNA 34b |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR34B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
|
|
G |
Mir34c |
microRNA 34c |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR34C mRNA ochratoxin A results in increased expression of MIR34C mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
|
|
G |
Mir374b |
microRNA 374b |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR374B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr X:68,591,732...68,591,799
Ensembl chr X:68,591,732...68,591,799
|
|
G |
Mir449a |
microRNA 449a |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR449A mRNA ochratoxin A results in increased expression of MIR449A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:44,670,714...44,670,804
Ensembl chr 2:44,670,714...44,670,804
|
|
G |
Mir449c |
microRNA 449c |
multiple interactions increases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in increased expression of MIR449C mRNA ochratoxin A results in increased expression of MIR449C mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:44,669,179...44,669,277
Ensembl chr 2:44,669,179...44,669,277
|
|
G |
Mir497 |
microRNA 497 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR497 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
|
|
G |
Mir542 |
microRNA 542 |
increases expression |
ISO |
ochratoxin A results in increased expression of MIR542 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:132,802,623...132,802,701
Ensembl chr X:132,802,623...132,802,701
|
|
G |
Mir92b |
microRNA 92b |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIR92B mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 2:174,633,890...174,633,972
Ensembl chr 2:174,633,890...174,633,972
|
|
G |
Mis18bp1 |
MIS18 binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MIS18BP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:83,182,497...83,231,978
Ensembl chr 6:83,182,499...83,231,383
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of MKI67 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of MKI67 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mlc1 |
modulator of VRAC current 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MLC1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:120,046,705...120,067,049
Ensembl chr 7:120,046,705...120,067,049
|
|
G |
Mme |
membrane metallo-endopeptidase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MME mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Mmp11 |
matrix metallopeptidase 11 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of MMP11 promoter] which results in increased expression of MMP11 mRNA ochratoxin A results in increased expression of MMP11 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:12,730,846...12,739,629
Ensembl chr20:12,730,836...12,739,628
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of MMP2 mRNA ochratoxin A results in increased expression of MMP2 mRNA; ochratoxin A results in increased expression of MMP2 protein ochratoxin A results in increased expression of and results in increased activity of MMP2 protein |
CTD |
PMID:31154016 PMID:32617660 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions increases expression |
EXP ISO |
Ethanol affects the reaction [ochratoxin A results in increased expression of MMP9 protein] ochratoxin A results in increased expression of MMP9 mRNA; ochratoxin A results in increased expression of MMP9 protein NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of MMP9 protein] ochratoxin A results in increased expression of and results in increased activity of MMP9 protein |
CTD |
PMID:16622519 PMID:28710020 PMID:32617660 PMID:37162024 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mog |
myelin oligodendrocyte glycoprotein |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of MOG mRNA; ochratoxin A results in decreased expression of MOG protein SHH protein inhibits the reaction [ochratoxin A results in decreased expression of MOG mRNA] |
CTD |
PMID:24792326 |
|
NCBI chr20:1,513,137...1,523,473
Ensembl chr20:1,513,239...1,523,474
|
|
G |
Morf4l1 |
mortality factor 4 like 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of MORF4L1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:90,642,988...90,664,518
Ensembl chr 8:90,642,988...90,664,519
|
|
G |
Mpdu1 |
mannose-P-dolichol utilization defect 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MPDU1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr10:54,374,719...54,380,301
Ensembl chr10:54,374,725...54,380,447
|
|
G |
Mpg |
N-methylpurine-DNA glycosylase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MPG mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
|
|
G |
Mprip |
myosin phosphatase Rho interacting protein |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MPRIP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:44,453,949...44,573,843
Ensembl chr10:44,453,929...44,569,118
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of MRC1 mRNA |
CTD |
PMID:24792326 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mrc2 |
mannose receptor, C type 2 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of MRC2 promoter [ochratoxin A results in increased acetylation of MRC2 promoter] which results in increased expression of MRC2 mRNA ochratoxin A results in increased expression of MRC2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:90,261,986...90,323,187
Ensembl chr10:90,261,394...90,322,856
|
|
G |
Mri1 |
methylthioribose-1-phosphate isomerase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MRI1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr19:23,907,327...23,913,721
Ensembl chr19:23,907,335...23,913,320
|
|
G |
Mrpl54 |
mitochondrial ribosomal protein L54 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of MRPL54 mRNA ochratoxin A results in increased methylation of MRPL54 gene |
CTD |
PMID:37162024 |
|
NCBI chr 7:8,452,801...8,455,321
Ensembl chr 7:8,452,716...8,455,321
|
|
G |
Mrps34 |
mitochondrial ribosomal protein S34 |
increases methylation decreases expression |
EXP |
ochratoxin A results in increased methylation of MRPS34 gene ochratoxin A results in decreased expression of MRPS34 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:13,916,024...13,917,155
Ensembl chr10:13,916,026...13,918,406
|
|
G |
Mrtfa |
myocardin related transcription factor A |
increases expression |
EXP |
ochratoxin A results in increased expression of MRTFA mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:112,544,305...112,714,418
Ensembl chr 7:112,544,312...112,714,418
|
|
G |
Msh5 |
mutS homolog 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of MSH5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr20:3,773,867...3,793,337
Ensembl chr20:3,776,942...3,793,336
|
|
G |
Msln |
mesothelin |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of MSLN mRNA [ochratoxin A results in increased acetylation of MSLN promoter] which results in increased expression of MSLN mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
|
|
G |
Msra |
methionine sulfoxide reductase A |
affects expression |
EXP |
ochratoxin A affects the expression of MSRA mRNA |
CTD |
PMID:17483316 |
|
NCBI chr15:38,363,459...38,677,406
Ensembl chr15:38,351,445...38,676,585
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
multiple interactions increases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ATP6 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ATP6 mRNA ochratoxin A results in increased expression of ATP6 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ATP8 mRNA; [Zearalenone co-treated with ochratoxin A] results in decreased expression of ATP8 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A] results in decreased expression of COX1 mRNA; [Zearalenone co-treated with ochratoxin A] results in decreased expression of COX1 mRNA ochratoxin A results in decreased expression of COX1 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A] results in decreased expression of COX3 mRNA; [Zearalenone co-treated with ochratoxin A] results in decreased expression of COX3 mRNA ochratoxin A results in decreased expression of COX3 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
|
|
G |
Mt-nd2 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 |
multiple interactions increases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND2 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND2 mRNA ochratoxin A results in increased expression of ND2 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
|
|
G |
Mt-nd3 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND3 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND3 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798
Ensembl chr MT:9,451...9,798
|
|
G |
Mt-nd4 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of ND4 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND4 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ND4 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND4 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537
Ensembl chr MT:10,160...11,537
|
|
G |
Mt-nd4l |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND4L mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND4L mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND4L mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166
Ensembl chr MT:9,870...10,166
|
|
G |
Mt-nd5 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of ND5 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND5 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of ND5 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of ND5 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND5 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
|
|
G |
Mt-nd6 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND6 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of ND6 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of ND6 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
|
|
G |
Mt1 |
metallothionein 1 |
decreases expression multiple interactions increases expression |
EXP ISO |
ochratoxin A results in decreased expression of MT1A protein [MT1A protein co-treated with MT2A protein] inhibits the reaction [ochratoxin A results in decreased expression of MBP protein] ochratoxin A results in increased expression of MT1A mRNA [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc co-treated with ochratoxin A] results in increased expression of MT1A mRNA; Zinc promotes the reaction [ochratoxin A results in increased expression of MT1A mRNA] |
CTD |
PMID:19720134 PMID:23391613 PMID:24792326 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions increases expression decreases expression |
ISO EXP |
[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc co-treated with ochratoxin A] results in increased expression of MT2A mRNA; Zinc deficiency inhibits the reaction [ochratoxin A results in increased expression of MT2A mRNA]; Zinc promotes the reaction [ochratoxin A results in increased expression of MT2A mRNA] ochratoxin A results in decreased expression of MT2A protein [MT1A protein co-treated with MT2A protein] inhibits the reaction [ochratoxin A results in decreased expression of MBP protein] |
CTD |
PMID:19720134 PMID:23391613 PMID:24792326 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mterf3 |
mitochondrial transcription termination factor 3 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of MTERF3 mRNA ochratoxin A results in decreased acetylation of MTERF3 promoter [ochratoxin A results in decreased acetylation of MTERF3 promoter] which results in decreased expression of MTERF3 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:63,826,418...63,844,747
Ensembl chr 7:63,826,427...63,844,658
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases phosphorylation multiple interactions decreases expression |
ISO |
ochratoxin A results in increased phosphorylation of MTOR protein INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of MTOR protein] ochratoxin A results in decreased expression of MTOR mRNA |
CTD |
PMID:25002221 PMID:30287338 PMID:34748853 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mtus1 |
microtubule associated scaffold protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MTUS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr16:51,202,497...51,347,794
Ensembl chr16:51,253,562...51,347,793
|
|
G |
Muc1 |
mucin 1, cell surface associated |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MUC1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[Aflatoxin M1 co-treated with ochratoxin A] results in decreased secretion of MUC2 protein; [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of MUC2 mRNA; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased expression of MUC2 mRNA; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased secretion of MUC2 protein |
CTD |
PMID:30904571 |
|
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased expression of MUC5AC mRNA; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in increased secretion of MUC5AC protein |
CTD |
PMID:30904571 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[Aflatoxin M1 co-treated with ochratoxin A] results in decreased expression of MUC5B mRNA; [Aflatoxin M1 co-treated with ochratoxin A] results in decreased secretion of MUC5B protein; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased expression of MUC5B mRNA; [Aflatoxin M1 co-treated with Zearalenone co-treated with ochratoxin A] results in decreased secretion of MUC5B protein |
CTD |
PMID:30904571 |
|
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of MYBL1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of MYC mRNA ochratoxin A results in increased expression of MYC mRNA sulforaphane inhibits the reaction [ochratoxin A results in increased expression of MYC mRNA] |
CTD |
PMID:16251485 PMID:17316727 PMID:19237604 PMID:19717638 PMID:28710020 PMID:30763683 PMID:31154016 PMID:37162024 More...
|
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myo1b |
myosin Ib |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MYO1B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:49,690,043...49,852,373
Ensembl chr 9:49,690,086...49,850,798
|
|
G |
Myof |
myoferlin |
decreases expression |
ISO |
ochratoxin A results in decreased expression of MYOF protein |
CTD |
PMID:26861962 |
|
NCBI chr 1:235,673,666...235,822,413
Ensembl chr 1:235,673,666...235,822,334
|
|
G |
Naa40 |
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NAA40 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:204,410,636...204,430,890
Ensembl chr 1:204,413,498...204,430,717
|
|
G |
Naga |
alpha-N-acetylgalactosaminidase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NAGA mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 7:113,846,358...113,855,430
Ensembl chr 7:113,846,374...113,855,315
|
|
G |
Nagk |
N-acetylglucosamine kinase |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of NAGK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:116,281,179...116,293,870
Ensembl chr 4:116,281,328...116,313,137
|
|
G |
Nanos1 |
nanos C2HC-type zinc finger 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of NANOS1 mRNA; ochratoxin A results in decreased expression of NANOS1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:259,897,663...259,901,561
Ensembl chr 1:259,897,939...259,898,730
|
|
G |
Naprt |
nicotinate phosphoribosyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAPRT mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:107,576,645...107,580,102
Ensembl chr 7:107,576,627...107,580,102
|
|
G |
Nat2 |
N-acetyltransferase 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NAT2 mRNA |
CTD |
PMID:26505656 |
|
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nat8 |
N-acetyltransferase 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAT8 mRNA |
CTD |
PMID:17483316 PMID:18417182 |
|
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
|
|
G |
Nat8b |
N-acetyltransferase 8B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAT8B mRNA |
CTD |
PMID:17483316 PMID:30449730 |
|
NCBI chr 4:118,359,445...118,364,351
Ensembl chr 4:118,359,443...118,363,563
|
|
G |
Nat8f1 |
N-acetyltransferase 8 (GCN5-related) family member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAT8F1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 4:118,336,208...118,342,923
Ensembl chr 4:118,332,862...118,344,035
|
|
G |
Nat8f2 |
N-acetyltransferase 8 (GCN5-related) family member 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of NAT8F2 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:118,319,984...118,323,159
Ensembl chr 4:118,319,988...118,324,395
|
|
G |
Nat8f3 |
N-acetyltransferase 8 (GCN5-related) family member 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NAT8F3 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:118,241,792...118,246,010
Ensembl chr 4:118,239,304...118,285,500
|
|
G |
Ncbp1 |
nuclear cap binding protein subunit 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NCBP1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:60,416,023...60,449,004
Ensembl chr 5:60,415,982...60,449,089
|
|
G |
Ncoa3 |
nuclear receptor coactivator 3 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of NCOA3 promoter [ochratoxin A results in decreased acetylation of NCOA3 promoter] which results in decreased expression of NCOA3 mRNA ochratoxin A results in decreased expression of NCOA3 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594
|
|
G |
Ndufa1 |
NADH:ubiquinone oxidoreductase subunit A1 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFA1 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr X:116,424,223...116,427,875
Ensembl chr X:116,424,223...116,428,633
|
|
G |
Ndufa10 |
NADH:ubiquinone oxidoreductase subunit A10 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFA10 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 9:93,007,034...93,041,825
Ensembl chr 9:93,007,042...93,042,560
|
|
G |
Ndufa2 |
NADH:ubiquinone oxidoreductase subunit A2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NDUFA2 mRNA |
CTD |
PMID:34481902 |
|
NCBI chr18:28,355,774...28,357,863
Ensembl chr18:28,355,774...28,358,076
|
|
G |
Ndufa3 |
NADH:ubiquinone oxidoreductase subunit A3 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFA3 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 1:65,597,567...65,600,197
Ensembl chr 1:65,597,578...65,600,235
|
|
G |
Ndufa7 |
NADH:ubiquinone oxidoreductase subunit A7 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFA7 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 7:14,609,283...14,622,064
Ensembl chr 7:14,609,146...14,631,976
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFB2 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
|
|
G |
Ndufb7 |
NADH:ubiquinone oxidoreductase subunit B7 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFB7 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr19:24,568,241...24,572,579
Ensembl chr19:24,568,241...24,572,579
|
|
G |
Ndufc1 |
NADH:ubiquinone oxidoreductase subunit C1 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFC1 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 2:135,447,067...135,450,950
Ensembl chr 2:135,447,119...135,450,874
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NDUFS1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Ndufs6 |
NADH:ubiquinone oxidoreductase subunit S6 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFS6 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 1:29,968,833...29,977,423
Ensembl chr 1:29,968,842...29,977,467
|
|
G |
Ndufs7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
increases expression |
ISO |
ochratoxin A results in increased expression of NDUFS7 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
|
|
G |
Ndufs8 |
NADH:ubiquinone oxidoreductase core subunit S8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NDUFS8 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:201,140,585...201,144,573
Ensembl chr 1:201,140,585...201,144,511
|
|
G |
Ndufv2 |
NADH:ubiquinone oxidoreductase core subunit V2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NDUFV2 protein |
CTD |
PMID:31369848 |
|
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
|
|
G |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of NECAB2 mRNA ochratoxin A results in decreased methylation of NECAB2 gene |
CTD |
PMID:18417182 PMID:37162024 |
|
NCBI chr19:47,501,351...47,527,722
Ensembl chr19:47,501,302...47,527,684
|
|
G |
Nectin1 |
nectin cell adhesion molecule 1 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of NECTIN1 promoter ochratoxin A results in increased expression of NECTIN1 mRNA [ochratoxin A results in increased acetylation of NECTIN1 promoter] which results in increased expression of NECTIN1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787
|
|
G |
Nefh |
neurofilament heavy chain |
multiple interactions |
EXP |
ochratoxin A results in decreased expression of and results in decreased phosphorylation of NEFH protein |
CTD |
PMID:24792326 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nes |
nestin |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of NES mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of NES mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Neto2 |
neuropilin and tolloid like 2 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of NETO2 promoter |
CTD |
PMID:29098329 |
|
NCBI chr19:21,344,299...21,415,524
Ensembl chr19:21,344,289...21,417,023
|
|
G |
Neurl2 |
neuralized E3 ubiquitin protein ligase 2 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of NEURL2 mRNA ochratoxin A results in increased methylation of NEURL2 gene |
CTD |
PMID:37162024 |
|
NCBI chr 3:153,566,659...153,569,380
Ensembl chr 3:153,566,660...153,569,380
|
|
G |
Neurod1 |
neuronal differentiation 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NEUROD1 mRNA |
CTD |
PMID:21703336 |
|
NCBI chr 3:64,359,554...64,363,526
Ensembl chr 3:64,359,395...64,363,649
|
|
G |
Nexn |
nexilin (F actin binding protein) |
increases expression |
EXP |
ochratoxin A results in increased expression of NEXN mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342
|
|
G |
Nf1 |
neurofibromin 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of NF1 mRNA; ochratoxin A results in increased expression of NF1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of NFATC1 mRNA [ochratoxin A results in increased acetylation of NFATC1 promoter] which results in increased expression of NFATC1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases activity increases expression affects response to substance affects localization increases methylation |
EXP ISO |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein]; ochratoxin A inhibits the reaction [NFE2L2 protein binds to GSTP1 protein] ochratoxin A results in increased expression of NFE2L2 mRNA [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of CAT mRNA; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of GSR mRNA; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA mRNA; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA protein; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased abundance of Creatinine; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of BBC3 protein; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of ICAM1 protein; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TGFB1 protein; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TIMP2 mRNA; NFE2L2 protein affects the reaction [ochratoxin A results in decreased expression of TGFB2 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of MMP9 protein]; ochratoxin A affects the reaction [NFE2L2 protein affects the expression of HMOX1 mRNA]; ochratoxin A promotes the reaction [NFE2L2 protein affects the expression of BBC3 mRNA] ochratoxin A affects the localization of NFE2L2 protein AHR protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA] ochratoxin A results in increased methylation of NFE2L2 promoter |
CTD |
PMID:17110534 PMID:24120684 PMID:28710020 PMID:30291945 PMID:30559759 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfe2l3 |
NFE2 like bZIP transcription factor 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of NFE2L3 mRNA; ochratoxin A results in decreased expression of NFE2L3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 4:80,506,756...80,534,629
Ensembl chr 4:80,506,756...80,534,629
|
|
G |
Nfia |
nuclear factor I/A |
increases expression |
EXP |
ochratoxin A results in increased expression of NFIA mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 5:112,436,655...112,781,878
Ensembl chr 5:112,436,644...112,775,885
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases degradation increases phosphorylation decreases expression |
ISO |
ochratoxin A results in increased degradation of NFKBIA protein ochratoxin A results in increased phosphorylation of NFKBIA protein ochratoxin A results in decreased expression of NFKBIA mRNA |
CTD |
PMID:18647641 PMID:23172667 PMID:30763683 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nisch |
nischarin |
increases expression |
EXP |
ochratoxin A results in increased expression of NISCH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr16:6,364,370...6,400,675
Ensembl chr16:6,364,374...6,400,668
|
|
G |
Nit2 |
nitrilase family, member 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NIT2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr11:43,363,839...43,378,713
Ensembl chr11:43,363,985...43,375,024
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of NLRP3 mRNA; ochratoxin A results in increased expression of NLRP3 protein |
CTD |
PMID:33543323 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nmb |
neuromedin B |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of NMB gene ochratoxin A results in increased expression of NMB mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NME2 protein |
CTD |
PMID:26861962 |
|
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
|
|
G |
Nnt |
nicotinamide nucleotide transhydrogenase |
increases expression |
ISO |
ochratoxin A results in increased expression of NNT protein |
CTD |
PMID:26861962 |
|
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression multiple interactions |
ISO EXP |
ochratoxin A results in increased expression of NOS2 protein 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of NOS2 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of NOS2 mRNA] ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] ochratoxin A results in increased expression of NOS2 mRNA; ochratoxin A results in increased expression of NOS2 protein |
CTD |
PMID:15994020 PMID:18647641 PMID:19414514 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of NOTCH1 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Notch2 |
notch receptor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NOTCH2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Noxa1 |
NADPH oxidase activator 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NOXA1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:7,895,488...7,907,011
Ensembl chr 3:7,895,488...7,905,967
|
|
G |
Npc1l1 |
NPC1 like intracellular cholesterol transporter 1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of NPC1L1 gene |
CTD |
PMID:26431795 |
|
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
|
|
G |
Npm1 |
nucleophosmin 1 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of NPM1 protein ochratoxin A results in increased expression of NPM1 mRNA |
CTD |
PMID:19445961 PMID:23358140 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
|
|
G |
Nppa |
natriuretic peptide A |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of NPPA gene ochratoxin A results in increased expression of NPPA mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
decreases expression increases expression multiple interactions increases activity |
EXP ISO |
ochratoxin A results in decreased expression of NQO1 mRNA; ochratoxin A results in decreased expression of NQO1 protein ochratoxin A results in increased expression of NQO1 mRNA [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of NQO1 protein] ochratoxin A results in increased activity of NQO1 protein |
CTD |
PMID:17110534 PMID:17316727 PMID:19717638 PMID:25209566 PMID:30291945 PMID:30559759 More...
|
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nqo2 |
N-ribosyldihydronicotinamide:quinone dehydrogenase 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NQO2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions decreases expression increases expression affects localization |
ISO |
Dactinomycin inhibits the reaction [ochratoxin A results in decreased expression of NR1I2 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA]; ochratoxin A inhibits the reaction [Rifampin results in increased activity of NR1I2 protein] ochratoxin A analog results in decreased expression of NR1I2 protein; ochratoxin A results in decreased expression of NR1I2 mRNA; ochratoxin A results in decreased expression of NR1I2 protein ochratoxin A results in increased expression of NR1I2 mRNA ochratoxin A affects the localization of NR1I2 protein |
CTD |
PMID:26341324 PMID:30291945 PMID:32659470 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nrdc |
nardilysin convertase |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of NRDC mRNA; ochratoxin A results in increased expression of NRDC mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 5:123,755,807...123,818,910
Ensembl chr 5:123,755,806...123,818,595
|
|
G |
Nrde2 |
NRDE-2, necessary for RNA interference, domain containing |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of NRDE2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 6:119,405,103...119,446,861
Ensembl chr 6:119,404,334...119,448,915
|
|
G |
Nrg1 |
neuregulin 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of NRG1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of NTRK1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
|
|
G |
Nudt15 |
nudix hydrolase 15 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NUDT15 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:48,707,776...48,713,847
Ensembl chr15:48,709,700...48,747,363
|
|
G |
Nudt21 |
nudix hydrolase 21 |
increases expression |
EXP |
ochratoxin A results in increased expression of NUDT21 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
|
|
G |
Nuf2 |
NUF2 component of NDC80 kinetochore complex |
increases expression |
EXP |
ochratoxin A results in increased expression of NUF2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
|
|
G |
Nup133 |
nucleoporin 133 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of NUP133 promoter ochratoxin A results in decreased expression of NUP133 mRNA [ochratoxin A results in decreased acetylation of NUP133 promoter] which results in decreased expression of NUP133 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr19:51,891,606...51,941,243
Ensembl chr19:51,891,629...51,941,239
|
|
G |
Nup50 |
nucleoporin 50 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NUP50 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:116,047,960...116,065,231
Ensembl chr 7:116,048,021...116,066,905
|
|
G |
Nup88 |
nucleoporin 88 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NUP88 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:55,667,903...55,692,249
Ensembl chr10:55,667,906...55,692,257
|
|
G |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of NXPE2 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 8:48,661,708...48,695,555
Ensembl chr 8:48,661,708...48,698,035
|
|
G |
Oat |
ornithine aminotransferase |
increases expression decreases expression decreases methylation |
ISO EXP |
ochratoxin A results in increased expression of OAT protein ochratoxin A results in decreased expression of OAT mRNA ochratoxin A results in decreased methylation of OAT gene |
CTD |
PMID:16251485 PMID:18417182 PMID:19445961 PMID:26431795 |
|
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
|
|
G |
Ocln |
occludin |
decreases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in decreased expression of OCLN mRNA illite affects the reaction [ochratoxin A results in decreased expression of OCLN mRNA] ochratoxin A results in increased acetylation of OCLN promoter |
CTD |
PMID:27153755 PMID:29098329 PMID:30763683 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
increases activity |
ISO |
ochratoxin A results in increased activity of ODC1 protein |
CTD |
PMID:23172667 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
decreases methylation decreases expression |
EXP ISO |
ochratoxin A results in decreased methylation of OGDH gene ochratoxin A results in decreased expression of OGDH protein |
CTD |
PMID:26431795 PMID:32835834 |
|
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
|
|
G |
Ogfrl1 |
opioid growth factor receptor-like 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of OGFRL1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:25,828,869...25,842,352
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of OGG1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Olig2 |
oligodendrocyte transcription factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of OLIG2 mRNA |
CTD |
PMID:34748853 |
|
NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152
|
|
G |
Oosp1 |
oocyte secreted protein 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of OOSP1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 1:208,515,497...208,547,077
|
|
G |
Or2d2 |
olfactory receptor family 2 subfamily D member 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of OR2D2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:160,979,415...160,980,362
Ensembl chr 1:160,979,043...160,983,787
|
|
G |
Or6c75 |
olfactory receptor family 6 subfamily C member 75 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of OR6C75 gene |
CTD |
PMID:26431795 |
|
NCBI chr 7:5,400,918...5,401,862
Ensembl chr 7:5,398,500...5,403,735
|
|
G |
Ormdl2 |
ORMDL sphingolipid biosynthesis regulator 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ORMDL2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 7:1,247,869...1,250,999
Ensembl chr 7:1,246,479...1,250,907
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of OSGIN1 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of OSGIN1 mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of OSGIN1 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
Osm |
oncostatin M |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of OSM gene ochratoxin A results in increased expression of OSM mRNA |
CTD |
PMID:37162024 |
|
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
|
|
G |
Pag1 |
phosphoprotein membrane anchor with glycosphingolipid microdomains 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of PAG1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:91,935,378...92,076,937
Ensembl chr 2:92,057,216...92,069,849
|
|
G |
Pak3 |
p21 (RAC1) activated kinase 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of PAK3 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr X:107,116,308...107,374,342
Ensembl chr X:107,260,898...107,368,314
|
|
G |
Papola |
poly (A) polymerase alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PAPOLA mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:124,682,015...124,734,706
Ensembl chr 6:124,682,105...124,734,468
|
|
G |
Pard6b |
par-6 family cell polarity regulator beta |
increases expression decreases expression |
ISO |
ochratoxin A metabolite results in increased expression of PARD6B mRNA; ochratoxin A results in increased expression of PARD6B mRNA ochratoxin A results in decreased expression of PARD6B mRNA |
CTD |
PMID:26314263 PMID:30763683 |
|
NCBI chr 3:156,790,540...156,811,620
Ensembl chr 3:156,790,540...156,811,622
|
|
G |
Parm1 |
prostate androgen-regulated mucin-like protein 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PARM1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:16,468,309...16,577,339
Ensembl chr14:16,468,459...16,577,314
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage increases expression multiple interactions decreases expression |
ISO |
ochratoxin A results in increased cleavage of PARP1 protein ochratoxin A results in increased expression of PARP1 protein [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of PARP1 protein ochratoxin A results in decreased expression of PARP1 mRNA |
CTD |
PMID:25002221 PMID:34126166 PMID:34481902 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parp12 |
poly (ADP-ribose) polymerase family, member 12 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PARP12 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions decreases activity decreases expression |
EXP |
ochratoxin A inhibits the reaction [Cyclic AMP results in increased expression of PCK1 mRNA] ochratoxin A results in decreased activity of PCK1 protein ochratoxin A results in decreased expression of PCK1 mRNA; ochratoxin A results in decreased expression of PCK1 protein |
CTD |
PMID:2569870 PMID:3753873 PMID:6859860 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PCK2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of PCNA mRNA ochratoxin A results in increased expression of PCNA; ochratoxin A results in increased expression of PCNA mRNA |
CTD |
PMID:17316727 PMID:23358140 PMID:25218026 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdcd10 |
programmed cell death 10 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PDCD10 mRNA; ochratoxin A results in decreased expression of PDCD10 protein |
CTD |
PMID:30428381 |
|
NCBI chr 2:160,303,465...160,346,086
Ensembl chr 2:160,303,449...160,346,018
|
|
G |
Pdcd2 |
programmed cell death 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PDCD2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:56,484,947...56,490,437
Ensembl chr 1:56,463,931...56,490,437
|
|
G |
Pdcd4 |
programmed cell death 4 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of PDCD4 mRNA ochratoxin A results in decreased expression of PDCD4 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pde4dip |
phosphodiesterase 4D interacting protein |
increases expression |
EXP |
ochratoxin A results in increased expression of PDE4DIP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of PDGFRA mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of PDGFRA mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
increases expression |
ISO |
ochratoxin A results in increased expression of PDHB protein |
CTD |
PMID:19445961 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of PDIA3 protein |
CTD |
PMID:26861962 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
increases expression increases phosphorylation affects phosphorylation affects expression |
EXP ISO |
ochratoxin A results in increased expression of PDK1 protein ochratoxin A results in increased phosphorylation of PDK1 protein ochratoxin A affects the phosphorylation of PDK1 protein ochratoxin A affects the expression of PDK1 protein |
CTD |
PMID:17651772 PMID:25002221 PMID:30876885 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Pdk2 |
pyruvate dehydrogenase kinase 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PDK2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:79,972,550...79,987,074
Ensembl chr10:79,972,556...79,987,085
|
|
G |
Pdk3 |
pyruvate dehydrogenase kinase 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PDK3 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:58,486,699...58,553,533
Ensembl chr X:58,486,554...58,553,557
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of PDPK1 gene |
CTD |
PMID:26431795 |
|
NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,105,498...13,174,623
|
|
G |
Pdpn |
podoplanin |
increases expression |
EXP |
ochratoxin A results in increased expression of PDPN mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
|
|
G |
Pear1 |
platelet endothelial aggregation receptor 1 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of PEAR1 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 2:173,206,298...173,234,106
Ensembl chr 2:173,207,664...173,227,440
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PECAM1 mRNA; ochratoxin A results in increased expression of PECAM1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pecr |
peroxisomal trans-2-enoyl-CoA reductase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PECR mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:73,897,877...73,926,511
Ensembl chr 9:73,897,880...73,926,511
|
|
G |
Pepd |
peptidase D |
increases expression |
EXP |
ochratoxin A results in increased expression of PEPD protein |
CTD |
PMID:31369848 |
|
NCBI chr 1:87,536,650...87,681,233
Ensembl chr 1:87,536,609...87,681,231
|
|
G |
Per3 |
period circadian regulator 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of PER3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
|
|
G |
Pfkl |
phosphofructokinase, liver type |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PFKL mRNA |
CTD |
PMID:19287073 |
|
NCBI chr20:10,664,285...10,686,324
Ensembl chr20:10,664,272...10,686,315
|
|
G |
Pfkm |
phosphofructokinase, muscle |
increases expression |
EXP |
ochratoxin A results in increased expression of PFKM mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192
|
|
G |
Pfkp |
phosphofructokinase, platelet |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of PFKP mRNA ochratoxin A results in increased expression of PFKP protein |
CTD |
PMID:19717638 PMID:32835834 |
|
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
|
|
G |
Pgam2 |
phosphoglycerate mutase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of PGAM2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940
|
|
G |
Pggt1b |
protein geranylgeranyltransferase type I subunit beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PGGT1B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr18:38,952,147...38,995,656
Ensembl chr18:38,952,914...38,995,503
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PGK1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Phb1 |
prohibitin 1 |
decreases expression increases expression |
EXP ISO |
ochratoxin A results in decreased expression of PHB1 protein ochratoxin A results in increased expression of PHB1 protein |
CTD |
PMID:19445961 PMID:31369848 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Pheta2 |
PH domain containing endocytic trafficking adaptor 2 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of PHETA2 gene ochratoxin A results in increased expression of PHETA2 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 7:113,855,437...113,861,910
Ensembl chr 7:113,857,249...113,861,871
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PHGDH mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of PHLDA3 mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
|
|
G |
Phldb2 |
pleckstrin homology-like domain, family B, member 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PHLDB2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:54,859,173...55,078,212
Ensembl chr11:54,859,135...55,078,467
|
|
G |
Pigv |
phosphatidylinositol glycan anchor biosynthesis, class V |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PIGV mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 5:145,889,642...145,901,533
Ensembl chr 5:145,889,646...145,901,533
|
|
G |
Pigz |
phosphatidylinositol glycan anchor biosynthesis, class Z |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PIGZ mRNA |
CTD |
PMID:19287073 |
|
NCBI chr11:68,831,847...68,851,798
|
|
G |
Pik3ap1 |
phosphoinositide-3-kinase adaptor protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of PIK3AP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:240,090,854...240,245,007
Ensembl chr 1:240,093,065...240,204,828
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PIK3CA mRNA; ochratoxin A results in increased expression of PIK3CA mRNA; ochratoxin A results in increased expression of PIK3CA protein |
CTD |
PMID:25002221 PMID:26314263 |
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PIK3CB mRNA; ochratoxin A results in increased expression of PIK3CB mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PIK3CD mRNA; ochratoxin A results in decreased expression of PIK3CD mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PIK3CG mRNA; ochratoxin A results in increased expression of PIK3CG mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PIK3R3 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
|
|
G |
Pik3r5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PIK3R5 mRNA; ochratoxin A results in decreased expression of PIK3R5 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:53,132,585...53,200,663
Ensembl chr10:53,132,603...53,199,374
|
|
G |
Pim3 |
Pim-3 proto-oncogene, serine/threonine kinase |
increases methylation decreases expression |
EXP |
ochratoxin A results in increased methylation of PIM3 gene ochratoxin A results in decreased expression of PIM3 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:119,953,175...119,956,587
|
|
G |
Pink1 |
PTEN induced kinase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of PINK1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PITPNB protein |
CTD |
PMID:26861962 |
|
NCBI chr12:45,249,308...45,298,388
Ensembl chr12:45,249,333...45,298,314
|
|
G |
Piwil2 |
piwi-like RNA-mediated gene silencing 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of PIWIL2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
|
|
G |
Pkib |
cAMP-dependent protein kinase inhibitor beta |
increases expression |
ISO |
ochratoxin A results in increased expression of PKIB mRNA |
CTD |
PMID:30559759 |
|
NCBI chr20:36,965,172...37,062,190
Ensembl chr20:36,905,340...37,062,187
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PKLR mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pkm |
pyruvate kinase M1/2 |
multiple interactions |
ISO |
ochratoxin A results in increased phosphorylation of and results in decreased activity of and affects the localization of PKM protein |
CTD |
PMID:32835834 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of PKMYT1 mRNA TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of PKMYT1 mRNA] |
CTD |
PMID:25636497 |
|
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
|
|
G |
Plaat3 |
phospholipase A and acyltransferase 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PLAAT3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:204,782,608...204,816,397
Ensembl chr 1:204,782,729...204,817,667
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of PLAUR mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PLCG1 mRNA; ochratoxin A results in decreased expression of PLCG1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Plcg2 |
phospholipase C, gamma 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PLCG2 mRNA; ochratoxin A results in decreased expression of PLCG2 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr19:45,547,416...45,683,930
Ensembl chr19:45,547,416...45,683,930
|
|
G |
Pld2 |
phospholipase D2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PLD2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
|
|
G |
Plekhg2 |
pleckstrin homology and RhoGEF domain containing G2 |
increases expression |
EXP |
ochratoxin A results in increased expression of PLEKHG2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:83,651,902...83,665,063
Ensembl chr 1:83,647,748...83,665,063
|
|
G |
Plin1 |
perilipin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PLIN1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:133,664,892...133,676,828
|
|
G |
Plin2 |
perilipin 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PLIN2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plin3 |
perilipin 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PLIN3 protein |
CTD |
PMID:19445961 |
|
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Plk1 |
polo-like kinase 1 |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of PLK1 mRNA TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of PLK1 mRNA] |
CTD |
PMID:16251485 PMID:19237604 PMID:23358140 PMID:25636497 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Plk2 |
polo-like kinase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of PLK2 mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plpp1 |
phospholipid phosphatase 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of PPAP2A mRNA; ochratoxin A results in decreased expression of PPAP2A mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 2:44,439,002...44,500,430
Ensembl chr 2:44,438,994...44,501,268
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PMAIP1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pmp22 |
peripheral myelin protein 22 |
increases expression |
EXP |
ochratoxin A results in increased expression of PMP22 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714
|
|
G |
Pms1 |
PMS1 homolog 1, mismatch repair system component |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of PMS1 mRNA ochratoxin A results in decreased acetylation of PMS1 promoter [ochratoxin A results in decreased acetylation of PMS1 promoter] which results in decreased expression of PMS1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237
|
|
G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PNKP mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:95,341,465...95,346,921
Ensembl chr 1:95,341,620...95,346,920
|
|
G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PNRC1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
|
|
G |
Polb |
DNA polymerase beta |
increases expression |
EXP |
ochratoxin A results in increased expression of POLB mRNA |
CTD |
PMID:19562491 |
|
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
|
|
G |
Pold4 |
DNA polymerase delta 4, accessory subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of POLD4 mRNA |
CTD |
PMID:18417182 PMID:23358140 |
|
NCBI chr 1:201,526,591...201,528,406
Ensembl chr 1:201,526,665...201,528,401
|
|
G |
Polr2i |
RNA polymerase II subunit I |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of POLR2I promoter ochratoxin A results in increased expression of POLR2I mRNA [ochratoxin A results in increased acetylation of POLR2I promoter] which results in increased expression of POLR2I mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:85,483,515...85,484,952
Ensembl chr 1:85,483,515...85,484,952
|
|
G |
Pom121 |
POM121 transmembrane nucleoporin |
increases expression |
EXP |
ochratoxin A results in increased expression of POM121 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr12:21,273,713...21,294,299
Ensembl chr12:21,276,913...21,294,294
|
|
G |
Pon1 |
paraoxonase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PON1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Postn |
periostin |
increases expression |
EXP |
ochratoxin A results in increased expression of POSTN mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression decreases activity increases phosphorylation multiple interactions increases expression |
ISO EXP |
ochratoxin A results in decreased expression of PPARG ochratoxin A results in decreased activity of PPARG protein ochratoxin A results in increased phosphorylation of PPARG protein 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA] |
CTD |
PMID:15994020 PMID:20590410 PMID:27481073 PMID:32905824 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppif |
peptidylprolyl isomerase F |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of PPIF protein Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of PPIF protein] |
CTD |
PMID:33465424 |
|
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
|
|
G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of PPM1D mRNA |
CTD |
PMID:23358140 PMID:30559759 |
|
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
|
|
G |
Ppp1r11 |
protein phosphatase 1, regulatory (inhibitor) subunit 11 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PPP1R11 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr20:1,601,350...1,604,857
Ensembl chr20:1,601,346...1,604,846
|
|
G |
Ppp1r14b |
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of PPP1R14B promoter] which results in increased expression of PPP1R14B mRNA ochratoxin A results in increased expression of PPP1R14B mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
|
|
G |
Ppp2r1b |
protein phosphatase 2 scaffold subunit A beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PPP2R1B mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
|
|
G |
Ppp3cb |
protein phosphatase 3 catalytic subunit beta |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of PPP3CB mRNA |
CTD |
PMID:19287073 PMID:22124623 |
|
NCBI chr15:3,759,950...3,804,976
Ensembl chr15:3,760,030...3,804,981
|
|
G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of PPP3R1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:91,556,743...91,606,391
Ensembl chr14:91,604,121...91,606,907
|
|
G |
Prcp |
prolylcarboxypeptidase |
increases expression |
ISO |
ochratoxin A results in increased expression of PRCP mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:146,931,487...146,983,891
Ensembl chr 1:146,930,561...146,984,530
|
|
G |
Prdx2 |
peroxiredoxin 2 |
multiple interactions increases expression increases acetylation decreases expression |
ISO EXP |
[ochratoxin A results in increased acetylation of PRDX2 promoter] which results in increased expression of PRDX2 mRNA ochratoxin A results in increased expression of PRDX2 mRNA; ochratoxin A results in increased expression of PRDX2 protein ochratoxin A results in decreased expression of PRDX2 protein |
CTD |
PMID:29098329 PMID:31276768 PMID:31369848 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prdx6 |
peroxiredoxin 6 |
increases expression |
ISO |
ochratoxin A results in increased expression of PRDX6 protein |
CTD |
PMID:19445961 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Preb |
prolactin regulatory element binding |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of PREB mRNA |
CTD |
PMID:19287073 PMID:22124623 |
|
NCBI chr 6:25,418,805...25,422,594
Ensembl chr 6:25,418,776...25,422,590
|
|
G |
Prelp |
proline and arginine rich end leucine rich repeat protein |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of PRELP promoter [ochratoxin A results in increased acetylation of PRELP promoter] which results in increased expression of PRELP mRNA ochratoxin A results in increased expression of PRELP mRNA |
CTD |
PMID:29098329 |
|
NCBI chr13:45,368,407...45,391,480
Ensembl chr13:45,370,533...45,380,270
|
|
G |
Prg2 |
proteoglycan 2, pro eosinophil major basic protein |
increases expression |
ISO |
ochratoxin A results in increased expression of PRG2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:70,062,535...70,066,102
Ensembl chr 3:70,062,535...70,066,101
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of PRKACA promoter ochratoxin A results in increased expression of PRKACA mRNA [ochratoxin A results in increased acetylation of PRKACA promoter] which results in increased expression of PRKACA mRNA |
CTD |
PMID:29098329 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prkca |
protein kinase C, alpha |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PRKCA mRNA |
CTD |
PMID:12700408 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcb |
protein kinase C, beta |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PRKCB mRNA; ochratoxin A results in increased expression of PRKCB mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Prkcsh |
PRKCSH beta subunit of glucosidase II |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of PRKCSH promoter] which results in increased expression of PRKCSH mRNA ochratoxin A results in increased expression of PRKCSH mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:20,534,787...20,546,493
Ensembl chr 8:20,534,880...20,546,492
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
increases expression |
EXP |
ochratoxin A results in increased expression of PRKDC mRNA |
CTD |
PMID:23358140 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Prlr |
prolactin receptor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PRLR mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
|
|
G |
Prox1 |
prospero homeobox 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PROX1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr13:101,669,184...101,719,804
Ensembl chr13:101,669,184...101,711,183
|
|
G |
Prpf4b |
pre-mRNA processing factor 4B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PRP4K mRNA |
CTD |
PMID:22124623 |
|
NCBI chr17:29,985,343...30,020,285
Ensembl chr17:29,985,343...30,019,625
|
|
G |
Psen1 |
presenilin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PSEN1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Psmb6 |
proteasome 20S subunit beta 6 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PSMB6 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:55,239,256...55,241,586
Ensembl chr10:55,239,241...55,241,586
|
|
G |
Psmd11 |
proteasome 26S subunit, non-ATPase 11 |
increases expression |
EXP |
ochratoxin A results in increased expression of PSMD11 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
|
|
G |
Psme2 |
proteasome activator subunit 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PSME2 protein |
CTD |
PMID:26861962 |
|
NCBI chr15:29,078,495...29,082,794
Ensembl chr15:29,078,500...29,082,946
|
|
G |
Psme3 |
proteasome activator subunit 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PSME3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:86,257,672...86,265,458
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Pten |
phosphatase and tensin homolog |
decreases expression decreases phosphorylation increases expression |
ISO |
ochratoxin A results in decreased expression of PTEN mRNA ochratoxin A results in decreased phosphorylation of PTEN protein ochratoxin A metabolite results in increased expression of PTEN mRNA; ochratoxin A results in increased expression of PTEN mRNA; ochratoxin A results in increased expression of PTEN protein |
CTD |
PMID:19287073 PMID:25002221 PMID:26314263 PMID:34101318 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgds |
prostaglandin D2 synthase |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of PTGDS promoter ochratoxin A results in increased expression of PTGDS mRNA [ochratoxin A results in increased acetylation of PTGDS promoter] which results in increased expression of PTGDS mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
increases expression |
ISO |
ochratoxin A results in increased expression of PTGER4 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptgfrn |
prostaglandin F2 receptor inhibitor |
increases expression |
EXP |
ochratoxin A results in increased expression of PTGFRN mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 2:188,469,521...188,544,795
Ensembl chr 2:188,469,521...188,544,795
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PTGR1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression decreases expression |
ISO |
ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; ochratoxin A promotes the reaction [FOS protein binds to PTGS2 promoter]; ochratoxin A promotes the reaction [RELA protein binds to PTGS2 promoter] ochratoxin A results in increased expression of PTGS2 mRNA; ochratoxin A results in increased expression of PTGS2 protein ochratoxin A results in decreased expression of PTGS2 mRNA [ochratoxin A co-treated with Citrinin] results in decreased expression of PTGS2 mRNA; [ochratoxin A co-treated with Citrinin] results in decreased expression of PTGS2 protein |
CTD |
PMID:18647641 PMID:23172667 PMID:26505656 PMID:29673704 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PTK2 mRNA; ochratoxin A results in increased expression of PTK2 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Ptma |
prothymosin alpha |
decreases expression |
EXP |
ochratoxin A results in decreased expression of PTMA mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
|
|
G |
Ptp4a1 |
protein tyrosine phosphatase 4A1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PTP4A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of PTPN11 mRNA; ochratoxin A results in increased expression of PTPN11 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
increases expression |
EXP |
ochratoxin A results in increased expression of PTPRK mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605
|
|
G |
Ptrh2 |
peptidyl-tRNA hydrolase 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of PTRH2 protein |
CTD |
PMID:26861962 |
|
NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
increases expression |
EXP |
ochratoxin A results in increased expression of PTTG1 mRNA |
CTD |
PMID:19237604 |
|
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Pwp1 |
PWP1 homolog, endonuclein |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of PWP1 mRNA ochratoxin A results in decreased acetylation of PWP1 promoter [ochratoxin A results in decreased acetylation of PWP1 promoter] which results in decreased expression of PWP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:17,982,730...17,998,728
Ensembl chr 7:17,982,235...17,998,731
|
|
G |
Pycard |
PYD and CARD domain containing |
increases expression |
ISO |
ochratoxin A results in increased expression of PYCARD mRNA; ochratoxin A results in increased expression of PYCARD protein |
CTD |
PMID:33543323 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Pygm |
glycogen phosphorylase, muscle associated |
increases expression |
EXP |
ochratoxin A results in increased expression of PYGM mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368
|
|
G |
Rab40c |
Rab40c, member RAS oncogene family |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RAB40C mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:14,900,926...14,936,153
Ensembl chr10:14,900,929...14,936,557
|
|
G |
Rac2 |
Rac family small GTPase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of RAC2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
|
|
G |
Rad1 |
RAD1 checkpoint DNA exonuclease |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of RAD1 promoter [ochratoxin A results in decreased acetylation of RAD1 promoter] which results in decreased expression of RAD1 mRNA ochratoxin A results in decreased expression of RAD1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:59,461,597...59,469,707
Ensembl chr 2:59,461,607...59,469,689
|
|
G |
Rad18 |
RAD18 E3 ubiquitin protein ligase |
increases expression |
EXP |
ochratoxin A results in increased expression of RAD18 mRNA |
CTD |
PMID:18417182 PMID:23358140 PMID:24243707 |
|
NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069
|
|
G |
Rad51 |
RAD51 recombinase |
multiple interactions decreases expression increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of RAD51]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of RAD51]; TP53 mutant form inhibits the reaction [ochratoxin A results in decreased expression of RAD51] ochratoxin A results in increased expression of RAD51 mRNA; ochratoxin A results in increased expression of RAD51 protein |
CTD |
PMID:24243707 PMID:24525463 PMID:37162024 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rad54b |
RAD54 homolog B |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of RAD54B promoter ochratoxin A results in decreased expression of RAD54B mRNA [ochratoxin A results in decreased acetylation of RAD54B promoter] which results in decreased expression of RAD54B mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:25,032,112...25,104,630
Ensembl chr 5:25,032,066...25,104,616
|
|
G |
Radx |
RPA1 related single stranded DNA binding protein, X-linked |
increases expression |
ISO |
ochratoxin A results in increased expression of RADX mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:103,089,284...103,176,840
Ensembl chr X:103,089,284...103,176,838
|
|
G |
Ralbp1 |
ralA binding protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of RALBP1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:105,456,425...105,493,235
Ensembl chr 9:105,456,425...105,492,707
|
|
G |
Ralgdsl1 |
ral guanine nucleotide dissociation stimulator like 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of RGL1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:64,634,489...64,904,170
Ensembl chr13:64,635,246...64,904,191
|
|
G |
Ranbp1 |
RAN binding protein 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of RANBP1 mRNA ochratoxin A results in increased expression of RANBP1 protein |
CTD |
PMID:19445961 PMID:23358140 |
|
NCBI chr11:82,742,603...82,750,836
Ensembl chr11:82,742,600...82,750,838
|
|
G |
Rap2b |
RAP2B, member of RAS oncogene family |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RAP2B mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:145,599,714...145,600,265
Ensembl chr 2:145,599,116...145,603,069
|
|
G |
Rapgef2 |
Rap guanine nucleotide exchange factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RAPGEF2 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of RAPGEF4 mRNA; ochratoxin A results in increased expression of RAPGEF4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rapgef6 |
Rap guanine nucleotide exchange factor 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RAPGEF6 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr10:38,655,854...38,824,227
Ensembl chr10:38,655,867...38,823,211
|
|
G |
Rara |
retinoic acid receptor, alpha |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RARA mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rasgrp1 |
RAS guanyl releasing protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RASGRP1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:104,168,549...104,230,107
Ensembl chr 3:104,170,013...104,230,056
|
|
G |
Rassf5 |
Ras association domain family member 5 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of RASSF5 mRNA; ochratoxin A results in increased expression of RASSF5 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr13:42,637,513...42,703,024
Ensembl chr13:42,637,549...42,703,024
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
ochratoxin A affects the expression of and affects the phosphorylation of RB1 protein |
CTD |
PMID:28286205 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbbp4 |
RB binding protein 4, chromatin remodeling factor |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RBBP4 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284
|
|
G |
Rbbp6 |
RB binding protein 6, ubiquitin ligase |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of RBBP6 mRNA ochratoxin A results in increased expression of RBBP6 mRNA |
CTD |
PMID:17483316 PMID:22124623 |
|
NCBI chr 1:177,503,988...177,537,397
Ensembl chr 1:177,503,313...177,535,678
|
|
G |
Rbm3 |
RNA binding motif protein 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of RBM3 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
|
|
G |
Rbp4 |
retinol binding protein 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RBP4 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
|
|
G |
Rchy1 |
ring finger and CHY zinc finger domain containing 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RCHY1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:16,113,263...16,129,017
Ensembl chr14:16,113,224...16,129,167
|
|
G |
Rdh5 |
retinol dehydrogenase 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RDH5 mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr 7:1,341,172...1,346,863
Ensembl chr 7:1,340,934...1,351,558
|
|
G |
Rdx |
radixin |
increases expression |
EXP |
ochratoxin A results in increased expression of RDX mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
|
|
G |
Recql4 |
RecQ like helicase 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RECQL4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of RELA protein ochratoxin A promotes the reaction [RELA protein binds to CCND1 promoter]; ochratoxin A promotes the reaction [RELA protein binds to PTGS2 promoter] |
CTD |
PMID:18647641 PMID:23172667 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rev1 |
REV1, DNA directed polymerase |
increases expression |
EXP |
ochratoxin A results in increased expression of REV1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:40,278,100...40,351,764
Ensembl chr 9:40,278,101...40,351,576
|
|
G |
Rfc4 |
replication factor C subunit 4 |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of RFC4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
|
|
G |
Rfc5 |
replication factor C subunit 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RFC5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312
|
|
G |
Rfwd3 |
ring finger and WD repeat domain 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RFWD3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr19:39,235,883...39,268,479
Ensembl chr19:39,236,787...39,268,479
|
|
G |
Rfx5 |
regulatory factor X5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RFX5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:182,521,191...182,528,720
Ensembl chr 2:182,521,202...182,528,717
|
|
G |
Rgn |
regucalcin |
affects expression decreases expression |
EXP |
ochratoxin A affects the expression of RGN mRNA ochratoxin A results in decreased expression of RGN mRNA; ochratoxin A results in decreased expression of RGN protein |
CTD |
PMID:12700408 PMID:16251485 PMID:17483316 PMID:18417182 PMID:19237604 PMID:31369848 More...
|
|
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of RGS2 mRNA ochratoxin A metabolite results in decreased expression of RGS2 mRNA; ochratoxin A results in decreased expression of RGS2 mRNA |
CTD |
PMID:23358140 PMID:24356939 |
|
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
|
|
G |
Rgs20 |
regulator of G-protein signaling 20 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of RGS20 mRNA ochratoxin A results in decreased methylation of RGS20 gene |
CTD |
PMID:37162024 |
|
NCBI chr 5:14,484,436...14,614,317
Ensembl chr 5:14,534,775...14,614,084
|
|
G |
Rhob |
ras homolog family member B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RHOB mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Rhoq |
ras homolog family member Q |
increases expression |
EXP |
ochratoxin A results in increased expression of RHOQ mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 6:7,613,632...7,652,047
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RIPK1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of RIPK2 promoter ochratoxin A results in decreased expression of RIPK2 mRNA [ochratoxin A results in decreased acetylation of RIPK2 promoter] which results in decreased expression of RIPK2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
|
|
G |
Rnf113a1 |
ring finger protein 113A1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RNF113A mRNA |
CTD |
PMID:18417182 |
|
NCBI chr X:116,427,941...116,429,164
Ensembl chr X:116,427,684...116,433,762
|
|
G |
Rnf144b |
ring finger protein 144B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RNF144B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:17,431,271...17,580,687
Ensembl chr17:17,432,786...17,562,760
|
|
G |
Rnf167 |
ring finger protein 167 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RNF167 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:55,360,603...55,364,927
Ensembl chr10:55,360,543...55,364,927
|
|
G |
Rnf2 |
ring finger protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of RNF2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr13:63,553,964...63,584,047
Ensembl chr13:63,554,862...63,583,099
|
|
G |
Rnf8 |
ring finger protein 8 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of RNF8 mRNA ochratoxin A results in decreased acetylation of RNF8 promoter [ochratoxin A results in decreased acetylation of RNF8 promoter] which results in decreased expression of RNF8 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:7,682,258...7,710,448
Ensembl chr20:7,682,322...7,708,491
|
|
G |
Rnmt |
RNA (guanine-7-) methyltransferase |
increases expression |
EXP |
ochratoxin A results in increased expression of RNMT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr18:61,886,230...61,909,775
Ensembl chr18:61,886,292...61,909,775
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ROCK1 mRNA; ochratoxin A results in increased expression of ROCK1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ROCK2 mRNA; ochratoxin A results in increased expression of ROCK2 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of ROR1 mRNA ochratoxin A results in increased methylation of ROR1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 5:114,744,311...115,088,155
Ensembl chr 5:114,744,304...115,088,155
|
|
G |
Rpa1 |
replication protein A1 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of RPA1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
|
|
G |
Rpe |
ribulose-5-phosphate-3-epimerase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of RPE mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:68,191,027...68,211,295
Ensembl chr 9:68,191,292...68,211,591
|
|
G |
Rpl13 |
ribosomal protein L13 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of RPL13 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014
|
|
G |
Rpl6 |
ribosomal protein L6 |
increases expression |
EXP |
ochratoxin A results in increased expression of RPL6 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
|
|
G |
Rpp30 |
ribonuclease P/MRP subunit p30 |
increases expression |
ISO |
ochratoxin A results in increased expression of RPP30 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:233,786,048...233,808,958
Ensembl chr 1:233,786,099...233,808,952
|
|
G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator homolog |
increases expression |
EXP |
ochratoxin A results in increased expression of RPRM mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 3:38,539,581...38,540,998
Ensembl chr 3:38,539,581...38,540,998
|
|
G |
Rps15 |
ribosomal protein S15 |
increases expression |
ISO |
ochratoxin A results in increased expression of RPS15 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:9,416,003...9,417,442
Ensembl chr 7:9,416,004...9,417,450
|
|
G |
Rps15a |
ribosomal protein S15a |
increases expression |
EXP |
ochratoxin A results in increased expression of RPS15A mRNA |
CTD |
PMID:19717638 PMID:22124623 |
|
NCBI chr 1:172,420,151...172,427,021
Ensembl chr 1:172,419,761...172,426,995
|
|
G |
Rps6 |
ribosomal protein S6 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of RPS6 protein |
CTD |
PMID:25002221 PMID:31154016 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Rps6ka1 |
ribosomal protein S6 kinase A1 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of RPS6KA1 protein |
CTD |
PMID:31154016 |
|
NCBI chr 5:146,079,018...146,118,272
Ensembl chr 5:146,079,021...146,118,272
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of RPS6KB1 protein |
CTD |
PMID:31154016 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rptor |
regulatory associated protein of MTOR, complex 1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of RPTOR gene |
CTD |
PMID:26431795 |
|
NCBI chr10:104,878,487...105,176,986
Ensembl chr10:104,878,487...105,176,983
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
ISO |
ochratoxin A results in increased expression of RRM2B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
Rrs1 |
ribosome biogenesis regulator 1 homolog |
increases expression |
EXP |
ochratoxin A results in increased expression of RRS1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:9,733,486...9,735,119
Ensembl chr 5:9,733,091...9,735,140
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of RSAD2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
|
|
G |
Rsrc1 |
arginine and serine rich coiled-coil 1 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of RSRC1 gene |
CTD |
PMID:26431795 |
|
NCBI chr 2:151,226,821...151,632,771
Ensembl chr 2:151,231,156...151,632,765
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of HLA-E promoter] which results in increased expression of HLA-E mRNA ochratoxin A results in increased expression of HLA-E mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:4,870,939...4,910,183
|
|
G |
RT1-CE5 |
RT1 class I, locus CE5 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of HLA-F promoter] which results in increased expression of HLA-F mRNA ochratoxin A results in increased expression of HLA-F mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:3,403,418...3,479,476
|
|
G |
Rtn4r |
reticulon 4 receptor |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of RTN4R mRNA ochratoxin A results in decreased methylation of RTN4R gene |
CTD |
PMID:37162024 |
|
NCBI chr11:82,844,309...82,869,251
Ensembl chr11:82,844,309...82,869,466
|
|
G |
Rufy1 |
RUN and FYVE domain containing 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RUFY1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:34,705,741...34,750,644
Ensembl chr10:34,705,741...34,750,644
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RUNX1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of RUNX2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Ruvbl1 |
RuvB-like AAA ATPase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of RUVBL1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:120,932,486...120,967,400
Ensembl chr 4:120,932,417...121,029,384
|
|
G |
S100g |
S100 calcium binding protein G |
increases expression |
EXP |
ochratoxin A results in increased expression of S100G mRNA |
CTD |
PMID:30449730 |
|
NCBI chr X:31,705,853...31,708,422
Ensembl chr X:31,705,866...31,708,433
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of S1PR1 mRNA; ochratoxin A results in decreased expression of S1PR1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
|
|
G |
Sars1 |
seryl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
|
|
G |
Sbds |
Sbds, ribosome maturation factor |
increases expression |
EXP |
ochratoxin A results in increased expression of SBDS mRNA |
CTD |
PMID:23358140 |
|
NCBI chr12:26,420,410...26,429,650
Ensembl chr12:26,420,414...26,429,649
|
|
G |
Sbf1 |
SET binding factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SBF1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 7:120,358,338...120,385,022
Ensembl chr 7:120,358,338...120,384,902
|
|
G |
Sc5d |
sterol-C5-desaturase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SC5D mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
|
|
G |
Scaf4 |
SR-related CTD-associated factor 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of SCAF4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr11:29,460,479...29,521,153
Ensembl chr11:29,465,106...29,521,153
|
|
G |
Scaf8 |
SR-related CTD-associated factor 8 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SCAF8 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:43,727,686...43,855,889
Ensembl chr 1:43,727,794...43,804,977
|
|
G |
Scand1 |
SCAN domain-containing 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SCAND1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:144,818,615...144,819,479
Ensembl chr 3:144,818,611...144,820,025
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SCD mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sct |
secretin |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of SCT gene ochratoxin A results in increased expression of SCT mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
|
|
G |
Sdha |
succinate dehydrogenase complex flavoprotein subunit A |
multiple interactions decreases expression |
ISO |
BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA protein] ochratoxin A results in decreased expression of SDHA mRNA; ochratoxin A results in decreased expression of SDHA protein |
CTD |
PMID:24755393 |
|
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SDHB mRNA |
CTD |
PMID:34481902 |
|
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
|
|
G |
Sele |
selectin E |
increases expression |
ISO |
ochratoxin A results in increased expression of SELE protein |
CTD |
PMID:28710020 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Selenop |
selenoprotein P |
increases expression |
EXP |
ochratoxin A results in increased expression of SELENOP mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Sema3g |
semaphorin 3G |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SEMA3G mRNA; ochratoxin A results in decreased expression of SEMA3G mRNA |
CTD |
PMID:24356939 |
|
NCBI chr16:6,413,589...6,425,221
Ensembl chr16:6,413,589...6,425,221
|
|
G |
Sema4f |
ssemaphorin 4F |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SEMA4F mRNA; ochratoxin A results in decreased expression of SEMA4F mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 4:115,411,411...115,437,721
Ensembl chr 4:115,411,417...115,437,721
|
|
G |
Septin4 |
septin 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SEPTIN4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:72,366,729...72,390,764
Ensembl chr10:72,366,873...72,390,768
|
|
G |
Serpina1 |
serpin family A member 1 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of SERPINA1 promoter ochratoxin A results in increased expression of SERPINA1 mRNA [ochratoxin A results in increased acetylation of SERPINA1 promoter] which results in increased expression of SERPINA1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Serpinb2 |
serpin family B member 2 |
multiple interactions |
ISO |
ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of SERPINB2 mRNA]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of SERPINB2 protein] |
CTD |
PMID:18289624 |
|
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
|
|
G |
Serpine1 |
serpin family E member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of SERPINE1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sertad1 |
SERTA domain containing 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SERTAD1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
|
|
G |
Sesn2 |
sestrin 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SESN2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Set |
Set nuclear proto-oncogene |
increases expression |
EXP |
ochratoxin A results in increased expression of SET mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567
|
|
G |
Setd6 |
SET domain containing 6, protein lysine methyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SETD6 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr19:9,343,309...9,350,477
Ensembl chr19:9,347,458...9,350,453
|
|
G |
Sfn |
stratifin |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of SFN mRNA ochratoxin A results in decreased expression of SFN mRNA |
CTD |
PMID:19237604 PMID:30008028 PMID:30559759 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sfrp2 |
secreted frizzled-related protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of SFRP2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SGK1 mRNA; ochratoxin A results in decreased expression of SGK1 mRNA |
CTD |
PMID:24356939 PMID:32910239 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sh3rf1 |
SH3 domain containing ring finger 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SH3RF1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr16:28,735,522...28,901,261
Ensembl chr16:28,735,440...28,901,644
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SHANK2 mRNA |
CTD |
PMID:34748853 |
|
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
|
|
G |
Shc1 |
SHC adaptor protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SHC1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Shh |
sonic hedgehog signaling molecule |
multiple interactions |
EXP |
SHH protein inhibits the reaction [ochratoxin A affects the expression of SOX10 mRNA]; SHH protein inhibits the reaction [ochratoxin A results in decreased expression of CSPG4 mRNA]; SHH protein inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]; SHH protein inhibits the reaction [ochratoxin A results in decreased expression of MOG mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of ASCL1 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of CCND2 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DCX mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DLL3 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of GLI1 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of HES5 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of MKI67 mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of NES mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of PDGFRA mRNA]; SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of SOX2 mRNA] |
CTD |
PMID:21703336 PMID:24792326 |
|
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Shisa2 |
shisa family member 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SHISA2 mRNA; ochratoxin A results in decreased expression of SHISA2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr15:33,806,715...33,811,013
Ensembl chr15:33,805,958...33,811,013
|
|
G |
Siae |
sialic acid acetylesterase |
increases expression |
ISO |
ochratoxin A results in increased expression of SIAE mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:37,318,724...37,354,004
Ensembl chr 8:37,318,747...37,353,996
|
|
G |
Siah1 |
siah E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SIAH1 mRNA; ochratoxin A results in decreased expression of SIAH1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
|
|
G |
Sigirr |
single Ig and TIR domain containing |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SIGIRR mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:196,195,363...196,208,692
Ensembl chr 1:196,199,462...196,202,269
|
|
G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
multiple interactions decreases expression |
ISO |
Ursolic Acid inhibits the reaction [ochratoxin A results in decreased expression of SIGMAR1 protein] |
CTD |
PMID:36587836 |
|
NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017
|
|
G |
Sirt1 |
sirtuin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of SIRT1 mRNA |
CTD |
PMID:34481902 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Ska1 |
spindle and kinetochore associated complex subunit 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of SKA1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037
|
|
G |
Ska2 |
spindle and kinetochore associated complex subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of SKA2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:71,921,474...71,939,461
Ensembl chr10:71,921,582...71,939,458
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of SLC11A2 mRNA |
CTD |
PMID:19287073 PMID:22124623 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc15a1 |
solute carrier family 15 member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC15A1 mRNA |
CTD |
PMID:29126803 |
|
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
|
|
G |
Slc15a2 |
solute carrier family 15 member 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC15A2 mRNA |
CTD |
PMID:29126803 |
|
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
|
|
G |
Slc16a13 |
solute carrier family 16, member 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC16A13 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:54,925,973...54,937,860
Ensembl chr10:54,926,760...54,937,788
|
|
G |
Slc16a14 |
solute carrier family 16, member 14 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of SLC16A14 gene |
CTD |
PMID:26431795 |
|
NCBI chr 9:86,110,066...86,137,546
Ensembl chr 9:86,112,894...86,137,318
|
|
G |
Slc17a1 |
solute carrier family 17 member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC17A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr17:41,219,461...41,255,199
Ensembl chr17:41,222,049...41,253,304
|
|
G |
Slc17a9 |
solute carrier family 17 member 9 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC17A9 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 3:167,839,246...167,857,462
Ensembl chr 3:167,839,385...167,855,985
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
affects expression |
EXP |
ochratoxin A affects the expression of SLC1A2 protein |
CTD |
PMID:20558201 |
|
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Slc1a3 |
solute carrier family 1 member 3 |
affects expression |
EXP |
ochratoxin A affects the expression of SLC1A3 protein |
CTD |
PMID:20558201 |
|
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
|
|
G |
Slc1a4 |
solute carrier family 1 member 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC1A4 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC1A5 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A1 mRNA; ochratoxin A results in decreased expression of SLC22A1 protein ochratoxin A results in increased expression of SLC22A1 mRNA |
CTD |
PMID:16251485 PMID:17483316 PMID:30120945 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a12 |
solute carrier family 22 member 12 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A12 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
|
|
G |
Slc22a13 |
solute carrier family 22 member 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A13 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 8:118,922,367...118,934,020
Ensembl chr 8:118,922,367...118,953,635
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
decreases expression multiple interactions increases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A2 mRNA; ochratoxin A results in decreased expression of SLC22A2 protein SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CASP3 mRNA]; SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CDK1 protein]; SLC22A2 protein promotes the reaction [ochratoxin A results in increased expression of CASP3 protein] ochratoxin A results in increased expression of SLC22A2 mRNA; ochratoxin A results in increased expression of SLC22A2 protein |
CTD |
PMID:12700408 PMID:16251485 PMID:18417182 PMID:30120945 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a20 |
solute carrier family 22 member 20 |
multiple interactions |
ISO |
ochratoxin A inhibits the reaction [SLC22A20 protein results in increased uptake of estrone sulfate] |
CTD |
PMID:16478971 |
|
NCBI chr 1:203,257,374...203,273,854
Ensembl chr 1:203,257,374...203,273,822
|
|
G |
Slc22a22 |
solute carrier family 22 member 22 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A22 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:88,720,425...88,750,111
Ensembl chr 7:88,720,427...88,750,111
|
|
G |
Slc22a24 |
solute carrier family 22, member 24 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC22A24 mRNA |
CTD |
PMID:29126803 |
|
NCBI chr 1:204,910,450...204,965,538
Ensembl chr 1:204,910,455...204,965,538
|
|
G |
Slc22a25 |
solute carrier family 22, member 25 |
increases expression decreases expression increases uptake multiple interactions affects transport |
EXP ISO |
ochratoxin A results in increased expression of SLC22A9 protein ochratoxin A results in decreased expression of SLC22A9 mRNA SLC22A9 protein results in increased uptake of ochratoxin A 2,4-Dichlorophenoxyacetic Acid inhibits the reaction [SLC22A19 protein results in increased uptake of ochratoxin A]; estrone sulfate inhibits the reaction [SLC22A19 protein results in increased uptake of ochratoxin A]; Probenecid inhibits the reaction [SLC22A19 protein results in increased uptake of ochratoxin A]; Salicylates inhibits the reaction [SLC22A19 protein results in increased uptake of ochratoxin A] SLC22A19 protein affects the transport of ochratoxin A |
CTD |
PMID:15068970 PMID:16079298 PMID:18441515 PMID:19538982 |
|
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions increases uptake increases expression decreases expression |
EXP ISO |
Citrinin inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; Glutarates affects the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; octanoic acid inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; p-Aminohippuric Acid inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; Piroxicam inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]; Probenecid inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A] ochratoxin A results in increased expression of SLC22A6 protein Chlorides promotes the reaction [SLC22A6 protein results in increased uptake of ochratoxin A] ochratoxin A results in decreased expression of SLC22A6 mRNA; ochratoxin A results in decreased expression of SLC22A6 protein |
CTD |
PMID:10336520 PMID:12700408 PMID:15068970 PMID:16098483 PMID:16251485 PMID:17353191 PMID:18417182 PMID:19538982 PMID:19717638 PMID:29126803 More...
|
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
decreases expression increases expression increases uptake affects methylation |
EXP ISO |
ochratoxin A results in decreased expression of SLC22A7 mRNA ochratoxin A results in increased expression of SLC22A7 protein SLC22A7 protein results in increased uptake of ochratoxin A ochratoxin A affects the methylation of SLC22A7 promoter |
CTD |
PMID:12065749 PMID:19538982 PMID:29126803 PMID:30449730 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
decreases expression increases expression affects transport increases uptake |
EXP ISO |
ochratoxin A results in decreased expression of SLC22A8 mRNA; ochratoxin A results in decreased expression of SLC22A8 protein ochratoxin A results in increased expression of SLC22A8 mRNA; ochratoxin A results in increased expression of SLC22A8 protein SLC22A8 protein affects the transport of ochratoxin A SLC22A8 protein results in increased uptake of ochratoxin A |
CTD |
PMID:10224140 PMID:11306713 PMID:16098483 PMID:19538982 PMID:29126803 PMID:30120945 More...
|
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc25a20 |
solute carrier family 25 member 20 |
increases expression |
EXP |
ochratoxin A results in increased expression of SLC25A20 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
|
|
G |
Slc25a23 |
solute carrier family 25 member 23 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of SLC25A23 mRNA ochratoxin A results in increased methylation of SLC25A23 gene |
CTD |
PMID:37162024 |
|
NCBI chr 9:1,882,636...1,898,369
Ensembl chr 9:1,882,621...1,898,561
|
|
G |
Slc25a3 |
solute carrier family 25 member 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of SLC25A3 protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:25,611,937...25,619,401
Ensembl chr 7:25,586,725...25,667,727
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of SLC2A1 mRNA; ochratoxin A results in increased expression of SLC2A1 protein |
CTD |
PMID:32835834 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of SLC2A2 mRNA |
CTD |
PMID:16251485 PMID:19717638 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Slc2a5 |
solute carrier family 2 member 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC2A5 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:160,583,234...160,611,106
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
multiple interactions |
ISO |
ochratoxin A promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLC30A1 mRNA]; Zinc inhibits the reaction [ochratoxin A promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLC30A1 mRNA]] |
CTD |
PMID:19720134 |
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Slc30a5 |
solute carrier family 30 member 5 |
multiple interactions |
ISO |
[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with ochratoxin A] results in decreased expression of SLC30A5 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
|
|
G |
Slc30a6 |
solute carrier family 30 member 6 |
multiple interactions |
ISO |
[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with ochratoxin A] results in decreased expression of SLC30A6 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr 6:21,020,931...21,050,785
Ensembl chr 6:21,020,931...21,050,785
|
|
G |
Slc30a7 |
solute carrier family 30 member 7 |
multiple interactions decreases expression |
ISO |
[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with ochratoxin A co-treated with Zinc] results in decreased expression of SLC30A7 mRNA; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [ochratoxin A results in decreased expression of SLC30A7 mRNA] |
CTD |
PMID:19720134 |
|
NCBI chr 2:203,855,484...203,922,155
Ensembl chr 2:203,859,175...203,922,132
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC34A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
|
|
G |
Slc39a1 |
solute carrier family 39 member 1 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of SLC39A1 mRNA Zinc deficiency promotes the reaction [ochratoxin A results in decreased expression of SLC39A1 mRNA] |
CTD |
PMID:19720134 |
|
NCBI chr 2:175,703,413...175,709,063
Ensembl chr 2:175,703,441...175,709,058
|
|
G |
Slc39a10 |
solute carrier family 39 member 10 |
multiple interactions |
ISO |
[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc] results in decreased expression of SLC39A10 mRNA; [ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A10 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr 9:54,836,841...54,960,325
Ensembl chr 9:54,876,141...54,960,325
|
|
G |
Slc39a14 |
solute carrier family 39 member 14 |
multiple interactions |
ISO |
[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A14 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
|
|
G |
Slc39a6 |
solute carrier family 39 member 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC39A6 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr18:15,864,874...15,885,417
Ensembl chr18:15,864,875...15,885,417
|
|
G |
Slc39a7 |
solute carrier family 39 member 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC39A7 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr20:4,823,166...4,826,538
Ensembl chr20:4,822,012...4,826,537
|
|
G |
Slc39a9 |
solute carrier family 39, member 9 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC39A9 mRNA |
CTD |
PMID:19720134 |
|
NCBI chr 6:100,291,537...100,330,419
Ensembl chr 6:100,291,573...100,330,408
|
|
G |
Slc3a1 |
solute carrier family 3 member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC3A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 6:9,608,169...9,641,881
Ensembl chr 6:9,608,178...9,641,907
|
|
G |
Slc43a1 |
solute carrier family 43 member 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SLC43A1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 3:69,920,586...69,946,768
Ensembl chr 3:69,920,649...69,946,768
|
|
G |
Slc4a1 |
solute carrier family 4 member 1 (Diego blood group) |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of SLC4A1 gene ochratoxin A results in increased expression of SLC4A1 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
|
|
G |
Slc50a1 |
solute carrier family 50 member 1 |
decreases expression multiple interactions increases expression increases acetylation |
EXP ISO |
ochratoxin A results in decreased expression of RAG1AP1 mRNA [ochratoxin A results in increased acetylation of SLC50A1 promoter] which results in increased expression of SLC50A1 mRNA ochratoxin A results in increased expression of SLC50A1 mRNA |
CTD |
PMID:22124623 PMID:29098329 |
|
NCBI chr 2:174,677,985...174,680,366
Ensembl chr 2:174,677,708...174,680,366
|
|
G |
Slc51b |
SLC51 subunit beta |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC51B mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
|
|
G |
Slc5a1 |
solute carrier family 5 member 1 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of SLC5A1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of SLC5A1 mRNA |
CTD |
PMID:29673704 |
|
NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547
|
|
G |
Slc5a10 |
solute carrier family 5 member 10 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC5A10 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:46,352,060...46,400,795
Ensembl chr10:46,352,061...46,399,811
|
|
G |
Slc5a2 |
solute carrier family 5 member 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of SLC5A2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:182,847,185...182,853,309
Ensembl chr 1:182,847,106...182,853,306
|
|
G |
Slc6a18 |
solute carrier family 6 member 18 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC6A18 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:29,608,077...29,621,925
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SLC6A4 mRNA |
CTD |
PMID:34748853 |
|
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
affects expression |
ISO |
ochratoxin A affects the expression of SLC7A11 mRNA |
CTD |
PMID:23824090 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a12 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLC7A12 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 2:87,079,724...87,146,875
Ensembl chr 2:87,079,749...87,146,875
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
increases expression |
ISO |
ochratoxin A results in increased expression of SLC7A5 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slc9a8 |
solute carrier family 9 member A8 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of SLC9A8 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 3:156,147,855...156,198,497
Ensembl chr 3:156,148,104...156,198,471
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
affects transport decreases expression increases uptake |
ISO EXP |
SLCO1A4 protein affects the transport of ochratoxin A ochratoxin A results in decreased expression of SLCO1A2 mRNA SLCO1A2 protein results in increased uptake of ochratoxin A |
CTD |
PMID:9928634 PMID:19833843 PMID:28532671 PMID:29126803 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Slco1a8 |
solute carrier organic anion transporter family, member 1a8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SLCO1A3 mRNA; ochratoxin A results in decreased expression of SLCO1A3 protein |
CTD |
PMID:12700408 PMID:16251485 PMID:18417182 |
|
NCBI chr 4:174,975,119...175,018,640
Ensembl chr 4:174,975,122...175,014,586
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
increases transport |
ISO |
SLCO1B2 protein results in increased transport of ochratoxin A SLCO1B3 protein results in increased transport of ochratoxin A |
CTD |
PMID:32470353 |
|
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
increases uptake |
ISO |
SLCO2B1 protein results in increased uptake of ochratoxin A |
CTD |
PMID:28532671 |
|
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
|
|
G |
Slfn5 |
schlafen family member 5 |
decreases expression increases methylation |
ISO |
ochratoxin A results in decreased expression of SLFN5 mRNA ochratoxin A results in increased methylation of SLFN5 promoter |
CTD |
PMID:30559759 |
|
NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions increases expression increases response to substance |
ISO |
4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of SMAD2 mRNA]; 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of SMAD2 protein]; ochratoxin A results in increased expression of and results in increased phosphorylation of SMAD2 protein; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 protein] SMAD2 results in increased susceptibility to ochratoxin A |
CTD |
PMID:32617660 PMID:35543154 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
increases expression multiple interactions increases response to substance |
ISO |
ochratoxin A results in increased expression of SMAD3 mRNA 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of SMAD3 mRNA]; 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of SMAD3 protein]; ochratoxin A results in increased expression of and results in increased phosphorylation of SMAD3 protein; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 protein] SMAD3 results in increased susceptibility to ochratoxin A |
CTD |
PMID:32617660 PMID:35543154 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Snrpc |
small nuclear ribonucleoprotein polypeptide C |
increases expression |
EXP |
ochratoxin A results in increased expression of SNRPC mRNA |
CTD |
PMID:18417182 |
|
NCBI chr20:5,888,453...5,906,638
Ensembl chr20:5,888,453...5,906,638
|
|
G |
Snx12 |
sorting nexin 12 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SNX12 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr X:66,226,995...66,356,945
Ensembl chr X:66,227,053...66,356,950
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
multiple interactions |
ISO |
ochratoxin A inhibits the reaction [Antigens results in increased expression of SOCS1 mRNA] |
CTD |
PMID:28935500 |
|
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
multiple interactions |
ISO |
ochratoxin A inhibits the reaction [Antigens results in increased expression of SOCS2 mRNA] |
CTD |
PMID:28935500 |
|
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of SOCS3 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression increases expression |
EXP ISO |
ochratoxin A results in decreased expression of SOD1 mRNA ochratoxin A results in increased expression of SOD1 mRNA |
CTD |
PMID:23358140 PMID:23391613 PMID:27923682 PMID:28710020 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of SOD2 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of SOD3 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sord |
sorbitol dehydrogenase |
increases expression |
ISO |
ochratoxin A results in increased expression of SORD mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
|
|
G |
Sos2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SOS2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:88,042,966...88,156,140
Ensembl chr 6:88,042,966...88,156,692
|
|
G |
Sox10 |
SRY-box transcription factor 10 |
affects expression multiple interactions |
EXP |
ochratoxin A affects the expression of SOX10 mRNA SHH protein inhibits the reaction [ochratoxin A affects the expression of SOX10 mRNA] |
CTD |
PMID:24792326 |
|
NCBI chr 7:110,725,274...110,734,651
Ensembl chr 7:110,725,274...110,735,544
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of SOX2 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of SOX2 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Spaca9 |
sperm acrosome associated 9 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of SPACA9 gene ochratoxin A results in increased expression of SPACA9 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 3:12,019,376...12,028,801
Ensembl chr 3:12,019,363...12,029,119
|
|
G |
Spart |
spartin |
increases expression |
ISO |
ochratoxin A results in increased expression of SPART mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:139,292,630...139,319,248
Ensembl chr 2:139,292,355...139,319,248
|
|
G |
Spast |
spastin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPAST mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 6:21,055,349...21,106,586
Ensembl chr 6:21,055,349...21,107,954
|
|
G |
Spata20 |
spermatogenesis associated 20 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of SPATA20 mRNA [ochratoxin A results in increased acetylation of SPATA20 promoter] which results in increased expression of SPATA20 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:79,427,525...79,435,472
Ensembl chr10:79,427,528...79,434,368
|
|
G |
Spata7 |
spermatogenesis associated 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SPATA7 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 6:117,879,828...117,925,284
Ensembl chr 6:117,879,823...117,925,284
|
|
G |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of SPATS2L mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:59,319,949...59,493,864
Ensembl chr 9:59,320,276...59,493,967
|
|
G |
Spdl1 |
spindle apparatus coiled-coil protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of SPDL1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127
|
|
G |
Spetex2d |
Spetex-2D protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2D mRNA |
CTD |
PMID:30449730 |
|
|
|
G |
Spetex2e |
Spetex-2E protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2E mRNA |
CTD |
PMID:30449730 |
|
NCBI chr15:4,813,644...4,816,793
Ensembl chr15:4,739,331...4,816,815
|
|
G |
Spetex2f |
Spetex-2F protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2F mRNA |
CTD |
PMID:30449730 |
|
NCBI chr15:17,716,315...17,720,203
Ensembl chr15:17,716,358...17,733,744
|
|
G |
Spetex2g |
Spetex-2G protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2G mRNA |
CTD |
PMID:30449730 |
|
NCBI chr15:4,615,554...4,619,166
Ensembl chr15:4,615,466...4,662,812
|
|
G |
Spetex2h |
Spetex-2H protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPETEX2H mRNA |
CTD |
PMID:30449730 |
|
|
|
G |
Sphk1 |
sphingosine kinase 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of SPHK1 mRNA; ochratoxin A results in decreased expression of SPHK1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
|
|
G |
Spock1 |
sparc/osteonectin, cwcv and kazal like domains proteoglycan 1 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of SPOCK1 promoter ochratoxin A results in increased expression of SPOCK1 mRNA [ochratoxin A results in increased acetylation of SPOCK1 promoter] which results in increased expression of SPOCK1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr17:6,741,504...7,221,685
Ensembl chr17:6,742,273...7,224,935
|
|
G |
Spon1 |
spondin 1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of SPON1 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
|
|
G |
Spon2 |
spondin 2 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A metabolite results in increased expression of SPON2 mRNA; ochratoxin A results in increased expression of SPON2 mRNA [ochratoxin A results in increased acetylation of SPON2 promoter] which results in increased expression of SPON2 mRNA |
CTD |
PMID:26314263 PMID:29098329 |
|
NCBI chr14:77,505,695...77,518,001
Ensembl chr14:77,511,901...77,517,996
|
|
G |
Spop |
speckle type BTB/POZ protein |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of SPOP gene |
CTD |
PMID:26431795 |
|
NCBI chr10:80,358,121...80,438,983
Ensembl chr10:80,358,124...80,483,955
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of SPP1 mRNA; ochratoxin A results in increased expression of SPP1 protein |
CTD |
PMID:18308701 PMID:30008028 PMID:30449730 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Spr |
sepiapterin reductase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SPR mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:117,671,948...117,676,292
Ensembl chr 4:117,671,949...117,675,678
|
|
G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SPTBN1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507
|
|
G |
Sqstm1 |
sequestosome 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SQSTM1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of SRC protein |
CTD |
PMID:25002221 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srpk2 |
SRSF protein kinase 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SRPK2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
|
|
G |
Srpra |
SRP receptor subunit alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SRPRA mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SRSF1 protein |
CTD |
PMID:19445961 |
|
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression decreases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of SRXN1 mRNA ochratoxin A results in decreased expression of SRXN1 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA; [Zearalenone co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA |
CTD |
PMID:32905824 PMID:34015425 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Ssu72 |
SSU72 homolog, RNA polymerase II CTD phosphatase |
increases expression |
EXP |
ochratoxin A results in increased expression of SSU72 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 5:166,312,267...166,343,432
Ensembl chr 5:166,313,650...166,343,429
|
|
G |
St13 |
ST13, Hsp70 interacting protein |
increases expression |
ISO |
ochratoxin A results in increased expression of ST13 protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:112,891,007...112,925,727
Ensembl chr 7:112,844,375...112,925,945
|
|
G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of ST3GAL5 mRNA [ochratoxin A results in increased acetylation of ST3GAL5 promoter] which results in increased expression of ST3GAL5 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:104,134,613...104,192,558
Ensembl chr 4:104,134,613...104,192,558
|
|
G |
Stag2 |
STAG2 cohesin complex component |
increases expression |
EXP |
ochratoxin A results in increased expression of STAG2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
|
|
G |
Stam2 |
signal transducing adaptor molecule 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of STAM2 mRNA; ochratoxin A results in decreased expression of STAM2 mRNA |
CTD |
PMID:19287073 PMID:24356939 |
|
NCBI chr 3:37,186,145...37,234,810
Ensembl chr 3:37,186,145...37,234,812
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT1 mRNA |
CTD |
PMID:28935500 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT3 mRNA |
CTD |
PMID:28935500 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA |
CTD |
PMID:28935500 |
|
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stc1 |
stanniocalcin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of STC1 mRNA |
CTD |
PMID:22124623 PMID:30559759 |
|
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Stra6 |
signaling receptor and transporter of retinol STRA6 |
increases expression |
EXP |
ochratoxin A results in increased expression of STRA6 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
|
|
G |
Stx3 |
syntaxin 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of STX3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:208,617,018...208,686,240
Ensembl chr 1:208,639,115...208,685,805
|
|
G |
Stx7 |
syntaxin 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of STX7 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of SULT1A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Sult1c2a |
sulfotransferase family 1C member 2A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of SULT1C2A mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734
|
|
G |
Supt16h |
SPT16 homolog, facilitates chromatin remodeling subunit |
increases expression |
EXP |
ochratoxin A results in increased expression of SUPT16H mRNA |
CTD |
PMID:17483316 |
|
NCBI chr15:24,867,697...24,904,818
Ensembl chr15:24,866,489...24,904,846
|
|
G |
Syk |
spleen associated tyrosine kinase |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of SYK mRNA; ochratoxin A results in increased expression of SYK mRNA |
CTD |
PMID:26314263 |
|
NCBI chr17:12,604,615...12,678,437
Ensembl chr17:12,604,619...12,661,410
|
|
G |
Syvn1 |
synoviolin 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of SYVN1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
|
|
G |
Tacc2 |
transforming, acidic coiled-coil containing protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of TACC2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:185,139,223...185,327,881
Ensembl chr 1:185,116,111...185,327,881
|
|
G |
Taf9 |
TATA-box binding protein associated factor 9 |
increases expression |
EXP |
ochratoxin A results in increased expression of TAF9 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:31,794,316...31,798,324
Ensembl chr 2:31,794,142...31,798,769
|
|
G |
Tagln2 |
transgelin 2 |
affects expression |
ISO |
ochratoxin A affects the expression of TAGLN2 protein |
CTD |
PMID:26861962 |
|
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
|
|
G |
Tagln3 |
transgelin 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of TAGLN3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:55,099,887...55,113,457
Ensembl chr11:55,099,743...55,113,485
|
|
G |
Tardbp |
TAR DNA binding protein |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TARDBP mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
G |
Tars1 |
threonyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
|
|
G |
Tbc1d1 |
TBC1 domain family member 1 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of TBC1D1 gene |
CTD |
PMID:26431795 |
|
NCBI chr14:43,936,820...44,135,133
Ensembl chr14:43,935,636...44,136,499
|
|
G |
Tbc1d5 |
TBC1 domain family, member 5 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of TBC1D5 gene |
CTD |
PMID:26431795 |
|
NCBI chr 9:3,503,328...4,017,131
Ensembl chr 9:3,513,623...4,016,913
|
|
G |
Tbx10 |
T-box transcription factor 10 |
increases expression |
EXP |
ochratoxin A results in increased expression of TBX10 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 1:201,285,729...201,292,676
Ensembl chr 1:201,279,829...201,292,601
|
|
G |
Tcf3 |
transcription factor 3 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of TCF3 gene |
CTD |
PMID:26431795 |
|
NCBI chr 7:9,280,571...9,302,315
Ensembl chr 7:9,280,571...9,302,314
|
|
G |
Tdg |
thymine-DNA glycosylase |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of TDG promoter [ochratoxin A results in decreased acetylation of TDG promoter] which results in decreased expression of TDG mRNA ochratoxin A results in decreased expression of TDG mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
|
|
G |
Tesk2 |
testis associated actin remodelling kinase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of TESK2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:130,178,715...130,270,594
Ensembl chr 5:130,185,033...130,271,292
|
|
G |
Tf |
transferrin |
increases expression |
EXP |
ochratoxin A results in increased expression of TF mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tfam |
transcription factor A, mitochondrial |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TFAM mRNA |
CTD |
PMID:34481902 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tfdp2 |
transcription factor Dp-2 |
multiple interactions decreases acetylation decreases expression |
ISO |
[ochratoxin A results in decreased acetylation of TFDP2 promoter] which results in decreased expression of TFDP2 mRNA ochratoxin A results in decreased expression of TFDP2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of TGFB1 mRNA [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TGFB1 protein ochratoxin A results in increased expression of TGFB1 mRNA; ochratoxin A results in increased expression of TGFB1 protein |
CTD |
PMID:23358140 PMID:28710020 PMID:30876885 PMID:32617660 PMID:33543323 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
increases expression multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of TGFB2 mRNA ochratoxin A metabolite results in increased expression of TGFB2 mRNA; ochratoxin A results in increased expression of TGFB2 mRNA NFE2L2 protein affects the reaction [ochratoxin A results in decreased expression of TGFB2 mRNA] |
CTD |
PMID:23208426 PMID:23358140 PMID:26314263 PMID:28710020 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of TGFBR1 mRNA; ochratoxin A results in increased expression of TGFBR1 protein |
CTD |
PMID:32617660 PMID:35543154 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions decreases activity |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased activity of THRB protein ochratoxin A results in decreased activity of THRB protein |
CTD |
PMID:27481073 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of THY1 mRNA; ochratoxin A results in decreased expression of THY1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TICAM1 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Timm10b |
translocase of inner mitochondrial membrane 10B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TIMM10B mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:159,980,525...159,983,371
Ensembl chr 1:159,980,484...159,981,642
|
|
G |
Timm22 |
translocase of inner mitochondrial membrane 22 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TIMM22 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:61,253,459...61,261,217
Ensembl chr10:61,253,450...61,261,755
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of TIMP1 mRNA; ochratoxin A results in increased expression of TIMP1 protein |
CTD |
PMID:16622519 PMID:18308701 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions increases acetylation increases expression |
ISO |
[NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TIMP2 mRNA ochratoxin A results in increased acetylation of TIMP2 promoter ochratoxin A results in increased expression of TIMP2 mRNA [ochratoxin A results in increased acetylation of TIMP2 promoter] which results in increased expression of TIMP2 mRNA |
CTD |
PMID:28710020 PMID:29098329 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TIMP3 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
ISO |
ochratoxin A results in decreased expression of and affects the localization of TJP1 protein |
CTD |
PMID:30763683 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tmco6 |
transmembrane and coiled-coil domains 6 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of TMCO6 mRNA; ochratoxin A results in decreased expression of TMCO6 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr18:28,349,248...28,355,843
Ensembl chr18:28,349,248...28,355,843
|
|
G |
Tmem177 |
transmembrane protein 177 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of TMEM177 mRNA; ochratoxin A results in decreased expression of TMEM177 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
|
|
G |
Tmem236 |
transmembrane protein 236 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TMEM236 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr17:77,180,919...77,241,258
Ensembl chr17:77,188,163...77,238,671
|
|
G |
Tmem35a |
transmembrane protein 35A |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of TMEM35A mRNA ochratoxin A results in decreased methylation of TMEM35A gene |
CTD |
PMID:37162024 |
|
NCBI chr X:97,503,350...97,514,198
Ensembl chr X:97,503,350...97,514,197
|
|
G |
Tmem37 |
transmembrane protein 37 |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of TMEM37 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr13:31,184,322...31,191,477
Ensembl chr13:31,171,355...31,191,077
|
|
G |
Tmem42 |
transmembrane protein 42 |
increases methylation decreases expression |
EXP |
ochratoxin A results in increased methylation of TMEM42 gene ochratoxin A results in decreased expression of TMEM42 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 8:122,674,793...122,677,290
Ensembl chr 8:122,674,070...122,677,276
|
|
G |
Tmem50b |
transmembrane protein 50B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TMEM50B mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:30,804,835...30,837,675
Ensembl chr11:30,804,837...30,837,661
|
|
G |
Tmem67 |
transmembrane protein 67 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of TMEM67 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 5:25,536,458...25,589,378
Ensembl chr 5:25,536,458...25,589,334
|
|
G |
Tmigd1 |
transmembrane and immunoglobulin domain containing 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TMIGD1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:61,739,071...61,751,025
Ensembl chr10:61,736,462...61,751,025
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
[ochratoxin A co-treated with Citrinin] results in increased expression of TNF mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of TNF protein; ochratoxin A inhibits the reaction [TNF protein results in increased expression of F3 protein]; pyrazolanthrone inhibits the reaction [[ochratoxin A co-treated with Citrinin] results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [ochratoxin A results in increased expression of TNF protein]; U 0126 inhibits the reaction [[ochratoxin A co-treated with Citrinin] results in increased expression of TNF mRNA] ochratoxin A results in increased expression of TNF mRNA ochratoxin A results in increased expression of TNF mRNA; ochratoxin A results in increased expression of TNF protein [Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of TNF protein; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of TNF protein |
CTD |
PMID:18289624 PMID:24792326 PMID:25532488 PMID:27193732 PMID:28935500 PMID:29673704 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip1 |
TNF alpha induced protein 1 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of TNFAIP1 mRNA ochratoxin A results in decreased expression of TNFAIP1 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:63,417,774...63,432,466
Ensembl chr10:63,417,775...63,432,466
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
multiple interactions increases acetylation increases expression decreases expression |
ISO |
[ochratoxin A results in increased acetylation of TNFAIP3 promoter] which results in increased expression of TNFAIP3 mRNA ochratoxin A results in increased expression of TNFAIP3 mRNA ochratoxin A results in decreased expression of TNFAIP3 mRNA |
CTD |
PMID:29098329 PMID:30559759 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfrsf12a |
TNF receptor superfamily member 12A |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of TNFRSF12A mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of TNFRSF12A mRNA |
CTD |
PMID:30428381 |
|
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
increases expression decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of TNFRSF1A mRNA ochratoxin A results in decreased expression of TNFRSF1A mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of TNFRSF1A mRNA |
CTD |
PMID:17316727 PMID:19562491 PMID:30428381 PMID:30763683 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfsf9 |
TNF superfamily member 9 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TNFSF9 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
|
|
G |
Tomm70 |
translocase of outer mitochondrial membrane 70 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TOMM70 protein |
CTD |
PMID:26861962 |
|
NCBI chr11:43,378,719...43,417,166
Ensembl chr11:43,377,216...43,417,202
|
|
G |
Top2a |
DNA topoisomerase II alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of TOP2A mRNA; ochratoxin A results in increased expression of TOP2A protein |
CTD |
PMID:19237604 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Topbp1 |
DNA topoisomerase II binding protein 1 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of TOPBP1 promoter [ochratoxin A results in decreased acetylation of TOPBP1 promoter] which results in decreased expression of TOPBP1 mRNA ochratoxin A results in decreased expression of TOPBP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
|
|
G |
Tp53 |
tumor protein p53 |
increases expression increases phosphorylation decreases response to substance decreases expression multiple interactions increases response to substance |
ISO EXP |
ochratoxin A results in increased expression of TP53 mRNA; ochratoxin A results in increased expression of TP53 protein ochratoxin A results in increased phosphorylation of TRP53 protein TRP53 protein results in decreased susceptibility to ochratoxin A ochratoxin A results in decreased expression of TP53 ochratoxin A results in increased expression of and results in increased phosphorylation of TP53 protein; TP53 mutant form inhibits the reaction [ochratoxin A results in decreased expression of RAD51] ochratoxin A results in increased expression of TRP53 protein TRP53 gene mutant form inhibits the reaction [ochratoxin A results in increased expression of CDKN1A mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of AURKA mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CCNE1 mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CDK1 mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of PKMYT1 mRNA]; TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of PLK1 mRNA] TRP53 gene mutant form results in increased susceptibility to ochratoxin A |
CTD |
PMID:19367635 PMID:19445961 PMID:19562491 PMID:23208426 PMID:23261758 PMID:24525463 PMID:25218026 PMID:25636497 PMID:28286205 PMID:31154016 PMID:32910239 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TP53INP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
|
|
G |
Tph2 |
tryptophan hydroxylase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of TPH2 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 7:50,685,694...50,789,424
Ensembl chr 7:50,685,694...50,789,424
|
|
G |
Tpk1 |
thiamin pyrophosphokinase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of TERF2IP mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:72,170,134...72,557,707
Ensembl chr 4:72,170,134...72,557,694
|
|
G |
Tpm3 |
tropomyosin 3 |
increases expression decreases expression |
ISO EXP |
ochratoxin A results in increased expression of TPM3 mRNA ochratoxin A results in decreased expression of TPM3 protein |
CTD |
PMID:22124623 PMID:31369848 |
|
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
|
|
G |
Tpm4 |
tropomyosin 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TPM4 protein |
CTD |
PMID:31369848 |
|
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRAF6 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Trak1 |
trafficking kinesin protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRAK1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:120,984,445...121,139,357
Ensembl chr 8:120,984,431...121,139,367
|
|
G |
Trak2 |
trafficking kinesin protein 2 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of TRAK2 promoter [ochratoxin A results in decreased acetylation of TRAK2 promoter] which results in decreased expression of TRAK2 mRNA ochratoxin A results in decreased expression of TRAK2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 9:60,348,531...60,414,036
Ensembl chr 9:60,350,012...60,413,996
|
|
G |
Trap1 |
TNF receptor-associated protein 1 |
multiple interactions decreases expression |
ISO |
Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of TRAP1 protein]; TRAP1 protein affects the reaction [ochratoxin A results in decreased expression of BCL2 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of BAX protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of CYCS protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of DDIT3 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of HSPA5 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein]]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of TRAP1 protein]]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein]]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein]]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]] |
CTD |
PMID:33465424 |
|
NCBI chr10:11,464,882...11,498,931
Ensembl chr10:11,464,821...11,498,981
|
|
G |
Triap1 |
TP53 regulated inhibitor of apoptosis 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRIAP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression multiple interactions decreases expression decreases acetylation |
EXP ISO |
ochratoxin A results in increased expression of TRIB3 mRNA [ochratoxin A results in decreased acetylation of TRIB3 promoter] which results in decreased expression of TRIB3 mRNA ochratoxin A results in decreased expression of TRIB3 mRNA |
CTD |
PMID:23358140 PMID:29098329 PMID:30008028 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Trim24 |
tripartite motif-containing 24 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRIM24 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:66,567,342...66,692,029
Ensembl chr 4:66,566,686...66,717,241
|
|
G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TRPM8 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:88,897,039...88,990,167
Ensembl chr 9:88,903,880...88,988,552
|
|
G |
Trrap |
transformation/transcription domain-associated protein |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TRRAP mRNA |
CTD |
PMID:19287073 |
|
NCBI chr12:9,738,006...9,827,708
Ensembl chr12:9,738,006...9,827,674
|
|
G |
Tsc2 |
TSC complex subunit 2 |
increases response to substance |
EXP |
TSC2 gene mutant form results in increased susceptibility to ochratoxin A |
CTD |
PMID:17483316 |
|
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Tsnax |
translin-associated factor X |
multiple interactions decreases expression decreases acetylation |
ISO |
[ochratoxin A results in decreased acetylation of TSNAX promoter] which results in decreased expression of TSNAX mRNA ochratoxin A results in decreased expression of TSNAX mRNA |
CTD |
PMID:29098329 |
|
NCBI chr19:52,975,848...52,989,886
Ensembl chr19:52,975,659...52,989,878
|
|
G |
Tspoap1 |
TSPO associated protein 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of TSPOAP1 mRNA; ochratoxin A results in increased expression of TSPOAP1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412
|
|
G |
Tubal3 |
tubulin, alpha-like 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TUBAL3 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:66,323,733...66,332,423
Ensembl chr17:66,323,733...66,335,355
|
|
G |
Tubb1 |
tubulin, beta 1 class VI |
decreases expression |
ISO |
ochratoxin A results in decreased expression of TUBB1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 3:163,247,990...163,257,460
Ensembl chr 3:163,247,967...163,256,063
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
increases expression |
EXP |
ochratoxin A results in increased expression of TUBB5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
|
|
G |
Twf1 |
twinfilin actin-binding protein 1 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of TWF1 promoter [ochratoxin A results in decreased acetylation of TWF1 promoter] which results in decreased expression of TWF1 mRNA ochratoxin A results in decreased expression of TWF1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:125,715,938...125,727,834
Ensembl chr 7:125,716,015...125,727,894
|
|
G |
Txn2 |
thioredoxin 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of TXN2 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txnip |
thioredoxin interacting protein |
multiple interactions increases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of TXNIP mRNA; [Zearalenone co-treated with ochratoxin A] results in increased expression of TXNIP mRNA ochratoxin A results in increased expression of TXNIP mRNA |
CTD |
PMID:34015425 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of TXNRD1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of UBA1 protein |
CTD |
PMID:26861962 |
|
NCBI chr X:1,508,700...1,530,677
Ensembl chr X:1,508,666...1,530,636
|
|
G |
Ubap2l |
ubiquitin associated protein 2-like |
increases expression |
ISO |
ochratoxin A results in increased expression of UBAP2L mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:175,438,703...175,494,085
Ensembl chr 2:175,438,703...175,493,998
|
|
G |
Ubb |
ubiquitin B |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of UBB mRNA; ochratoxin A results in decreased expression of UBB mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
|
|
G |
Ubd |
ubiquitin D |
increases expression |
EXP |
ochratoxin A results in increased expression of UBD mRNA |
CTD |
PMID:23208426 |
|
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
|
|
G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
increases expression |
EXP |
ochratoxin A results in increased expression of UBE2C mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
|
|
G |
Ube2l3 |
ubiquitin-conjugating enzyme E2L 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of UBE2L3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:83,797,722...83,838,862
Ensembl chr11:83,797,722...83,838,862
|
|
G |
Ube2q1 |
ubiquitin conjugating enzyme E2 Q1 |
increases expression |
EXP |
ochratoxin A results in increased expression of UBE2Q1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:175,198,793...175,209,152
Ensembl chr 2:175,198,873...175,207,942
|
|
G |
Ucp1 |
uncoupling protein 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of UCP1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
|
|
G |
Ucp2 |
uncoupling protein 2 |
decreases expression increases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of UCP2 mRNA ochratoxin A results in increased expression of UCP2 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A] results in increased expression of UCP2 mRNA |
CTD |
PMID:17316727 PMID:19287073 PMID:22124623 PMID:34015425 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Ucp3 |
uncoupling protein 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of UCP3 mRNA |
CTD |
PMID:17316727 PMID:22124623 |
|
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of UGDH mRNA |
CTD |
PMID:32905824 |
|
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases expression |
ISO |
ochratoxin A results in increased expression of UGT1A6 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of UGT2B7 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Unc13d |
unc-13 homolog D |
increases expression |
EXP |
ochratoxin A results in increased expression of UNC13D mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:101,296,755...101,311,513
Ensembl chr10:101,296,776...101,311,687
|
|
G |
Upb1 |
beta-ureidopropionase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of UPB1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
|
|
G |
Upf3b |
UPF3B, regulator of nonsense mediated mRNA decay |
decreases expression |
ISO |
ochratoxin A results in decreased expression of UPF3B mRNA |
CTD |
PMID:22124623 |
|
NCBI chr X:116,335,308...116,353,332
Ensembl chr X:116,335,308...116,353,236
|
|
G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
increases expression |
ISO |
ochratoxin A results in increased expression of UQCR11 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
|
|
G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
increases expression |
ISO |
ochratoxin A results in increased expression of UQCRH mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 5:129,545,978...129,554,173
Ensembl chr 5:129,545,984...129,554,242
|
|
G |
Uqcrq |
ubiquinol-cytochrome c reductase, complex III subunit VII |
increases expression |
ISO |
ochratoxin A results in increased expression of UQCRQ mRNA |
CTD |
PMID:17316727 |
|
NCBI chr10:37,585,864...37,589,328
Ensembl chr10:37,586,888...37,589,169
|
|
G |
Uxt |
ubiquitously-expressed, prefoldin-like chaperone |
decreases expression |
EXP |
ochratoxin A results in decreased expression of UXT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr X:1,126,110...1,138,670
Ensembl chr X:1,126,162...1,138,663
|
|
G |
Vars1 |
valyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr20:3,805,774...3,820,468
Ensembl chr20:3,805,776...3,820,298
|
|
G |
Vat1 |
vesicle amine transport 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VAT1 protein |
CTD |
PMID:26861962 |
|
NCBI chr10:86,389,549...86,397,167
Ensembl chr10:86,389,545...86,397,224
|
|
G |
Vav3 |
vav guanine nucleotide exchange factor 3 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of VAV3 mRNA; ochratoxin A results in increased expression of VAV3 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 2:197,011,901...197,354,321
Ensembl chr 2:197,011,831...197,354,321
|
|
G |
Vcp |
valosin-containing protein |
increases expression |
ISO |
ochratoxin A results in increased expression of VCP protein |
CTD |
PMID:19445961 |
|
NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VDAC1 mRNA |
CTD |
PMID:34748853 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions decreases expression affects expression |
ISO |
EPAS1 protein inhibits the reaction [ochratoxin A results in decreased expression of VEGFA protein]; Oxygen deficiency inhibits the reaction [ochratoxin A results in decreased expression of VEGFA protein] ochratoxin A results in decreased expression of VEGFA mRNA [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA mRNA; [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA protein ochratoxin A affects the expression of VEGFA mRNA |
CTD |
PMID:21554934 PMID:28710020 PMID:30876885 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of VIM protein ochratoxin A results in increased expression of VIM; ochratoxin A results in increased expression of VIM mRNA; ochratoxin A results in increased expression of VIM protein [ochratoxin A co-treated with Citrinin] results in decreased expression of VIM mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of VIM protein |
CTD |
PMID:15994020 PMID:18308701 PMID:19445961 PMID:25218026 PMID:29673704 PMID:31369848 PMID:33543323 More...
|
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vldlr |
very low density lipoprotein receptor |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VLDLR mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
|
|
G |
Vnn1 |
vanin 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of VNN1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
|
|
G |
Vom1r6 |
vomeronasal 1 receptor 6 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of VOM1R6 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:59,826,557...59,830,125
Ensembl chr 1:59,815,362...59,833,596
|
|
G |
Vps50 |
VPS50 subunit of EARP/GARPII complex |
decreases expression |
ISO |
ochratoxin A results in decreased expression of VPS50 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:31,484,424...31,585,617
Ensembl chr 4:31,484,463...31,585,617
|
|
G |
Wdr33 |
WD repeat domain 33 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of WDR33 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr18:23,432,233...23,535,460
Ensembl chr18:23,432,191...23,468,597
|
|
G |
Wdr46 |
WD repeat domain 46 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of WDR46 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr20:4,937,845...4,945,796
Ensembl chr20:4,937,847...4,946,535
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of WEE1 mRNA ochratoxin A results in decreased expression of WEE1 mRNA |
CTD |
PMID:23358140 PMID:24243707 PMID:30763683 |
|
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
|
|
G |
Wipf1 |
WAS/WASL interacting protein family, member 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of WIPF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:58,314,521...58,416,668
Ensembl chr 3:58,314,542...58,372,742
|
|
G |
Wnt1 |
Wnt family member 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of WNT1 mRNA |
CTD |
PMID:32617660 |
|
NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651
|
|
G |
Wnt7b |
Wnt family member 7B |
increases expression |
ISO |
ochratoxin A results in increased expression of WNT7B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
|
|
G |
Wwp1 |
WW domain containing E3 ubiquitin protein ligase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of WWP1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:33,092,379...33,185,887
Ensembl chr 5:33,098,494...33,186,046
|
|
G |
Xaf1 |
XIAP associated factor 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of XAF1 mRNA; ochratoxin A results in decreased expression of XAF1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
|
|
G |
Xbp1 |
X-box binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of XBP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xdh |
xanthine dehydrogenase |
increases expression decreases expression |
ISO |
ochratoxin A results in increased expression of XDH mRNA ochratoxin A results in decreased expression of XDH mRNA |
CTD |
PMID:17316727 PMID:30559759 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of XRCC5 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of XRCC6 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
|
|
G |
Yap1 |
Yes1 associated transcriptional regulator |
increases expression |
EXP |
ochratoxin A results in increased expression of YAP1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
|
|
G |
Yars1 |
tyrosyl-tRNA synthetase 1 |
increases methylation decreases expression |
ISO |
ochratoxin A results in increased methylation of YARS1 promoter ochratoxin A results in decreased expression of YARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
|
|
G |
Ywhab |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
decreases expression |
EXP |
ochratoxin A results in decreased expression of YWHAB protein |
CTD |
PMID:31369848 |
|
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
|
|
G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
decreases expression |
EXP |
ochratoxin A results in decreased expression of YWHAZ protein |
CTD |
PMID:31369848 |
|
NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
|
|
G |
Zbtb18 |
zinc finger and BTB domain containing 18 |
multiple interactions decreases expression decreases acetylation |
ISO |
[ochratoxin A results in decreased acetylation of ZBTB18 promoter] which results in decreased expression of ZBTB18 mRNA ochratoxin A results in decreased expression of ZBTB18 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr13:89,439,501...89,447,958
Ensembl chr13:89,439,420...89,448,862
|
|
G |
Zbtb4 |
zinc finger and BTB domain containing 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ZBTB4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:54,480,698...54,501,492
Ensembl chr10:54,485,071...54,501,492
|
|
G |
Zfp148 |
zinc finger protein 148 |
increases expression |
ISO |
ochratoxin A results in increased expression of ZNF148 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:67,276,455...67,385,803
Ensembl chr11:67,281,707...67,385,772
|
|
G |
Zfp213 |
zinc finger protein 213 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of ZFP213 gene |
CTD |
PMID:26431795 |
|
NCBI chr10:12,592,368...12,599,296
Ensembl chr10:12,592,368...12,599,281
|
|
G |
Zfp518a |
zinc finger protein 518A |
multiple interactions decreases expression decreases acetylation |
ISO |
[ochratoxin A results in decreased acetylation of ZNF518A promoter] which results in decreased expression of ZNF518A mRNA ochratoxin A results in decreased expression of ZNF518A mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:239,719,305...239,744,978
Ensembl chr 1:239,719,505...239,744,979
|
|
G |
Zfp628 |
zinc finger protein 628 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ZNF628 mRNA; ochratoxin A results in decreased expression of ZNF628 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:68,913,600...68,921,186
Ensembl chr 1:68,910,401...68,921,243
|
|
G |
Zfp652 |
zinc finger protein 652 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ZNF652 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr10:80,626,555...80,706,397
Ensembl chr10:80,649,400...80,698,674
|
|
G |
Zmat3 |
zinc finger, matrin type 3 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of ZMAT3 mRNA ochratoxin A results in decreased expression of ZMAT3 mRNA |
CTD |
PMID:23358140 PMID:30559759 |
|
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
|
|
G |
Zmym3 |
zinc finger MYM-type containing 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ZMYM3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr X:66,528,585...66,544,234
Ensembl chr X:66,528,585...66,544,782
|
|
G |
Zzz3 |
zinc finger, ZZ-type containing 3 |
multiple interactions decreases expression decreases acetylation |
ISO |
[ochratoxin A results in decreased acetylation of ZZZ3 promoter] which results in decreased expression of ZZZ3 mRNA ochratoxin A results in decreased expression of ZZZ3 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:241,330,366...241,397,308
Ensembl chr 2:241,331,022...241,397,307
|
|